Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
Resident Posters
Home
Resident Posters
All Days
Wed, Dec 6
Resident Posters
Type here to filter the list
Wednesday, December 6, 2023
8:30 AM – 9:30 AM
(9-001) Medication Use Evaluation of Preoperative Vancomycin in Orthopedic Surgery Patients
Favorite
8:30 AM – 9:30 AM
(9-002) Medication Use Evaluation of Angiotensin ll
Favorite
8:30 AM – 9:30 AM
(9-003) Evaluation of Pharmacy and Social Work Interventions Made Within an Innovative, Ambulatory Care-Based Transitions of Care Service
Favorite
8:30 AM – 9:30 AM
(9-004) Evaluation of the impact of the addition of group education to an established employer-based weight loss service
Favorite
8:30 AM – 9:30 AM
(9-005) Assessment of the impact of a pharmacist-led pharmacogenomics service on statin utilization in Veterans with risk factors for ASCVD
Favorite
8:30 AM – 9:30 AM
(9-006) Alabama Pharmacist Confidence, Comfort, and Experience Screening for and Addressing Adverse Social Determinants of Health
Favorite
8:30 AM – 9:30 AM
(9-007) Dupixent Utilization in a Community-based Specialty Pharmacy—A Retrospective Chart Review
Favorite
8:30 AM – 9:30 AM
(9-008) Carbapenem Use Evaluation within the Baptist Health System
Favorite
8:30 AM – 9:30 AM
(9-009) The Appropriateness of Unfractionated Heparin Titrations Using a Heparin Infusion Protocol at a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-010) Evaluation of Epoetin Alfa
Favorite
8:30 AM – 9:30 AM
(9-011) Evaluation of Antibiotic Prophylaxis for Open Fractures at a Large Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-012) Evaluation of Piperacillin-Tazobactam Usage in a Large Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-013) Evaluating the Use of Midazolam Continuous Infusions in Intensive Care Units at a Large Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-014) Comparison of Antivenins Used for the Treatment of North American Pit Viper Envenomation at a Large Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-015) Evaluation of Fluid Bolus Volume for Sepsis and Septic Shock in the Emergency Department and the Effect on Patient Outcomes
Favorite
8:30 AM – 9:30 AM
(9-016) Comparing Two-Dose 1500 mg Dalbavancin to Standard of Care in the Outpatient Treatment of Invasive Gram-Positive Infections
Favorite
8:30 AM – 9:30 AM
(9-017) Evaluation of Pharmacist-Driven Nursing Protocol Changes and Education in Heparin Infusion Management
Favorite
8:30 AM – 9:30 AM
(9-018) Evaluation of Inpatient Alcohol Withdrawal Treatment Utilizing the Minnesota Detoxification Scale Monitoring Protocol
Favorite
8:30 AM – 9:30 AM
(9-019) Evaluation of Eravacycline Use in a Community Teaching Hospital
Favorite
8:30 AM – 9:30 AM
(9-020) Evaluation of Potassium Electrolyte Protocol Changes from the 2022 Update
Favorite
8:30 AM – 9:30 AM
(9-021) Evaluation of Micafungin Utilization at a Large Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-022) Pharmacist Driven Reduction of Medications Automatically Verified in the Emergency Department at a Large Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-023) Evaluation of Adverse Events with IV Iron Infusion Products in a Large Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-024) Evaluation of the safety and efficacy of activated prothrombin complex concentrate for the reversal of oral anticoagulant agents
Favorite
8:30 AM – 9:30 AM
(9-025) Evaluation of Nitroglycerin Initiated in the Emergency Department of a Large Community Health System for the Treatment of Sympathetic Crashing Acute Pulmonary Edema
Favorite
8:30 AM – 9:30 AM
(9-026) Evaluation of Inpatient Loop Diuretic Dosing Strategies for Patients on Chronic Diuretic Therapy
Favorite
8:30 AM – 9:30 AM
(9-027) Condensed versus Standard High Dose Cytarabine Consolidation Dosing Schedules in Acute Myeloid Leukemia
Favorite
8:30 AM – 9:30 AM
(9-028) Increasing the Presence of an Emergency Medicine Pharmacist in the Management of Sepsis
Favorite
8:30 AM – 9:30 AM
(9-029) Risk Factors for Community-Acquired and Hospital-Onset Isolation of Extended-Spectrum β-Lactamase Producing Enterobacterales at a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-030) Evaluation of Diabetic Ketoacidosis Management in a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-031) Timing of Dexmedetomidine Initiation on Development of New-Onset Atrial Fibrillation in the Medical Intensive Care Unit of a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-032) Effect of a Pharmacist on Post-Intubation Sedation in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-033) Evaluation of Opiate Usage for Acute Non-surgical Pain
Favorite
8:30 AM – 9:30 AM
(9-034) Outcomes Associated With Sodium Bicarbonate Administration During In-hospital Cardiac Arrest
Favorite
8:30 AM – 9:30 AM
(9-035) Characteristics of Antimicrobial-Related Medication Safety Incidents
Favorite
8:30 AM – 9:30 AM
(9-036) How does the Initial Loop Diuretic Dose in Acute Decompensated Heart Failure Affect Time to Decongestion?
Favorite
8:30 AM – 9:30 AM
(9-037) Assessment of Midodrine Initiation and Vasopressor Liberation in Patients with Septic Shock in a Community-Teaching Hospital
Favorite
8:30 AM – 9:30 AM
(9-038) Characterizing the empiric use of anti-pseudomonal beta-lactams in a community teaching hospital
Favorite
8:30 AM – 9:30 AM
(9-039) Evaluation of efficacy and safety outcomes between labetalol and hydralazine in acute blood pressure management
Favorite
8:30 AM – 9:30 AM
(9-040) Medicare Annual Wellness Visit Quality Measures and Provider Reimbursement: A Comparison of In-Person and Telehealth Modalities
Favorite
8:30 AM – 9:30 AM
(9-041) Evaluating the Usage and Titration of Glucagon-like Peptide-1 Receptor Agonists in Patients with Uncontrolled Type 2 Diabetes Mellitus
Favorite
8:30 AM – 9:30 AM
(9-042) Timing of VTE Prophylaxis After Neurosurgical Intervention for Traumatic Brain Injury
Favorite
8:30 AM – 9:30 AM
(9-043) Impact of MRSA Nasal PCR Screening on De-escalation of Anti-MRSA Therapy in Pneumonia at an Academic Medical Center
Favorite
8:30 AM – 9:30 AM
(9-044) Effect of midodrine versus droxidopa on time to intravenous vasopressor discontinuation in patients with hypotension in the Intensive Care Unit (ICU)
Favorite
8:30 AM – 9:30 AM
(9-045) Pre-post analysis of clinical safety outcomes for extended stability intrathecal chemotherapy preparations in adult and pediatric patients
Favorite
8:30 AM – 9:30 AM
(9-046) Impact of the removal of antibiotics from Emergency Department Auto-verification on the delivery of therapy
Favorite
8:30 AM – 9:30 AM
(9-047) Impact of an Ambulatory Care Pharmacist in a Pediatric Outpatient Clinic
Favorite
8:30 AM – 9:30 AM
(9-048) Potassium Replacement Protocol Efficacy within Banner Health
Favorite
8:30 AM – 9:30 AM
(9-049) Evaluation of a Weight-Based and Anti-Factor Xa Guided Enoxaparin Dosing Protocol in Adult Trauma Patients
Favorite
8:30 AM – 9:30 AM
(9-050) Characterization of Midodrine Utilization in Reducing Vasopressor Duration in the Adult Critical Care Population
Favorite
8:30 AM – 9:30 AM
(9-051) Evaluation of Time of Order Entry to Administration Time of Intravenous Push Levetiracetam Versus Intravenous Piggyback Levetiracetam
Favorite
8:30 AM – 9:30 AM
(9-052) Pharmacologic Management of Carbapenem-resistant Enterobacterales Across Banner Health
Favorite
8:30 AM – 9:30 AM
(9-053) Evaluating Antibiotic Utilization for Sinusitis in Ambulatory, Emergency, and Urgent Care Settings
Favorite
8:30 AM – 9:30 AM
(9-054) Clinical Outcomes in Obese vs Non-Obese Patients on a Heparin Infusion: A Multicenter Academic Retrospective Review
Favorite
8:30 AM – 9:30 AM
(9-055) Evaluation of Ketamine use for Acute Pain in the Emergency Department of a Rural Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-056) The Effect of Pre-Hospital Ketamine on Intubation Rates in Low-Severity and Non-Injured Trauma Patients
Favorite
8:30 AM – 9:30 AM
(9-057) Evaluation of Venous Thromboembolism Prophylaxis (VTE) Dosing in Low Body Weight Trauma Patients
Favorite
8:30 AM – 9:30 AM
(9-058) Utilization of Anti-Xa Levels in Lung Transplant Recipients on Apixaban (ULTRA)
Favorite
8:30 AM – 9:30 AM
(9-059) Evaluation of Efficacy and Safety of an Insulin Infusion Protocol for the Management of Severe Hypertriglyceridemia
Favorite
8:30 AM – 9:30 AM
(9-060) Implementation of a Nurse Initiated Protocol to Improve Enteral Medication Administration Documentation in Stroke Patients
Favorite
8:30 AM – 9:30 AM
(9-061) Risk Factors for Venous Thromboembolism in Trauma Patients, Optimizing the Use of Enoxaparin
Favorite
8:30 AM – 9:30 AM
(9-062) Trends in Non-Formulary Medication Requests - A Retrospective, Multicenter, Observational Study
Favorite
8:30 AM – 9:30 AM
(9-063) Evaluation of Systemic Heparin Infusion Management with Percutaneous Ventricular Assist Devices: A Comparison of Purge Fluids
Favorite
8:30 AM – 9:30 AM
(9-064) Analyzing Iron Replacement Therapy at Kingman Regional Medical Center
Favorite
8:30 AM – 9:30 AM
(9-065) Evaluation of Cefdinir Use and Patient Outcomes
Favorite
8:30 AM – 9:30 AM
(9-066) Evaluating internal approaches to increase prescription capture rate at a 340B federally qualified health center pharmacy
Favorite
8:30 AM – 9:30 AM
(9-067) Evaluation of Impact of Text Messages for Clinical Assessment Among Patients with Multiple Sclerosis
Favorite
8:30 AM – 9:30 AM
(9-068) Utilization of Predictive Analytics to Target Clinical Interventions: Addressing Barriers to Adherence in Patients with Multiple Sclerosis at a Large Mail-Order Specialty Pharmacy
Favorite
8:30 AM – 9:30 AM
(9-069) Impact of an Alternative Ordering Method, Schedule My Fill, on Medication Adherence and Persistence Among Patients with Multiple Sclerosis at a Large Mail-Order Specialty Pharmacy
Favorite
8:30 AM – 9:30 AM
(9-070) Impact of Automated Financial Assistance Enrollment at a Large Mail Order Specialty Pharmacy on Patient Outcomes
Favorite
8:30 AM – 9:30 AM
(9-072) Revised Workflow for Pharmacist-Led Hepatitis C Treatment Program at a Federally Qualified Health Center
Favorite
8:30 AM – 9:30 AM
(9-073) Deprescribing warfarin in favor of initiating a direct oral anticoagulant to improve medication therapy and streamline patient care in a Federally Qualified Health Center
Favorite
8:30 AM – 9:30 AM
(9-074) A Retrospective review of the utilization and evaluation of a revised nursing electrolyte replacement protocol
Favorite
8:30 AM – 9:30 AM
(9-075) Evaluation of Anti-Pseudomonal Broad-Spectrum Antibiotic Overuse for the Empiric Treatment of Diabetic Foot Infection in a Rural Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-076) Evaluation of Vancomycin Use for Appropriate Indications and Microbiology Cultures in Adults at a Rural Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-077) Assessment of Vitamin D Supplementation in Rheumatoid Arthritis Patients Receiving Glucocorticoid Regimens at a Specialty Pharmacy
Favorite
8:30 AM – 9:30 AM
(9-078) Association of a Rapid Molecular Diagnostic Approach Versus Conventional Culture and Susceptibility Methods with Achieving Pneumonia Resolution in Mechanically Ventilated Patients
Favorite
8:30 AM – 9:30 AM
(9-079) Comparison of Heparin versus Direct Thrombin Inhibitors for Venovenous Extracorporeal Membrane Oxygenation Anticoagulation
Favorite
8:30 AM – 9:30 AM
(9-080) Medication Use Evaluation of Sodium Zirconium Cyclosilicate at CHI St. Vincent Infirmary
Favorite
8:30 AM – 9:30 AM
(9-081) Medication Use Evaluation of Cefdinir at CHI St. Vincent Infirmary
Favorite
8:30 AM – 9:30 AM
(9-082) Clinical Utility of Methicillin-resistant Staphylococcus aureus (MRSA) Nasal Swab and Skin and Soft Structure Infection
Favorite
8:30 AM – 9:30 AM
(9-083) Phenobarbital Versus Lorazepam for Treatment of Alcohol Withdrawal Syndrome (AWS) in Hospitalized Patients
Favorite
8:30 AM – 9:30 AM
(9-084) Evaluating Readmission Rates in Chronic Obstructive Pulmonary Disease Patients Who Are Prescribed Systemic Corticosteroids
Favorite
8:30 AM – 9:30 AM
(9-085) Incidences of hospital acquired Clostridium difficile infections with the use of pantoprazole at NEA Baptist Memorial Hospital
Favorite
8:30 AM – 9:30 AM
(9-086) Impact of Dose Rounding of Oncolytic and Biologic Agents on Potential Cost Savings in an Outpatient Infusion Center
Favorite
8:30 AM – 9:30 AM
(9-087) Impact of a Pharmacist-driven Stress Ulcer Prophylaxis Discontinuation Protocol on Prescriptions at Discharge
Favorite
8:30 AM – 9:30 AM
(9-088) Identification of Patient Characteristics Leading to a Heightened Risk of Hypoglycemia in the Inpatient Setting
Favorite
8:30 AM – 9:30 AM
(9-089) Cost Analysis of Antidotes and Antivenoms Among Patients Presenting with Overdose or Envenomation Utilizing Various Purchasing Methods
Favorite
8:30 AM – 9:30 AM
(9-090) Comparing the Management of Urinary Tract Infections (UTI) before versus after Antibiotic Education to Physicians.
Favorite
8:30 AM – 9:30 AM
(9-091) Impact of Pharmacist-led Discharge Counseling on Heart Failure Readmission Rates in a Rural Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-092) Evaluating and comparing career growth between pharmacists who have and have not completed postgraduate residency or fellowship training
Favorite
8:30 AM – 9:30 AM
(9-094) Design and Evaluation of Ambulatory Care Geriatric Polypharmacy Clinic
Favorite
8:30 AM – 9:30 AM
(9-095) Cefazolin vs Second-line Antibiotics for Surgical Site Infection Prophylaxis in Pediatric Patients With a Beta-Lactam Allergy
Favorite
8:30 AM – 9:30 AM
(9-096) Use of Haloperidol for the Management of Pediatric Cannabinoid Hyperemesis Syndrome
Favorite
8:30 AM – 9:30 AM
(9-097) Evaluation of Adherence to the 2020 CDC Treatment Guideline Update for Gonorrhea and Chlamydia in Adults Presenting to the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-099) Efficacy and safety of intravenous ketamine infusion for pain and sedation in critically ill patients
Favorite
8:30 AM – 9:30 AM
(9-100) Evaluating the outcomes of propofol versus midazolam-based sedation among paralyzed patients with acute respiratory distress syndrome
Favorite
8:30 AM – 9:30 AM
(9-101) Evaluation of the safety and efficacy of intra-arterial nicardipine compared to intra-arterial verapamil for the treatment of vasospasm in aneurysmal subarachnoid hemorrhage
Favorite
8:30 AM – 9:30 AM
(9-102) Creation and Implementation of a Pharmacist-Managed Doxycycline Post-Exposure Prophylaxis (DoxyPEP) Protocol for Bacterial Sexually Transmitted Infections
Favorite
8:30 AM – 9:30 AM
(9-103) Assessing the Efficacy and Safety of Heparin and Lovenox (Enoxaparin) in the Management of Acute Coronary Syndrome Patients at Desert Valley Hospital: A Retrospective Study
Favorite
8:30 AM – 9:30 AM
(9-104) Assessing Impact of Clinical Pharmacist-Led Interventions to Achieve Blood Glucose, Blood Pressure, and Cholesterol Goals in Patients with Type 1 or Type 2 Diabetes Mellitus
Favorite
8:30 AM – 9:30 AM
(9-105) Assessing Optimization of Provider-Initiated DOAC Stroke Prophylaxis in Patients Diagnosed with Atrial Fibrillation
Favorite
8:30 AM – 9:30 AM
(9-106) Cangrelor Use in a Community Hospital Setting: A Retrospective Study Looking at Appropriate Use and Safety
Favorite
8:30 AM – 9:30 AM
(9-107) Implementation and Education on Order of Use for Titration Management of Vasopressors in Hospitalized Patients and Measurement of Compliance Post-Implementation
Favorite
8:30 AM – 9:30 AM
(9-108) Comparative Effectiveness of Daptomycin versus Vancomycin for Empiric Treatment of Gram Positive Cocci Infections
Favorite
8:30 AM – 9:30 AM
(9-109) Evaluation of Hypoglycemia Adverse Drug Reactions in Non-Critical Care Patients Receiving Subcutaneous Insulin Treatment
Favorite
8:30 AM – 9:30 AM
(9-110) Development and Implementation of the Drug Supply Chain Security Act (DSCSA) in a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-111) Pharmacist-Driven Nares Methicillin-Resistant Staphylococcus aureus PCR Testing Protocol to Guide Antibiotic De-escalation for the Treatment of Pneumonia
Favorite
8:30 AM – 9:30 AM
(9-112) Evaluation of a Pharmacy Driven Hepatitis B Screening Protocol in Patients Undergoing Anti-Cancer Treatment
Favorite
8:30 AM – 9:30 AM
(9-113) Impact of standardized fixed dose 4-factor prothrombin complex concentrate (4F-PCC) protocol on time to treatment in emergent anticoagulation reversal
Favorite
8:30 AM – 9:30 AM
(9-114) Methicillin-Resistant Staphylococcus aureus Nasal Screening for Guiding Empiric Therapy in Patients Admitted for Pneumonia
Favorite
8:30 AM – 9:30 AM
(9-115) Safety and Efficacy of 4-factor Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants in Intracranial Hemorrhage
Favorite
8:30 AM – 9:30 AM
(9-116) Evaluation of Intensive Care Unit (ICU) Initiated Antipsychotics Continued at Hospital Discharge
Favorite
8:30 AM – 9:30 AM
(9-117) Navigating morphine management using a real-time Clinical Decision Support tool in hospitalized patients with chronic kidney disease
Favorite
8:30 AM – 9:30 AM
(9-119) Evaluation of a Two-Day Intravenous Opioid Restriction at a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-120) Impact of Implementing Long-Acting Cabotegravir/Rilpivirine for the Management of HIV Infection at a Federally Qualified Health Center
Favorite
8:30 AM – 9:30 AM
(9-121) Evaluation of Sodium-glucose Cotransporter-2 inhibitors on Euglycemic Diabetic Ketoacidosis in Patients Admitted to an Academic Medical Center
Favorite
8:30 AM – 9:30 AM
(9-122) Single Center Retrospective Case Series: Evaluating Hospital Admissions for Pain Crisis in Sickle Cell Patients Receiving Crizanlizumab
Favorite
8:30 AM – 9:30 AM
(9-123) Beyond Borders: Mapping the Frontiers of Immunosuppression in Pediatric Lung Transplantation
Favorite
8:30 AM – 9:30 AM
(9-124) Isavuconazole medication utilization and monitoring evaluation at a free-standing children’s hospital
Favorite
8:30 AM – 9:30 AM
(9-125) From Inhalers to Solutions: A Journey to Cost Savings
Favorite
8:30 AM – 9:30 AM
(9-126) Drug Use Evaluation: Compare and Contrast - Indication and role of multiple contrast agents at a pediatric hospital
Favorite
8:30 AM – 9:30 AM
(9-127) Effect of Sulfamethoxazole/Trimethoprim on High-Dose Methotrexate Clearance
Favorite
8:30 AM – 9:30 AM
(9-129) Effect of Menstrual Suppression Guideline on the Shift to Outpatient Administration of Leuprolide Acetate and Breakthrough Bleeding in Postmenarchal Stem Cell Transplant Patients
Favorite
8:30 AM – 9:30 AM
(9-130) Impact of an Inhaler to Nebulizer Therapeutic Interchange in Hospitalized Patients with Chronic Obstructive Pulmonary Disease
Favorite
8:30 AM – 9:30 AM
(9-131) Use of Phenobarbital versus Benzodiazepine Based Protocol for Alcohol Withdrawal Syndrome within Intensive Care Units and Medical Floors
Favorite
8:30 AM – 9:30 AM
(9-132) Impact of Additional Comments on Microbiology Reporting for Organisms at Moderate to High Risk of AmpC De-Repression to Improve Appropriate Culture and Susceptibility Directed Therapy
Favorite
8:30 AM – 9:30 AM
(9-133) Assessing the Impact of Oral Vancomycin for Secondary Prevention of Clostridioides difficile Infection
Favorite
8:30 AM – 9:30 AM
(9-134) Prospective Observational Study on Obese Trauma Patients on Enoxaparin for Prophylaxis and the Prevalence of Deep Vein Thrombosis Based on Anti-Xa Levels
Favorite
8:30 AM – 9:30 AM
(9-135) Evaluating the Negative Predictive Value of MRSA Nares PCR Screen in Skin and Soft Tissue Infections Above the Waist
Favorite
8:30 AM – 9:30 AM
(9-136) Evaluating Ceftriaxone Dosing for the Treatment of Spontaneous Bacterial Peritonitis (SBP)
Favorite
8:30 AM – 9:30 AM
(9-137) Dexmedetomidine Sublingual Film Effectiveness and Safety in the Setting of Alcohol Withdrawal
Favorite
8:30 AM – 9:30 AM
(9-138) Impact of a Pharmacist-Driven Procalcitonin and B-type Natriuretic Peptide Lab Ordering Protocol on Outcomes of Patients Being Treated For Community-Acquired Pneumonia
Favorite
8:30 AM – 9:30 AM
(9-139) Comparison of the Efficacy and Safety of Vancomycin One-Level AUC Monitoring to Trough-Based and Two-Level AUC Monitoring in a Community Hospital Setting
Favorite
8:30 AM – 9:30 AM
(9-140) Impact of Implementing a Pharmacist-Led Stress Ulcer Prophylaxis De-Escalation Protocol in a Community Hospital Setting
Favorite
8:30 AM – 9:30 AM
(9-141) Implementation of a Pharmacist Driven Long-Acting Injectable Antipsychotic Transitions of Care Service
Favorite
8:30 AM – 9:30 AM
(9-142) Establishing the Minimum Effective Dose with Oral Risperidone Prior to Initiation of a Long-Acting Injectable Equivalence
Favorite
8:30 AM – 9:30 AM
(9-143) High-dose Phenobarbital for Severe Alcohol Withdrawal in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-144) Comparison of High-Dose Olanzapine and Standard-Dose Olanzapine in Adult Patients at a County Psychiatric Hospital: A Retrospective Study
Favorite
8:30 AM – 9:30 AM
(9-145) Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection
Favorite
8:30 AM – 9:30 AM
(9-146) Pharmacist Partnership with Clinics at Riverside University Health Systems to Improve Adult Diabetes Management
Favorite
8:30 AM – 9:30 AM
(9-148) Impact of Annual Neonatal and Pediatric Mock Code Educational Trainings on Inpatient Pharmacists' Competencies at a Community Hospital Over 3 years
Favorite
8:30 AM – 9:30 AM
(9-149) A retrospective analysis of psychiatric medication adherence between patients experiencing homelessness versus control at time of admission to a mental health hospital
Favorite
8:30 AM – 9:30 AM
(9-150) Evaluation of Febrile Neutropenia in AML and ALL Patients on Antimicrobial Prophylaxis After the Integration of Oncology Clinical Decision Support Tools Within a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-151) Evaluation of Adherence to Guideline Directed Therapy for Patients with Recent Acute Coronary Syndrome, History of Myocardial Infarction, and Peripheral Artery Disease at Hospital Discharge
Favorite
8:30 AM – 9:30 AM
(9-152) Venous Thromboembolism Transitions of Care Health Outcomes and Projects Evaluation
Favorite
8:30 AM – 9:30 AM
(9-153) Anticoagulation Quality Assessment and Risk Evaluation in Patients with Nonvalvular Atrial Fibrillation (NVAF)
Favorite
8:30 AM – 9:30 AM
(9-154) Assessment of Pharmacy Specific ALS Tool in Improving Pharmacist Competence and Confidence During Code Blue Situations
Favorite
8:30 AM – 9:30 AM
(9-155) Utilization of Vizient Benchmarking Database for Top Decile Target Drug Program
Favorite
8:30 AM – 9:30 AM
(9-156) Assessing methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa risk factors and association with antibiotic management in critically-ill patients with community acquired pneumonia
Favorite
8:30 AM – 9:30 AM
(9-157) Development and Impact of a Pharmacist-Driven ASCVD Prevention and Treatment Protocol in the Primary Care Setting
Favorite
8:30 AM – 9:30 AM
(9-158) Evaluating the Clinical and Financial Impact of Pharmacist Interventions in a Chronic Kidney Disease Program at Stanford Primary Care
Favorite
8:30 AM – 9:30 AM
(9-159) Impact of Transitions-of-Care Pharmacist Post-Discharge Follow-Up in Gastrointestinal Oncology Readmissions
Favorite
8:30 AM – 9:30 AM
(9-160) Sugammadex for Reversal of Rocuronium Blockade in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-161) Undiluted Intravenous Push versus Conventional Piggyback Infusion Levetiracetam Loading Strategies: A Comparison of Safety and Efficacy
Favorite
8:30 AM – 9:30 AM
(9-162) Impact of a Novel Inpatient Clinical Pharmacy Model on Patient Health Outcomes, Equity, and Satisfaction
Favorite
8:30 AM – 9:30 AM
(9-163) Evaluation of Hepatitis B Immune Globulin and Hepatitis B Antiviral Agents in Liver Transplant Recipients: Optimizing Use, Dosing, and Combination Therapy for Hepatitis B Prevention
Favorite
8:30 AM – 9:30 AM
(9-164) Implementation of a Pharmacogenomics Consult Service at a Rheumatology Clinic
Favorite
8:30 AM – 9:30 AM
(9-165) Impact of Induction Therapy with Rabbit Anti-Thymocyte Globulin (rATG) Based on Ideal Body Weight on Liver Transplant Outcomes: An Evaluation of a Single-Center Steroid-Free Protocol
Favorite
8:30 AM – 9:30 AM
(9-166) Antidepressant Bleeding Risks in Coronary Artery Bypass Grafting Surgery
Favorite
8:30 AM – 9:30 AM
(9-167) Evaluation of Adherence to a Stress Ulcer Prophylaxis Protocol
Favorite
8:30 AM – 9:30 AM
(9-168) Assessing the impact of storing long-acting insulin vials in automated dispensing cabinets
Favorite
8:30 AM – 9:30 AM
(9-169) Evaluation of Erythropoietin Stimulating Agent Use in a Community Hospital With a Level IV Neonatal Intensive Care Unit
Favorite
8:30 AM – 9:30 AM
(9-170) Optimization of the New Medication Onboarding Process at a Large Academic Medical Center
Favorite
8:30 AM – 9:30 AM
(9-172) Comparing Cardioembolic Stroke Risk and Bleed Risk Among Rivaroxaban, Apixaban, Warfarin, and No Anticoagulation in Patients with Atrial Fibrillation and Chronic Kidney Disease
Favorite
8:30 AM – 9:30 AM
(9-173) Implementation of Referral Criteria to Improve Access to Addiction Medicine Service
Favorite
8:30 AM – 9:30 AM
(9-174) The Effectiveness of Prior Authorization Removal on SGLT2 Inhibitor Utilization
Favorite
8:30 AM – 9:30 AM
(9-175) Sweet Success: Evaluating the Effect of Continuous Glucose Monitoring on Hemoglobin A1c in Patients with Diabetes
Favorite
8:30 AM – 9:30 AM
(9-176) Broadening Community Pharmacy Services: Delivery of Long-Acting Injectable Antiretroviral Therapy
Favorite
8:30 AM – 9:30 AM
(9-177) Evaluating the Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Thrombocytopenic Patients
Favorite
8:30 AM – 9:30 AM
(9-178) Determining the Impact of EHR Modifications and Pharmacist-Led Education on the Frequency of Medication Non-Administrations
Favorite
8:30 AM – 9:30 AM
(9-179) Evaluating the Effect of a Pharmacist-led Educational Intervention on Outpatient Azithromycin Prescribing Practices: A Comparative Analysis Before and After Provider Feedback
Favorite
8:30 AM – 9:30 AM
(9-180) Determining if pharmacist-led, real-time provider education and feedback increases the proportion of appropriate inpatient piperacillin-tazobactam utilization
Favorite
8:30 AM – 9:30 AM
(9-181) Evaluation of Proper Initiation and Use of Rifaximin in Hepatic Encephalopathy
Favorite
8:30 AM – 9:30 AM
(9-182) Assessment of a Skin and Soft Tissue Order Set at Hospitals in a Community Health System in Colorado and Kansas
Favorite
8:30 AM – 9:30 AM
(9-183) Evaluation of the Impact of Methadone Dose on Respiratory Support in Cardiac Surgery Patients
Favorite
8:30 AM – 9:30 AM
(9-184) Mannitol vs 3% Hypertonic Saline Use in Pediatric Patients with Traumatic Brain Injury
Favorite
8:30 AM – 9:30 AM
(9-185) Drug Use Evaluation of Anakinra Within a Pediatric Health System
Favorite
8:30 AM – 9:30 AM
(9-186) Larotrectinib for the Treatment of a Radiation-Induced Glioma with NTRK1 Gene Fusion in a Pediatric Patient
Favorite
8:30 AM – 9:30 AM
(9-187) Intrathecal Etoposide and Topotecan Use in Metastatic Relapsed/Refractory Fusion-Positive Rhabdomyosarcoma in Two Pediatric Patients
Favorite
8:30 AM – 9:30 AM
(9-188) Assessing Mycophenolate Safety and Usage within Children’s Hospital Colorado
Favorite
8:30 AM – 9:30 AM
(9-189) Assessing the use of famotidine across a pediatric health system
Favorite
8:30 AM – 9:30 AM
(9-190) Utility and Safety of Oral Ketamine for Self-Injurious Behaviors in a Pediatric Patient
Favorite
8:30 AM – 9:30 AM
(9-191) Drug Use Evaluation of Epoetin Alfa in a Pediatric Hospital
Favorite
8:30 AM – 9:30 AM
(9-192) Insulin for Hyperglycemia in the Neonatal Intensive Care Unit
Favorite
8:30 AM – 9:30 AM
(9-193) Development and Implementation of a Pediatric Ambulatory Care Pharmacist Managed Service
Favorite
8:30 AM – 9:30 AM
(9-194) Efficacy and Safety of a Nurse Driven Potassium Replacement Protocol in Non-Critically Ill Hospitalized Patients
Favorite
8:30 AM – 9:30 AM
(9-195) Cost Minimization and Tolerance of Concentrated Dexmedetomidine
Favorite
8:30 AM – 9:30 AM
(9-196) Enhancing Outcomes in Heart Failure Patients: Pharmacist-Led Medication Education and Its Impact on 30-Day Readmissions, Medication Knowledge, and Patient Satisfaction
Favorite
8:30 AM – 9:30 AM
(9-197) Evaluation in Utilization of Clinical Institute of Withdrawal Assessment Based Midazolam Dosing for Alcohol Withdrawal Syndrome
Favorite
8:30 AM – 9:30 AM
(9-198) Comparative Analysis of Alteplase and Tenecteplase in Acute Ischemic Stroke Treatment: An Observational Study at Lutheran Medical Center.
Favorite
8:30 AM – 9:30 AM
(9-199) Use of Cefazolin Alternatives for Surgical Infection Prophylaxis in Patients with Documented Penicillin Allergies Before and After Implementation of an Institutional Allergy Algorithm
Favorite
8:30 AM – 9:30 AM
(9-200) Evaluation of the appropriateness of long-acting lipoglycopeptides utilization in acute bacterial skin and soft tissue infections or other infections caused by susceptible gram-positive organisms
Favorite
8:30 AM – 9:30 AM
(9-201) Retrospective Review of Observed to Expected Sepsis-Related Mortality and Standardized Antibiotic Administration Ratios After Changes in Sepsis Screening and Prediction Scoring in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-202) Utilization of Ambulatory Pharmacy Services and Their Overall Impact on Patient Care within Internal Medicine Clinics
Favorite
8:30 AM – 9:30 AM
(9-203) Ketamine Use Beyond Pain and Sedation: Refractory Major Depressive Episode, a Patient Case
Favorite
8:30 AM – 9:30 AM
(9-204) Evaluation of the Use of Daptomycin In Pediatric Patients
Favorite
8:30 AM – 9:30 AM
(9-205) Tacrolimus Dosing in Bone Marrow Transplant Patients on Posaconazole Prior to Transplant
Favorite
8:30 AM – 9:30 AM
(9-206) Evaluating the Impact of an Educational Intervention on Pharmacists Confidence with Counseling on Continuous Glucose Monitor Use and Prescribing
Favorite
8:30 AM – 9:30 AM
(9-207) Assessing Pharmacists’ Perceptions of Substance Use Disorders and Their Dispensing of Recovery Medications
Favorite
8:30 AM – 9:30 AM
(9-208) Hypoglycemic risk in hospitalized patients receiving correctional scale insulin with and without administration at bedtime
Favorite
8:30 AM – 9:30 AM
(9-209) Evaluation of Continuing Opioid Use Disorder Medications Upon Hospital Admission
Favorite
8:30 AM – 9:30 AM
(9-210) Transition from Alteplase to Tenecteplase for Acute Ischemic Stroke; A Single Center Review
Favorite
8:30 AM – 9:30 AM
(9-211) Retrospective Review of Intramuscular Long-Acting Injectable Antipsychotics, a Cost-Benefit Analysis
Favorite
8:30 AM – 9:30 AM
(9-212) MRSA Nares Decolonization Efforts Pre and Post Pharmacy Policy Implementation at the Medical Center of Aurora
Favorite
8:30 AM – 9:30 AM
(9-213) Evaluation of Sugammadex Dosing Regimens to Determine Cost-Saving Interventions
Favorite
8:30 AM – 9:30 AM
(9-214) Analyzing the Financial Impact of Dalbavancin Usage at a Large Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-215) Inpatient utilization of FEIBA administration for postoperative bleeding after a cardiothoracic surgery
Favorite
8:30 AM – 9:30 AM
(9-216) Impact to Antimicrobial Stewardship and Laboratory with Changing from Rapid Antigen Detection Tests to Polymerase Chain Reaction Tests for Group A Streptococcal Pharyngitis.
Favorite
8:30 AM – 9:30 AM
(9-217) Inpatient Community Hospital Utilization of Elastomer Pumps for Continuous Local Anesthesia Infusions
Favorite
8:30 AM – 9:30 AM
(9-218) Evaluation of Injectable Venous Thromboembolism (VTE) Prophylaxis Refusals in Acutely Ill Hospitalized Patients to Assess Utility of Rivaroxaban as an Alternative Treatment
Favorite
8:30 AM – 9:30 AM
(9-219) Evaluation of Albumin Use and Associated Cost in UCHealth Northern Colorado Region Hospitals
Favorite
8:30 AM – 9:30 AM
(9-220) Incidence of Hypoglycemia During Treatment of Hyperkalemia with Regular Insulin
Favorite
8:30 AM – 9:30 AM
(9-221) Impact of Prospective Audit and Feedback by Transitions of Care (TOC) Pharmacists on the Management of Community Acquired Pneumonia
Favorite
8:30 AM – 9:30 AM
(9-222) Evaluation of compliance to brivaracetam restrictions within a large multicenter health system
Favorite
8:30 AM – 9:30 AM
(9-223) Evaluation of Current Monitoring Practices for Patients Receiving Infliximab
Favorite
8:30 AM – 9:30 AM
(9-224) Evaluation of Cost Savings Opportunity with the Use of an Alternative Factor VII Product within a Tertiary Academic Medical Center and Health System
Favorite
8:30 AM – 9:30 AM
(9-225) Analysis of Calcitonin Prescribing Patterns at a Large Health System
Favorite
8:30 AM – 9:30 AM
(9-226) Evaluation on the Management of Enterococcal Bacteremia in a Healthcare System
Favorite
8:30 AM – 9:30 AM
(9-227) Evaluation of HbA1c in Patients Followed by a Pharmacist and Pharmacy Liaison in an Endocrinology Clinic
Favorite
8:30 AM – 9:30 AM
(9-228) Comparison of Intravenous (IV) Cangrelor and IV Tirofiban on the Incidence of Bleeding When Used for a Peri-procedural Bridge Therapy Post Percutaneous Coronary Intervention (PCI)
Favorite
8:30 AM – 9:30 AM
(9-229) Effect of Enteral Clonidine versus Guanfacine on Dexmedetomidine Withdrawal Compared to Dexmedetomidine Monotherapy in Critically Ill Patients
Favorite
8:30 AM – 9:30 AM
(9-230) Impact of Erythropoietin and Intravenous Iron on Hemoglobin Recovery and Risk of Thromboembolism in Anemic Surgical Patients Declining Blood Products
Favorite
8:30 AM – 9:30 AM
(9-231) Comparison of a pharmacist-led outpatient anticoagulation clinic to a prescriber-led clinic on the management of direct-acting oral anticoagulants (DOACs) at UConn Health
Favorite
8:30 AM – 9:30 AM
(9-232) Beyond Prescriptions: Assessing Pharmacy-Led Harm Reduction Strategies for Opioid Use Disorder in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-233) Evaluating Ceftazidime Usage and Incidence of Neurotoxicity at a 500-Bed Hospital
Favorite
8:30 AM – 9:30 AM
(9-234) Evaluation of Post-Operative Opioid Prescribing Practices among a Multi-Network Academic Health System: Alignment with Current Guidelines
Favorite
8:30 AM – 9:30 AM
(9-235) Evaluation of Lidocaine Infusion Utilization for Non-Pain Indications in the Absence of Real-Time Therapeutic Drug Monitoring in a Five-Hospital Health System
Favorite
8:30 AM – 9:30 AM
(9-236) Impact of a Multi-Pronged Allergy Label Clarification Initiative (ACLI) on Utilization of Penicillins and Cephalosporins
Favorite
8:30 AM – 9:30 AM
(9-237) Determining the association between a pharmacy derived Cancer and Aging Research Group (CARG) toxicity score on emergency department visits and hospitalization rates
Favorite
8:30 AM – 9:30 AM
(9-238) Impact of Pharmacy-Led Lipid Optimization Workflow in the Transitions of Care Setting (LOW-TOC)
Favorite
8:30 AM – 9:30 AM
(9-239) Impact of Stewardship Pharmacist Driven MRSA Nasal Surveillance and De-escalation of Anti-MRSA Therapy
Favorite
8:30 AM – 9:30 AM
(9-240) Assessing real-world weight change in the treatment and prevention of HIV-1 with a cabotegravir-containing regimen
Favorite
8:30 AM – 9:30 AM
(9-241) Topical Tranexamic Acid Versus Usual Care for the Management of Epistaxis in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-242) Impact of Pharmacist-Led Type 2 Diabetes Mellitus Management on Hemoglobin A1c Outcomes in Patients with Uncontrolled Diabetes in a Primary Care Clinic
Favorite
8:30 AM – 9:30 AM
(9-243) Assessing Effectiveness of Status Epilepticus Management before and after Implementing a Tiered Treatment Order Set
Favorite
8:30 AM – 9:30 AM
(9-244) Impact of Therapeutic versus Sub-therapeutic Dosing of Etomidate in the Setting of Rapid Sequence Intubation
Favorite
8:30 AM – 9:30 AM
(9-245) Bleeding Risk among Cancer Patients Receiving Concurrent CYP-Interacting Tyrosine Kinase Inhibitors with Direct Oral Anticoagulants versus Alternative Anticoagulation Therapies
Favorite
8:30 AM – 9:30 AM
(9-246) Management of Agitation in Patients Intoxicated with Alcohol in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-247) Impact of Pharmacist Intervention on Statin Use in Adult Internal Medicine Patients with Diabetes
Favorite
8:30 AM – 9:30 AM
(9-248) Impact of Pharmacist Intervention on Screening Patients with Diabetes for Chronic Kidney Disease (CKD) and the use of guideline directed therapy
Favorite
8:30 AM – 9:30 AM
(9-249) Creation and Implementation of a Pharmacy Intern Development Program
Favorite
8:30 AM – 9:30 AM
(9-250) Determining Optimal Combinations of Multimodal Pain Medications for Enhanced Pain Management in Geriatric Patients
Favorite
8:30 AM – 9:30 AM
(9-251) Off-Label Prothrombin Complex Concentrate Utilization for Management of Life-threatening Bleeding due to Apixaban or Rivaroxaban at a Community Teaching Hospital
Favorite
8:30 AM – 9:30 AM
(9-252) Evaluation of Step-down from Intravenous to Oral Antibiotic Therapy in Patients with Uncomplicated Gram-negative Bacteremia in a Community Teaching Hospital
Favorite
8:30 AM – 9:30 AM
(9-253) Efficacy of Oral Vancomycin for Primary Prevention of Clostridioides difficile Infection in High-Risk Adults
Favorite
8:30 AM – 9:30 AM
(9-254) Evaluation of buprenorphine extended-release (XR) injection use after formulary addition across a large academic hospital system
Favorite
8:30 AM – 9:30 AM
(9-255) Evaluation of Adherence to Clinical Pathway for Treatment of Cellulitis
Favorite
8:30 AM – 9:30 AM
(9-256) Medication Use Evaluation of Inhaled Treprostinil for Patients Without the Propriety Nebulization Device within a Large Academic Medical Center
Favorite
8:30 AM – 9:30 AM
(9-257) Evaluation of Hydroxocobalamin for Vasoplegic Shock in Cardiac Surgery
Favorite
8:30 AM – 9:30 AM
(9-258) Evaluating the Efficacy of an Evidence Based Scoring System to Determine a Novel Formulary Status Classification for Therapeutics Undergoing Formulary Consideration
Favorite
8:30 AM – 9:30 AM
(9-259) Evaluation of a “Home Anticoagulant Not Ordered” Alert in the Electronic Medical Record Across the Yale New Haven Health System
Favorite
8:30 AM – 9:30 AM
(9-260) Evaluation of Alteplase for Catheter Clearance Across the Yale New Haven Health System
Favorite
8:30 AM – 9:30 AM
(9-261) Case Review of Elevated International Normalized Ratio (INR) Greater than Five in Hospitalized Inpatients on Warfarin Therapy Across Yale New Haven Health System
Favorite
8:30 AM – 9:30 AM
(9-262) Optimizing Healthcare Costs and Patient Outcomes: Shifting IV Biologic Agent Administrations from Inpatient to Post-Discharge Care in an Academic Health System
Favorite
8:30 AM – 9:30 AM
(9-263) Assessing the Use of Intravenous Procainamide in the Management of Cardiac Arrhythmias across a Five-hospital Health System
Favorite
8:30 AM – 9:30 AM
(9-264) Evaluation of 4-Factor Prothrombin Complex Concentration (4F-PCC) Utilization Patterns across Yale New Haven Health System and Alignment with Existing Evidence for Indication and Dosing
Favorite
8:30 AM – 9:30 AM
(9-265) Evaluation of the Appropriate Use of Pegfilgrastim as Primary Prophylaxis in Anticancer Therapy Associated with Moderate Risk for Febrile Neutropenia
Favorite
8:30 AM – 9:30 AM
(9-266) Evaluating the Effects of Activating Clotting Time for Heparin Resistance During Cardiac-Bypass Surgery on Antithrombin III Waste
Favorite
8:30 AM – 9:30 AM
(9-267) Evaluation of Tenecteplase Use and Safety Outcomes for Acute Ischemic Stroke Across a Tertiary Academic Medical Center and Its Health System
Favorite
8:30 AM – 9:30 AM
(9-268) Evaluation of Monitoring Parameters for Rituximab in the Ambulatory Care Setting
Favorite
8:30 AM – 9:30 AM
(9-269) Improving Immunization Rates of Patients Prescribed Specialty Immunomodulating Medications in a Large Academic Medical Center
Favorite
8:30 AM – 9:30 AM
(9-270) Analysis of Monitoring Parameters for Patients Receiving Adalimumab Therapy
Favorite
8:30 AM – 9:30 AM
(9-271) Evaluation of Oral Janus Kinase Inhibitors Use Across a Multi-Hospital Academic Health System
Favorite
8:30 AM – 9:30 AM
(9-272) Fungal Prophylaxis in Pediatric Oncology and Transplant and Cellular Therapy Patients
Favorite
8:30 AM – 9:30 AM
(9-273) Levofloxacin Prophylaxis in Pediatric Oncology and Transplant and Cellular Therapy Patients
Favorite
8:30 AM – 9:30 AM
(9-274) Evaluation of Prescribing Practices of Ceftolozane/tazobactam for Patients with Drug-resistant Gram-negative Organism Infections
Favorite
8:30 AM – 9:30 AM
(9-275) Assessment of Hydration Practices for Intravenous Acyclovir Administration at a Multi-Center Health System
Favorite
8:30 AM – 9:30 AM
(9-276) Evaluating levetiracetam for seizure prophylaxis in neurocritical care
Favorite
8:30 AM – 9:30 AM
(9-277) Real-world evaluation of eravacycline and cefiderocol use in the treatment of Stenotrophomonas maltophilia infections
Favorite
8:30 AM – 9:30 AM
(9-278) Evaluating the appropriateness of fecal occult blood testing in an inpatient hospital system
Favorite
8:30 AM – 9:30 AM
(9-279) Utilizing Flumazenil as a Trigger Tool to Identify Inpatient Benzodiazepine Reversals within an Eight-Campus Community Hospital System
Favorite
8:30 AM – 9:30 AM
(9-280) Evaluation of the Safe Use of Ibutilide in a Multicenter Health System
Favorite
8:30 AM – 9:30 AM
(9-281) Rabies Immunoglobulin: A Medication Use Evaluation
Favorite
8:30 AM – 9:30 AM
(9-282) Characterization of N-Acetylcysteine Utilization for Non-Acetaminophen-Induced Acute Liver Failure at a Community Network Hospital
Favorite
8:30 AM – 9:30 AM
(9-283) Use of Alteplase in Cardiac Arrest
Favorite
8:30 AM – 9:30 AM
(9-284) Evaluation of Protamine Use as a Trigger Medication in Response to Unfractionated Heparin or Low Molecular Weight Heparin Administration Across an Eight-Campus, Health Care System
Favorite
8:30 AM – 9:30 AM
(9-285) Retrospective Review of Pre-Operative Cefazolin Dosing in Patients Weighing 120 Kilogram and Higher for Total Knee or Hip Replacement at a Large Community Hospital.
Favorite
8:30 AM – 9:30 AM
(9-286) Evaluation of Adherence to Sugammadex Criteria for Use in Pediatric Patients
Favorite
8:30 AM – 9:30 AM
(9-287) Medication Use Evaluation of Leuprolide
Favorite
8:30 AM – 9:30 AM
(9-288) Medication Use Evaluation: Outpatient Oncology Biosimilar Utilization
Favorite
8:30 AM – 9:30 AM
(9-289) Opioid Reversal Utilizing Intravenous Naloxone Administration in the Inpatient Setting of a 9-Hospital Community Based Health System
Favorite
8:30 AM – 9:30 AM
(9-290) Assessing educational nursing intervention to reduce heparin protocol related events
Favorite
8:30 AM – 9:30 AM
(9-291) Comparison of the Rate of Ischemic Stroke in Elderly Patients with Atrial Fibrillation Who Are Taking an Anticoagulant
Favorite
8:30 AM – 9:30 AM
(9-292) Comparison of liposomal bupivacaine versus bupivacaine for use in TAP block in bariatric surgery patients
Favorite
8:30 AM – 9:30 AM
(9-293) AdventHealth Tampa Prospective Research Project: Premixed vs Customized Total Parenteral Nutrition on Safety Outcomes
Favorite
8:30 AM – 9:30 AM
(9-294) Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients With Severe Renal Impairment: A Multicenter Study
Favorite
8:30 AM – 9:30 AM
(9-295) Impact of Sacubitril/Valsartan Formulary Management on Transitions of Care in a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-296) Impact of Pharmacist Response to Rapid Diagnostics of Gram-Positive and Gram-Negative Blood Culture Identification and Antimicrobial Usage
Favorite
8:30 AM – 9:30 AM
(9-297) Emergency Department Contaminated Blood Cultures - an Infectious Diseases Pharmacist Led Multidisciplinary Team's Approach to a Multisite Problem
Favorite
8:30 AM – 9:30 AM
(9-298) Evaluation of the Efficacy of Intravenous Ketorolac Dose Capping for Acute Pain in a Pediatric Tertiary Care Center
Favorite
8:30 AM – 9:30 AM
(9-299) Evaluating ambulatory care pharmacists' impact on access to care, fiscal outcomes, chronic disease therapy management, and care quality through implementation of transitions of care
Favorite
8:30 AM – 9:30 AM
(9-300) Impact of pharmacist-led education on ketorolac dosing for pain management in the emergency department
Favorite
8:30 AM – 9:30 AM
(9-301) Comparison of sodium zirconium cyclosilicate versus sodium polystyrene sulfonate for the management of acute hyperkalemia
Favorite
8:30 AM – 9:30 AM
(9-302) Utilization of Ivabradine for Computed Tomography Angiography
Favorite
8:30 AM – 9:30 AM
(9-303) Evaluating Compliance of Antimicrobial Stewardship Committee Implemented Criteria for Use and Side Effect Profile After a Formulary Change From Tigecycline to Eravacycline
Favorite
8:30 AM – 9:30 AM
(9-304) Evaluation of appropriate utilization of echinocandin therapy
Favorite
8:30 AM – 9:30 AM
(9-305) Retrospective Analysis of Inpatient Rifaximin Utilization in Hepatic Encephalopathy
Favorite
8:30 AM – 9:30 AM
(9-306) Argatroban Medication Use Evaluation for the Acute Treatment of Heparin Induced Thrombocytopenia at Ascension St. Vincent’s Facilities in the Jacksonville Area
Favorite
8:30 AM – 9:30 AM
(9-307) Evaluation of cisatracurium's role in reducing sugammadex usage in cardiovascular surgeries at Ascension St. Vincent’s Riverside
Favorite
8:30 AM – 9:30 AM
(9-308) Compliance with Criteria for Use of Sodium Ferric Gluconate Across Ascension St. Vincent’s Campuses in Jacksonville, FL
Favorite
8:30 AM – 9:30 AM
(9-309) Retrospective Evaluation of Corticosteroid Use: A Quality Improvement Project
Favorite
8:30 AM – 9:30 AM
(9-310) Evaluation of a pharmacist-led antimicrobial allergy clarification and penicillin de-labeling service at a community teaching hospital
Favorite
8:30 AM – 9:30 AM
(9-311) Impact of Smoking Cessation Intervention by Clinical Pharmacist in Federally Qualified Centers; an Outpatient Setting
Favorite
8:30 AM – 9:30 AM
(9-313) Therapeutic and Economic Outcomes Before and After the Removal of EXPAREL® for Transversus Abdominis Plane (TAP) Regional Analgesia from a Community Based Health Care System
Favorite
8:30 AM – 9:30 AM
(9-314) Bad to the Bone: Medication Use Evaluation on Prolia® (denosumab) in Patients with Osteoporosis
Favorite
8:30 AM – 9:30 AM
(9-315) Evaluation of Linezolid Utilization and Clinical Outcomes Following Removal of a Health System-wide Formulary Restriction
Favorite
8:30 AM – 9:30 AM
(9-316) Comparative analysis of postoperative pain management: bupivacaine liposomal versus standard treatment for hysterectomy, total shoulder arthroplasty, and rotator cuff repair surgeries
Favorite
8:30 AM – 9:30 AM
(9-317) Evaluation of the Use of Praluent® (alirocumab) in Patients Requiring Additional LDL Lowering or Experienced Statin Intolerance
Favorite
8:30 AM – 9:30 AM
(9-318) Evaluating the impact of a pharmacist-led refill management program on outpatient provider visit rates and medication adherence at a large health system
Favorite
8:30 AM – 9:30 AM
(9-319) Evaluation of Anticoagulation Therapy in Non-Valvular Atrial Fibrillation (NVAF) Patients Treated with Thrombolytic Agents for Ischemic Stroke
Favorite
8:30 AM – 9:30 AM
(9-320) Pharmacy Informatics Considerations for a Healthcare Facility Move
Favorite
8:30 AM – 9:30 AM
(9-321) Evaluation of Appropriate Continuation of Home Oral Oncolytics in Hospitalized Patients
Favorite
8:30 AM – 9:30 AM
(9-322) Evaluation of Diuretic Dosing in the Emergency Department for the Management of Acute Decompensated Heart Failure in a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-323) Impact of Pharmacist Education on Inpatient Hyperglycemia Pharmacovigilance Alert Response
Favorite
8:30 AM – 9:30 AM
(9-324) Assessment of a Pharmacist’s Role on Non-Pulseless Rapid Response Teams
Favorite
8:30 AM – 9:30 AM
(9-325) Carboplatin Dose Calculation Inconsistencies: A Medication Use Evaluation at a Single-Site Cancer Center
Favorite
8:30 AM – 9:30 AM
(9-326) Risk Factors to Differentiate Bloodstream Infection from Contamination in Patients with Blood Cultures Containing Gram-Positive Bacteria
Favorite
8:30 AM – 9:30 AM
(9-327) Safety and Tolerability of High Dose Undiluted Levetiracetam Administered Via Rapid Intravenous Push
Favorite
8:30 AM – 9:30 AM
(9-328) Tolerability and Adverse Events Using Intravenous versus Oral Sotalol Initiations
Favorite
8:30 AM – 9:30 AM
(9-329) Carboplatin-induced Hematologic Toxicities in Obese Patients Compared to Non-obese Patients
Favorite
8:30 AM – 9:30 AM
(9-330) Evaluation of the Relationship Between Vancomycin Trough and Area Under the Curve/Minimum Inhibitory Concentration (AUC/MIC) Levels in Neonatal and Pediatric Patients
Favorite
8:30 AM – 9:30 AM
(9-331) Investigation of Outcomes Related to Duration of Antibiotic Use in Neonatal Ventilator Associated Tracheitis
Favorite
8:30 AM – 9:30 AM
(9-332) Evaluation of Amlodipine and Enalapril for Blood Pressure Control in Pediatric Patients
Favorite
8:30 AM – 9:30 AM
(9-333) Evaluation of Serious Immune-related Adverse Event Incidence in 200mg Versus 400mg Pembrolizumab Regimens
Favorite
8:30 AM – 9:30 AM
(9-334) Effect of Prolonged Dexmedetomidine Duration of Therapy on Agitation in Mechanically Ventilated Patients: A Retrospective Review
Favorite
8:30 AM – 9:30 AM
(9-335) Protocolized vs Non-Protocolized Management of Alcohol Withdrawal: A Retrospective Chart Review
Favorite
8:30 AM – 9:30 AM
(9-336) Full versus Partial Adherence to a Diabetic Ketoacidosis Protocol and Patient Outcomes
Favorite
8:30 AM – 9:30 AM
(9-337) Evaluating the Impact of a PCR-Based Pneumonia Panel on Antibiotic Therapy Optimization at a Community Hospital.
Favorite
8:30 AM – 9:30 AM
(9-338) Evaluation of Antibiotic Prescribing Patterns for Adults With Penicillin Allergy Labels Given Surgical Prophylaxis
Favorite
8:30 AM – 9:30 AM
(9-339) Leveraging A Novel Data-Driven Dashboard to Enhance Healthcare Cost Savings through Drug Waste Reduction
Favorite
8:30 AM – 9:30 AM
(9-340) Assessment of Acetazolamide versus Metolazone in Acute Decompensated Heart Failure
Favorite
8:30 AM – 9:30 AM
(9-341) Impact of Norepinephrine Dose at Time of Vasopressin Initiation in Clinical Outcomes in Septic Shock
Favorite
8:30 AM – 9:30 AM
(9-342) Assessment of an Anti-Xa Monitoring Protocol for Venous Thromboembolism Prophylaxis in Adults Diagnosed with Traumatic Brain Injury
Favorite
8:30 AM – 9:30 AM
(9-343) Characterization of Beta Blocker use in Trauma Patients with Traumatic Brain Injury at Two Academic Community Trauma Centers
Favorite
8:30 AM – 9:30 AM
(9-344) The Effect of Drug-Specific Questionnaires on Prior Authorization Processing Time for Electronic Requests in HealthPlan Marketplace Populations Requiring Biologic Therapy for Asthma Treatment
Favorite
8:30 AM – 9:30 AM
(9-345) Implementation and impact of a pharmacist-led transitions of care pilot program in a community hospital
Favorite
8:30 AM – 9:30 AM
(9-346) The Impact of Pharmacy Clinical Decision Support Tools on Secondary Stroke Prophylaxis in Patients with Atrial Fibrillation and Acute Ischemic Stroke
Favorite
8:30 AM – 9:30 AM
(9-347) Impact of serum sodium goals in management of intracranial pressure (ICP) in neurocritical care patients receiving hyperosmolar agents
Favorite
8:30 AM – 9:30 AM
(9-348) Assessing the Appropriateness of Empiric Antibiotic Therapy in an Emergency Room Sepsis Order Set
Favorite
8:30 AM – 9:30 AM
(9-349) Evaluation of Clinical Outcomes Associated with Oral Step-down Therapy in Hospitalized Patients with Uncomplicated Pseudomonas Bacteremia
Favorite
8:30 AM – 9:30 AM
(9-350) Incidence of Significant Bleeding within 24 hours Following Administration of Tenecteplase or Alteplase for Treatment of Acute Ischemic Stroke
Favorite
8:30 AM – 9:30 AM
(9-351) Evaluation of Cancer Patients with Colitis
Favorite
8:30 AM – 9:30 AM
(9-352) Evaluating the impact of a process improvement in patients on a nursing-driven electrolyte protocol at a community hospital
Favorite
8:30 AM – 9:30 AM
(9-353) Safety and Efficacy of Mafenide and Amphotericin Solution in Burn Patients
Favorite
8:30 AM – 9:30 AM
(9-354) Comparison of Benzodiazepines versus Phenobarbital in Alcohol Withdrawal Syndrome Treatment in the Emergency Department at Tertiary Level 2 Trauma Center
Favorite
8:30 AM – 9:30 AM
(9-355) Association between current dosing practices and serum trough levels in a Level III Neonatal Intensive Care Unit
Favorite
8:30 AM – 9:30 AM
(9-356) Management of Epoetin Alfa-Epbx in Anemia Due to Chronic Kidney Disease (CKD): Pre- and Post-Pharmacist Evaluation Consult
Favorite
8:30 AM – 9:30 AM
(9-357) Medication Use Evaluation of Urgent Therapy Antiepileptics in an Emergency Department at a Level II Trauma Center
Favorite
8:30 AM – 9:30 AM
(9-358) Medication Use Evaluation of Intramuscular Use of Glucagon at HCA Largo Florida
Favorite
8:30 AM – 9:30 AM
(9-359) Medication Use Evaluation of Intravenous Ceftolozane/Tazobactam at HCA Florida Largo Hospital
Favorite
8:30 AM – 9:30 AM
(9-360) Evaluating the Impact of a Pharmacist-led MRSA Nasal PCR Screening Protocol on Vancomycin Treated Pneumonia
Favorite
8:30 AM – 9:30 AM
(9-361) Pharmacists Intervention in Inappropriate Aspirin Prescribing in a Geriatric Primary Care Clinic
Favorite
8:30 AM – 9:30 AM
(9-362) Impact of Adding Methylene Blue to Vasopressors in Patients with Refractory Septic Shock
Favorite
8:30 AM – 9:30 AM
(9-363) Evaluating 30-Day Heart Failure Readmission Rates in Patients with HFrEF Initially Discharged on Guideline Directed Medical Therapy
Favorite
8:30 AM – 9:30 AM
(9-364) Comparison of Patient Blood Glucose Levels Upon Discharge Before and After Pharmacist Driven Education and Monitoring of Hyperglycemia Management
Favorite
8:30 AM – 9:30 AM
(9-365) Electrolytes Abnormalities with Total Parenteral Nutrition on Preterm Infants at the Neonatal Intensive Care Unit, a Retrospective Review
Favorite
8:30 AM – 9:30 AM
(9-366) Intubation Rates in Acutely Agitated Patients in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-367) Effect of Oral Antibiotic Bowel Preparation on Colorectal Surgical Site Infection Rates
Favorite
8:30 AM – 9:30 AM
(9-369) Inpatient Pharmacist Role in De-Labeling Beta-Lactam Allergies
Favorite
8:30 AM – 9:30 AM
(9-370) Outcomes in Stroke Patients who Received Alteplase vs. Patients who Received Tenecteplase
Favorite
8:30 AM – 9:30 AM
(9-371) Provider Satisfaction with medication reconciliation completed by pharmacy technicians and pharmacists
Favorite
8:30 AM – 9:30 AM
(9-372) Impact of Pharmacist-led Antimicrobial Streamlining from BioFire FilmArray Pneumonia Panel
Favorite
8:30 AM – 9:30 AM
(9-373) Safety of a pharmacist-driven, once-weekly intravenous levothyroxine interchange
Favorite
8:30 AM – 9:30 AM
(9-374) Effect of Intravenous Ketorolac on Opioid Requirements in Trauma Patients
Favorite
8:30 AM – 9:30 AM
(9-375) Amyloid Cardiomyopathy: Pharmacists Using Health Systemwide Data Analytics to Support Cardiologist Screening
Favorite
8:30 AM – 9:30 AM
(9-376) Risk Factors Associated with Refractory Post-Traumatic Seizures in Patients Receiving Levetiracetam After Traumatic Brain Injury
Favorite
8:30 AM – 9:30 AM
(9-377) Comparison of Ketamine and Etomidate for Rapid Sequence Intubation: A Multicenter Analysis of Post Intubation Hypotension
Favorite
8:30 AM – 9:30 AM
(9-378) "Impact of Pharmacist-Led Interventions on Utilization of a Discharge Medication Bedside Delivery Service"
Favorite
8:30 AM – 9:30 AM
(9-379) Utilization and Clinical Outcomes associated with a Pharmacy-Driven Expedited Intravenous (IV) to Oral (PO) Protocol for Azithromycin
Favorite
8:30 AM – 9:30 AM
(9-380) Comparison of Activated Partial Thromboplastin Time versus Anti-factor Xa in a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-381) Antithrombin Utilization and Associated Costs at a Children's Hospital: A Medication Use Evaluation
Favorite
8:30 AM – 9:30 AM
(9-382) Assessing the utilization of intravenous sotalol in pediatric cardiac patients
Favorite
8:30 AM – 9:30 AM
(9-383) Evaluation of Guideline Adherence in Patients on Multiple Antithrombotic Therapy and Use of Gastrointestinal Prophylaxis
Favorite
8:30 AM – 9:30 AM
(9-384) Albumin Use Post- Paracentesis in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-385) Implications of Staphylococcus non-aureus Blood Culture Positivity
Favorite
8:30 AM – 9:30 AM
(9-386) Transition from Continuous to Subcutaneous Insulin in Critically-ill Patients
Favorite
8:30 AM – 9:30 AM
(9-387) Evaluation of Opioid Analgesic Agent Use in Pediatric Sickle Cell Patients
Favorite
8:30 AM – 9:30 AM
(9-388) Reducing Inappropriate Treatment of Asymptomatic Bacteriuria (ASB) in an Urban Teaching Community Hospital Through a Pharmacist-Driven Educational Intervention
Favorite
8:30 AM – 9:30 AM
(9-389) Utilization of Angiotensin II in a Community Health System
Favorite
8:30 AM – 9:30 AM
(9-390) Evaluation of Preventable Administration of Hospital-Supplied Factor Products to Pediatric Patients with Hemophilia or Von Willebrand Disease
Favorite
8:30 AM – 9:30 AM
(9-391) Timing to analgesia and sedation after rapid sequence intubation in the emergency department
Favorite
8:30 AM – 9:30 AM
(9-392) Evaluation of Linezolid Restriction Criteria in a Community Health System
Favorite
8:30 AM – 9:30 AM
(9-393) Evaluation of Corticosteroid Utilization for Critically Ill Patients with Acute Respiratory Distress Syndrome
Favorite
8:30 AM – 9:30 AM
(9-394) Evaluating Prescribing Trends and Patient Outcomes: A Medication Use Evaluation of Cangrelor
Favorite
8:30 AM – 9:30 AM
(9-395) Impact of Perioperative Continuation of Buprenorphine on Postoperative Pain in Patients with Opioid Use Disorder
Favorite
8:30 AM – 9:30 AM
(9-396) Effect of Midodrine on the Duration of Intravenous Vasopressor Therapy in Intensive Care Unit Patients
Favorite
8:30 AM – 9:30 AM
(9-397) Safety comparison of calaspargase pegol-mknl versus pegaspargase in pediatric acute lymphoblastic leukemia patients
Favorite
8:30 AM – 9:30 AM
(9-398) Safety of Bevacizumab Administration following Central Venous Port Placement in Patients with Solid Tumor Malignancies
Favorite
8:30 AM – 9:30 AM
(9-399) Rituximab Administration: Implementing a Drug-Primed Strategy
Favorite
8:30 AM – 9:30 AM
(9-400) Dual Impact of Discharge Delays on Antibiotic Therapy Duration and Cost During the Inpatient to Outpatient Transition
Favorite
8:30 AM – 9:30 AM
(9-401) Comparative Efficacy of Crotalidae Immune F(ab')2 (Equine) versus Crotalidae Polyvalent Immune FabAV (Ovine) in Water Moccasin Envenomation: A Retrospective Multicenter Review
Favorite
8:30 AM – 9:30 AM
(9-403) Addressing the Pharmacy Technician Shortage: The Role of a Flexible Float Pool
Favorite
8:30 AM – 9:30 AM
(9-404) Efficacy of Insulin Lispro versus Regular Insulin in the Treatment of Hyperkalemia
Favorite
8:30 AM – 9:30 AM
(9-405) Evaluation of Agitation Post Fentanyl Infusion in the Intensive Care Unit
Favorite
8:30 AM – 9:30 AM
(9-406) Impact of a Pharmacist Intervention Scoring Tool on Heart Failure Patients' Clinical Outcomes
Favorite
8:30 AM – 9:30 AM
(9-407) Effects of Cost-Driven Medication Access Referral Services on Pharmacoequity in Oral Oncolytic Prescriptions
Favorite
8:30 AM – 9:30 AM
(9-408) Chemotherapy plus Immunotherapy after Progression on Targeted Therapy
Favorite
8:30 AM – 9:30 AM
(9-409) Surgeon Directed, Physician Managed, Pharmacist Monitored: Evaluation of Tacrolimus Goals Based on Real-world Practice
Favorite
8:30 AM – 9:30 AM
(9-410) Implementation of a System Wide Status Epilepticus Clinical Decision Action Plan in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-411) Assessment and Validation of the Wells Criteria for Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) in Hospitalized Patients
Favorite
8:30 AM – 9:30 AM
(9-412) Evaluation of Treatment Outcomes in Patients who received Bevacizumab Therapy for Radiation Induced Brain Necrosis
Favorite
8:30 AM – 9:30 AM
(9-413) Pharmacist-driven Inpatient Dapagliflozin Program: Assessing Appropriateness and Continuity of Care
Favorite
8:30 AM – 9:30 AM
(9-414) Impact of Sulfonylurea Removal from Formulary on Hypoglycemia Incidence
Favorite
8:30 AM – 9:30 AM
(9-415) Evaluation of Clinical Outcomes of Midodrine on Intravenous Vasopressor Requirements in Critically Ill Adults
Favorite
8:30 AM – 9:30 AM
(9-417) Impact of Concomitant High-Dose Corticosteroids and Immune Checkpoint Inhibitors in Patients with Brain Metastases Secondary to Lung Cancer or Melanoma
Favorite
8:30 AM – 9:30 AM
(9-418) Defining and Measuring Trial Activation Metrics for an Oncology Investigational Drug Service Pharmacy
Favorite
8:30 AM – 9:30 AM
(9-419) Financial Impact of Pharmacist-Led Toxicity Management in the Oncology Setting
Favorite
8:30 AM – 9:30 AM
(9-420) Phenobarbital-Based versus Benzodiazepine-Based Protocols for Alcohol Withdrawal Syndrome in the Intensive Care Unit
Favorite
8:30 AM – 9:30 AM
(9-421) Impact of Desmopressin on Intracranial Hemorrhage Expansion in Patients on Antiplatelet Agents
Favorite
8:30 AM – 9:30 AM
(9-422) Continuous Infusion Ketamine for Sedation in Critically Ill Patients
Favorite
8:30 AM – 9:30 AM
(9-423) Evaluation of Potassium and Magnesium Replacement Utilizing a Cardiac Electrolyte Replacement Protocol with Higher Goal Parameters
Favorite
8:30 AM – 9:30 AM
(9-424) Change in HbA1c in Type 2 Diabetes Patients on Real-Time Continuous Glucose Monitoring (CGM) Versus Routine Care
Favorite
8:30 AM – 9:30 AM
(9-425) Clostridioides difficile PCR Cycle Count Prediction of C. diff Toxin results and disease severity
Favorite
8:30 AM – 9:30 AM
(9-426) Ketamine for the Management of Acute Agitation in the Emergency Department
Favorite
8:30 AM – 9:30 AM
(9-427) Psychiatric Pharmacist Led Long-Acting Injectable Clinic: Impact on Readmission Rates and Patient Satisfaction
Favorite
8:30 AM – 9:30 AM
(9-428) Human Herpesvirus6 (HHV-6) Encephalitis in Immunocompetent Patients
Favorite
8:30 AM – 9:30 AM
(9-429) Efficacy and Safety of Midodrine in Critically Ill Pediatric Patients
Favorite
8:30 AM – 9:30 AM
(9-430) Clinical Pharmacist Impact on Chronic Kidney Disease Progression in Patients With Type 2 Diabetes
Favorite
8:30 AM – 9:30 AM
(9-431) Clozapine, Caffeine, and Smoking: a Correlational Study and Initiation of Pharmacist‐Led Interventions to Improve Clinical Outcomes
Favorite
8:30 AM – 9:30 AM
(9-432) Atropine as a First-Line Agent for the Treatment of Sialorrhea to Benefit Patients with Antipsychotic Treatment-Related Constipation Exacerbated by Oral Anticholinergic Sialorrhea Treatment
Favorite
8:30 AM – 9:30 AM
(9-433) Evaluation of burnout rates among entry level and advanced standing students in a traditional Doctor of Pharmacy program
Favorite
8:30 AM – 9:30 AM
(9-434) Urine Sodium Monitoring in Extremely Preterm Infants
Favorite
8:30 AM – 9:30 AM
(9-436) Financial Performance and Reimbursement of Co-Funded Faculty Pharmacist-Provided Services in a Privately Owned Family Medicine Practice
Favorite
8:30 AM – 9:30 AM
(9-437) Pharmacist-Led Screening for Metabolic Dysfunction-Associated Liver Disease Within a Family Medicine Clinic Using the FIB-4 Index in Patients 65 Years or Older.
Favorite
8:30 AM – 9:30 AM
(9-438) Impact of Pharmacist-Led Medication History Pilot Program on Discrepancies
Favorite
8:30 AM – 9:30 AM
(9-439) Evaluation of an eGlycemic Management System Compared with a Standard of Care Protocol for the Management of Diabetic Ketoacidosis
Favorite
8:30 AM – 9:30 AM
(9-440) Utilization of a Multidisciplinary Pain Service Alert to Assess the Appropriateness of Prolonged Intravenous Opioid Administration in Hospitalized Patients
Favorite
8:30 AM – 9:30 AM
(9-441) Pharmacist Impact on Rapid Sequence Intubation (RSI) Practices after Implementation of 24-hour Pharmacy Service Line in the Critical Care Setting
Favorite
8:30 AM – 9:30 AM
(9-442) Impact of Tenecteplase Compared to Alteplase as the Preferred Thrombolytic in Adult Patients with Acute Ischemic Stroke
Favorite
8:30 AM – 9:30 AM
(9-443) Impact of Hypoalbuminemia on Ertapenem Treatment Failure in Patients with Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bacteremia
Favorite
8:30 AM – 9:30 AM
(9-444) Evaluating the Safety and Efficacy of an Intravenous to Subcutaneous Insulin Conversion Protocol in Post-Coronary Artery Bypass Graft Patients in a Large Community Teaching Hospital
Favorite
8:30 AM – 9:30 AM
(9-445) Assessing Warfarin Efficacy and Safety in an Outpatient Anticoagulation Clinic Associated with an Acute Care Hospital
Favorite
8:30 AM – 9:30 AM
(9-446) Evaluation of Elevated Digoxin Levels and Incidence of Toxicity at an Acute Care Hospital with an Older Population.
Favorite
8:30 AM – 9:30 AM
(9-447) Evaluation of Discharge Oral Antibiotic Orders Post Hospital Care Within a Community Hospital
Favorite
8:30 AM – 9:30 AM
(9-448) Impact of Pharmacist Intervention on Antimicrobial Prescribing for Discharge for Common Infections
Favorite
8:30 AM – 9:30 AM
(9-449) Comparison of Clinical Outcomes for the Treatment of Patent Ductus Arteriosus Using Acetaminophen versus Indomethacin in Neonates
Favorite
8:30 AM – 9:30 AM
(9-450) Analyzing the safety and efficacy of high versus low dose recombinant activated Factor VIIa (NovoSeven®RT) for the treatment of bleeding in non-hemophiliac cardiac surgery patients.
Favorite
8:30 AM – 9:30 AM
(9-451) Optimizing Prevention of Hospital-Acquired Venous Thromboembolism (VTE): Retrospective Validation of a VTE Prophylaxis Clinical Decision Support Model
Favorite
8:30 AM – 9:30 AM
(9-452) The Efficacy of Cefepime Intravenous Push versus Intravenous Piggyback in Gram-Negative Bacteremia
Favorite
8:30 AM – 9:30 AM
(9-453) The Evaluation of Dexamethasone and Fludrocortisone versus Hydrocortisone in Critical Care Patients for Treatment of Septic Shock
Favorite
8:30 AM – 9:30 AM
(9-454) Evaluation of the Impact of a Pharmacy-Coordinated Glycemic Management Program
Favorite
8:30 AM – 9:30 AM
(9-455) Poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome
Favorite
8:30 AM – 9:30 AM
(9-456) Incidence of Hypophosphatemia in Patients Receiving Parenteral Nutrition Who Are At Risk for Refeeding Syndrome
Favorite
8:30 AM – 9:30 AM
(9-457) Comparative Efficacy of 3 mg versus 6 mg Rasburicase for the Treatment of Elevated Uric Acid in Patients Diagnosed with Tumor Lysis Syndrome
Favorite
8:30 AM – 9:30 AM
(9-458) Comparison of Weight-Based to Non-Weight-Based Epinephrine for Target Parameter Attainment
Favorite
8:30 AM – 9:30 AM
(9-459) Assessment of the Medication Repackaging Process at the BayCare Central Pharmacy
Favorite
8:30 AM – 9:30 AM
(9-460) High-Dose vs. Standard-Dose Subcutaneous Heparin for Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Obese Patients
Favorite
8:30 AM – 9:30 AM
(9-461) Assessment of the Bleeding Rates with DOAC Use in Patients with Thrombocytopenia
Favorite
8:30 AM – 9:30 AM
(9-462) Evaluation of appropriateness of total treatment days for Urinary Tract Infections (UTIs)
Favorite
8:30 AM – 9:30 AM
(9-463) Incidence of Adverse Reactions Between Intravenous Iron Formulations at an Outpatient Infusion Center: Ferric Derisomaltose vs Ferric Carboxymaltose
Favorite
8:30 AM – 9:30 AM
(9-464) Assessing the Impact of a Glycemic Management Pathway on the Utilization of Basal and Basal-Bolus Insulin Regimens in Established Diabetic Patients
Favorite
8:30 AM – 9:30 AM
(9-465) Clinical and Economic Impact of Pharmacist-Led Interventions in Reducing A1C among Indigent Patients at Transitions of Care Outpatient Clinic: A Value-Based Care Approach
Favorite
8:30 AM – 9:30 AM
(9-466) Reducing Inappropriate Utilization of Albumin in a Large Community Healthcare System: A Pre and Post Retrospective Study
Favorite
8:30 AM – 9:30 AM
(9-467) Evaluating the Compliance of Enoxaparin in Deep Vein Thrombosis (DVT) prophylaxis in hospitalized patients who refuse treatment.
Favorite
8:30 AM – 9:30 AM
(9-468) Impact of Targeted Education on Antibiotic Prescribing for Asymptomatic Bacteriuria
Favorite
8:30 AM – 9:30 AM
(9-469) Assessing Patient’s Knowledge of Respiratory Syncytial Virus (RSV) in a Community Pharmacy Setting
Favorite
8:30 AM – 9:30 AM
(9-470) The Impact of Pharmacy Led Vancomycin Dosing in an Interdisciplinary Research Institute
Favorite
8:30 AM – 9:30 AM
(9-471) Evaluation of Andexanet Alfa for Appropriate Use in Major Bleeding Events
Favorite
8:30 AM – 9:30 AM
(9-472) Evaluation of Clinical Interventions across Hospitals in a Multi-Hospital Health System: A Quality Improvement Project
Favorite
8:30 AM – 9:30 AM
(9-473) Implementation of a Collaborative Medication Order Verification Process across Multiple Hospitals in a Health System to Optimize Pharmacist Workflow
Favorite
8:30 AM – 9:30 AM
(9-474) Heart Failure Guideline Directed Medication Therapy Utilization With a Transitions of Care Pharmacy Service and Impact On Skilled Nursing Facility patients
Favorite
8:30 AM – 9:30 AM
(9-475) Evaluation of Clinical Response Using Carbapenems versus Non-Carbapenems for Extended Spectrum Beta-Lactamase Producing Enterobacterales Acute Cystitis
Favorite
8:30 AM – 9:30 AM
(9-476) Evaluation of Tranexamic Acid for Angiotensin Converting Enzyme Inhibitor-Induced Angioedema
Favorite
11:00 AM – 12:00 PM
(10-001) Evaluation of Medication Prescribing Before and After Implementation of a Post-Percutaneous Coronary Intervention (PCI) Pharmacist Consult Workflow
Favorite
11:00 AM – 12:00 PM
(10-002) Impact of Pharmacist Involvement in the Emergency Department Post-Discharge Culture Review Process
Favorite
11:00 AM – 12:00 PM
(10-003) One Bite at a Time: A Medication Use Evaluation of Crotalidae Immune F(ab’)2
Favorite
11:00 AM – 12:00 PM
(10-004) Race against time: Evaluating eptacog beta for bleeding cessation in pediatric patients
Favorite
11:00 AM – 12:00 PM
(10-005) Methylene Blue in Refractory Septic Shock
Favorite
11:00 AM – 12:00 PM
(10-006) Revisiting Midodrine Use for Single Vasopressor Weaning in Intensive Care Unit
Favorite
11:00 AM – 12:00 PM
(10-007) Impact of Recruitment-Focused Strategies in Improving Diversity, Equity, Inclusion, and Belonging in a Pharmacy Residency Program
Favorite
11:00 AM – 12:00 PM
(10-008) Incidence of Ruxolitinib- Associated Thromboembolism in Post-Allogeneic Stem Cell Patients
Favorite
11:00 AM – 12:00 PM
(10-009) Evaluation of Antithrombin Administration in Critically Ill Patients During Heparin Anticoagulation Outside of the Operating Room
Favorite
11:00 AM – 12:00 PM
(10-010) Direct Oral Anticoagulants In Acute Kidney Injury and the Incidence of Major Bleeding
Favorite
11:00 AM – 12:00 PM
(10-011) Impact of Cytomegalovirus Infection on Cardiac Allograft Vasculopathy, Rejection, and Survival Outcomes Among Heart Transplant Patients
Favorite
11:00 AM – 12:00 PM
(10-012) Impact of local implementation of national consensus guidelines on management of infections by potential AmpC-producing Enterobacterales
Favorite
11:00 AM – 12:00 PM
(10-013) Evaluation of antibiotic usage for community acquired MRSA skin and soft tissue infections in the emergency department after education of clindamycin resistance patterns
Favorite
11:00 AM – 12:00 PM
(10-014) Evaluation of Alteplase Therapy for Pulmonary Embolism in Cardiac Arrest
Favorite
11:00 AM – 12:00 PM
(10-016) The Impact of Implementing an Initial Specimen Diversion Device on the Prescribing Practices of Vancomycin
Favorite
11:00 AM – 12:00 PM
(10-017) Evaluation of a Pharmacist-Led Education Service on Hospital Consumer Assessment of Healthcare Providers and System (HCAHPS) Scores
Favorite
11:00 AM – 12:00 PM
(10-018) Causes of severe hyperglycemic events in non-critically ill hospitalized patients
Favorite
11:00 AM – 12:00 PM
(10-019) Assessing Clinical Outcomes of Prescribing Additional Antiretroviral Agents to Patients Unable to Achieve an Undetectable Viral Load on A Presumed Fully Active Regimen
Favorite
11:00 AM – 12:00 PM
(10-020) Prescribing practices of the four pharmacological pillars of heart failure with reduced ejection fraction therapy in an integrated healthcare system
Favorite
11:00 AM – 12:00 PM
(10-021) Assessing the impact of reduced default dispense quantities for opioid orders on initial prescription days’ supply
Favorite
11:00 AM – 12:00 PM
(10-022) Evaluation of factors that led to the achievement of A1c goal in patients with type II diabetes
Favorite
11:00 AM – 12:00 PM
(10-023) Oritavancin for completion of antibiotic therapy in patients requiring outpatient treatment
Favorite
11:00 AM – 12:00 PM
(10-024) A retrospective medication use evaluation of Prolacta supplementation in low birth-weight infants receiving parenteral nutrition
Favorite
11:00 AM – 12:00 PM
(10-025) A Comparison of Safety, Efficacy and Usage Between Crotalidae Immune F[ab’]2 [equine] (Anavip ®) and Crotalidae Polyvalent Fab [ovine] (CroFab ®) for Envenomation
Favorite
11:00 AM – 12:00 PM
(10-026) Safety and effectiveness of heparinized versus bicarbonate-based Impella purge solutions with concomitant systemic anticoagulation
Favorite
11:00 AM – 12:00 PM
(10-027) The incidence and effect of suboptimal vancomycin AUC/MIC levels collected by nursing vs non-nursing professionals
Favorite
11:00 AM – 12:00 PM
(10-028) Assessment of Tenecteplase Order Set Implementation for Ischemic Stroke
Favorite
11:00 AM – 12:00 PM
(10-029) Evaluation of Second Dose Antibiotic Administration Delay
Favorite
11:00 AM – 12:00 PM
(10-030) Duration of antibiotic therapy for common infections at a community hospital
Favorite
11:00 AM – 12:00 PM
(10-031) Evaluating the Use of Olanzapine for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) for Highly Emetic Chemotherapy Regimens
Favorite
11:00 AM – 12:00 PM
(10-032) A National Survey of Pharmacists Assessing Enteral Opioid Use for Weaning off Continuous Intravenous Opioids in Critically Ill, Mechanically Ventilated Adults
Favorite
11:00 AM – 12:00 PM
(10-033) Comparing the Efficacy Between Acetaminophen and Ibuprofen When Used As the Third Course of Pharmacotherapy for Patent Ductus Arteriosus Closure.
Favorite
11:00 AM – 12:00 PM
(10-034) Assessing the Impact of Guideline Updates on Empiric Treatment of Chlamydia and Gonorrhea in the Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-035) Comparison of pharmacy student perceptions and performance outcomes prior to and post-modification of a sepsis digital concept mapping tool
Favorite
11:00 AM – 12:00 PM
(10-036) Impact of a Pharmacist-Led Heart Failure Therapy Optimization Program on 30-day Hospital Readmission Rate in Patients with Reduced Ejection Fraction
Favorite
11:00 AM – 12:00 PM
(10-037) Effects of Pharmacist-Recommended Insulin Adjustments on Therapeutic Blood Glucose Days for Adult Patients in Intensive Care Units
Favorite
11:00 AM – 12:00 PM
(10-038) Pharmacists’ Low-density Lipoprotein (LDL) Monitoring Initiative Among Post Ischemic Stroke Patients in a Rehabilitation Center.
Favorite
11:00 AM – 12:00 PM
(10-039) Incidence of Natalizumab Discontinuation Beyond Two Years Based on Dosing Frequency
Favorite
11:00 AM – 12:00 PM
(10-040) Improving hypertension disease state management in patients identified as non-adherent to ACE/ARB therapy via pharmacy-led intervention
Favorite
11:00 AM – 12:00 PM
(10-041) Impact of BioFire BCID2 Panel testing on time to appropriate antimicrobial selection after standardizing provider education and including alert notifications within an electronic health record
Favorite
11:00 AM – 12:00 PM
(10-042) Evaluating the Efficacy and Safety of 4-Factor Prothrombin Complex Concentrate for Reversal of Gastrointestinal Bleeding Related to Factor Xa Inhibitors: A Retrospective Review
Favorite
11:00 AM – 12:00 PM
(10-043) Evaluation of Once-Daily Versus Twice-Daily Dosing of Caffeine for Apnea of Prematurity
Favorite
11:00 AM – 12:00 PM
(10-044) Evaluation of Acetylcysteine for Acetaminophen Toxicity in the Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-045) Medication Use Evaluation of Vancomycin Dosing in Continuous Renal Replacement Therapy
Favorite
11:00 AM – 12:00 PM
(10-046) Medication Use Evaluation of Insulin Transition Strategies from Intensive Care Infusions to Subcutaneous Dosing
Favorite
11:00 AM – 12:00 PM
(10-047) Medication Use Evaluation of Ceftazidime for Stenotrophomonas maltophilia Infections
Favorite
11:00 AM – 12:00 PM
(10-048) Medication use evaluation of tolvaptan for treatment of hyponatremia
Favorite
11:00 AM – 12:00 PM
(10-049) Statin Reinitiation in High-Risk Patients with a Documented Statin Allergy
Favorite
11:00 AM – 12:00 PM
(10-050) Evaluation of the Impact of Community Pharmacist Nutrition Focused Educational Intervention to Increase Patient Adherence to Diabetes Medications and Decrease Self-Reported Adverse Effects
Favorite
11:00 AM – 12:00 PM
(10-051) Assessment of the Impact of Social Determinants of Health Barriers on Community Pharmacist-Provided Nutrition Counseling
Favorite
11:00 AM – 12:00 PM
(10-052) Evaluation and Demand for Community Pharmacy Clinical Services: Access and Remuneration
Favorite
11:00 AM – 12:00 PM
(10-053) Implementation of a Pharmacist-Driven Review of Cancer-Associated Venous Thromboembolic Disease Prophylaxis at a Community Cancer Center
Favorite
11:00 AM – 12:00 PM
(10-054) Analyzing the Accuracy of Pharmacokinetic Estimation Models in Comparison to Two-Level Serum Area Under the Curve (AUC) Calculations for Vancomycin Inpatient Monitoring
Favorite
11:00 AM – 12:00 PM
(10-055) Evaluation of a Pharmacist-Driven Rapid Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Screening Protocol
Favorite
11:00 AM – 12:00 PM
(10-056) Evaluation of Inpatient Antipsychotic Initiation in Non-Psychiatric Admissions
Favorite
11:00 AM – 12:00 PM
(10-057) Clinical Efficacy Assessment of Intravenous (IV) Metronidazole Dosed Every 12-Hours Versus Every 8-Hours in a Community Health System
Favorite
11:00 AM – 12:00 PM
(10-058) The Effects of the Transition to Tenecteplase on Door to Needle Time at a Regional Stroke Center
Favorite
11:00 AM – 12:00 PM
(10-059) Optimizing Diabetic Ketoacidosis (DKA) Treatment in Critical Care Areas: Analyzing Hypoglycemia Incidence to Guide Protocol Alignment with Evidence-Based Practice
Favorite
11:00 AM – 12:00 PM
(10-060) Tenecteplase versus alteplase: incidence of conversion to intracranial hemorrhage after administration for acute ischemic stroke
Favorite
11:00 AM – 12:00 PM
(10-061) Development/Implentation of Meds2Beds Nicotine Replacement Therapy Protocol
Favorite
11:00 AM – 12:00 PM
(10-062) Increasing Safety of Patients with Pulmonary Hypertension Through Creation and Implementation of Order Panel and Education
Favorite
11:00 AM – 12:00 PM
(10-063) HIT a New Low: Pharmacist-led 4T Score for Heparin-Induced Thrombocytopenia Evaluation
Favorite
11:00 AM – 12:00 PM
(10-064) Development and Implementation of a Therapeutic Substitution Protocol
Favorite
11:00 AM – 12:00 PM
(10-065) Alcohol Withdrawal Order Set Implementation in a General Medicine Unit
Favorite
11:00 AM – 12:00 PM
(10-066) Fixed vs. Weight-Based Dosing of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Patients Presenting with an Acute Severe Bleed
Favorite
11:00 AM – 12:00 PM
(10-067) Cost effectiveness of migraine prophylaxis with eptinezumab or onabotulinumtoxinA - A retrospective chart review
Favorite
11:00 AM – 12:00 PM
(10-068) Implementation of Personal Insulin Pumps for Glycemic Control in Admitted Patients with Type 1 Diabetes
Favorite
11:00 AM – 12:00 PM
(10-069) Standardization of Continuous Glucose Monitor Education Services Provided by Transitions of Care Pharmacists
Favorite
11:00 AM – 12:00 PM
(10-070) Impact of a Novel, Individualized Approach to Diabetes Care on A1C at a Community Health Center When Social Determinants of Health May Be a Barrier
Favorite
11:00 AM – 12:00 PM
(10-071) Retrospective Review of the Effectiveness of Pseudoephedrine vs. Midodrine as Adjunctive Therapy for Weaning of Intravenous Vasopressors for Neurogenic Shock After Acute Spinal Cord Injury
Favorite
11:00 AM – 12:00 PM
(10-072) Implementation of Patient Self-Reporting of Medication Histories to Improve Emergency Department Medication Reconciliation
Favorite
11:00 AM – 12:00 PM
(10-073) Impact of Prescribing Tool Implementation on Outpatient Fluoroquinolone Use and Antibiotic Durations in Community-Acquired Pneumonia and Urinary Tract Infections
Favorite
11:00 AM – 12:00 PM
(10-074) Incidence of Ileus in Trauma Patients Receiving Gabapentin as part of an Opioid Sparing Treatment Regimen
Favorite
11:00 AM – 12:00 PM
(10-075) Impact of Levothyroxine Hormonal Therapy Administered to the Potential Organ Donor Following Catastrophic Traumatic Brain Injury
Favorite
11:00 AM – 12:00 PM
(10-076) Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients with Severe Renal Impairment: A Multicenter Study
Favorite
11:00 AM – 12:00 PM
(10-077) Impact of Intravenous Angiotensin II on Mean Arterial Pressure and Sum Norepinephrine Equivalent Dosing in Pediatric Patients with Vasodilatory Shock
Favorite
11:00 AM – 12:00 PM
(10-078) Frequency of thrombosis and bleeding in pediatric patients after palliative cardiac shunt or stent procedures with VerifyNow monitoring at a single center
Favorite
11:00 AM – 12:00 PM
(10-079) Evaluation of Hypophosphatemia Reduction in Patients Receiving Phosphate-Containing Versus Phosphate-Free Solution for Continuous Renal Replacement Therapy
Favorite
11:00 AM – 12:00 PM
(10-080) Assessing the Impact of a Meds-to-Beds Program on 30 day Readmission Rates
Favorite
11:00 AM – 12:00 PM
(10-081) Impact of Pharmacist-run Ambulatory Care Clinic Post-discharge Visits on Congestive Heart Failure Readmission Rates
Favorite
11:00 AM – 12:00 PM
(10-082) Evaluation of Patient Outcomes Pre- and Post-Implementation of Updates to the Diabetic Ketoacidosis/Hyperosmolar Hyperglycemic State Order Set at a Community Teaching Hospital
Favorite
11:00 AM – 12:00 PM
(10-083) Safety of linezolid in renal dysfunction
Favorite
11:00 AM – 12:00 PM
(10-084) Assessment of Total Duration of Antimicrobial Therapy in Patients With Pneumonia or Urinary Tract Infection
Favorite
11:00 AM – 12:00 PM
(10-085) Pharmacist-Driven Algorithm for Interpreting QTc Intervals
Favorite
11:00 AM – 12:00 PM
(10-086) Evaluating Continuous Infusion Diltiazem Use in Patients with Atrial Fibrillation with Rapid Ventricular Rate
Favorite
11:00 AM – 12:00 PM
(10-087) Assessing Risk Factors for PICC-related Thrombosis in an Inpatient Headache Unit
Favorite
11:00 AM – 12:00 PM
(10-088) Assessment of Parenteral Nutrition (PN) Usage: a Medication Use Evaluation
Favorite
11:00 AM – 12:00 PM
(10-089) Effects of Sodium Bicarbonate on 24-Hour Survival after Return of Spontaneous Circulation for In-Hospital Cardiac Arrest
Favorite
11:00 AM – 12:00 PM
(10-090) Vancomycin AUC/MIC Estimations Performed with Trough Only Levels
Favorite
11:00 AM – 12:00 PM
(10-091) Implementation of a Ketorolac Dose Limit and Evaluation of Analgesic Ceiling Effect in an Emergency Department Population
Favorite
11:00 AM – 12:00 PM
(10-092) Evaluation of Benzodiazepine Dosing Strategies in the Management of Status Epilepticus
Favorite
11:00 AM – 12:00 PM
(10-093) Liposomal Bupivacaine Versus Administration of Short-Acting Local Anesthetics Alone: Impact on Quality of Patient Analgesia and Post-Operative Opioid Therapy
Favorite
11:00 AM – 12:00 PM
(10-094) Pharmacist-Led Penicillin Allergy De-labeling in the Inpatient Setting
Favorite
11:00 AM – 12:00 PM
(10-095) Evaluation of duplicate bronchodilator therapy in a community hospital
Favorite
11:00 AM – 12:00 PM
(10-096) Evaluation of inpatient morphine use in adult patients with renal impairment
Favorite
11:00 AM – 12:00 PM
(10-097) Effects of Ketamine on Opioid Analgesia Requirements in Adult Patients in the Intensive Care Unit
Favorite
11:00 AM – 12:00 PM
(10-098) Pushed for Time: Time from Order Verification to Administration of IV Piggy-Back versus IV Push Levetiracetam
Favorite
11:00 AM – 12:00 PM
(10-099) Assessing Compliance to Linezolid Restricted Use Criteria - More Harm than Good? A Medication Use Evaluation
Favorite
11:00 AM – 12:00 PM
(10-100) Taste of Our Own Medicine: the Impact of Inappropriate Broad-Spectrum Antibiotic Use in Patients Hospitalized with Community-Acquired Pneumonia
Favorite
11:00 AM – 12:00 PM
(10-101) Evaluation of Adverse Effects Observed After Peripheral Administration of Hypertonic Saline
Favorite
11:00 AM – 12:00 PM
(10-102) A Comparative Study of Different Lead-in Dosing Strategies Using Direct Oral Anticoagulants (DOACs) for the Treatment of VTE
Favorite
11:00 AM – 12:00 PM
(10-103) Comparison of Twice Daily Hydralazine with Isosorbide mononitrate daily or dinitrate Twice Daily Compared to Thrice Daily Hydralazine with Isosorbide dinitrate in Congestive Heart Failure
Favorite
11:00 AM – 12:00 PM
(10-104) Identifying Errors in Discharge Medications in the General Medicine Population
Favorite
11:00 AM – 12:00 PM
(10-105) Evaluation of Mycophenolate Dose Reductions During Viral Infections in Patients with a Heart Transplant
Favorite
11:00 AM – 12:00 PM
(10-106) Evaluation of Sugammadex Usage in the Perioperative Setting for Patients who Received Rocuronium or Vecuronium
Favorite
11:00 AM – 12:00 PM
(10-107) Evaluating Intravenous Heparin Infusion Related Errors in a Non-Critical Care Patient Population
Favorite
11:00 AM – 12:00 PM
(10-108) Use of Rasburicase for Hyperuricemia Associated with Malignancy
Favorite
11:00 AM – 12:00 PM
(10-109) Evaluation of IV Proton Pump Inhibitor (PPI) Use in Adult Patients
Favorite
11:00 AM – 12:00 PM
(10-110) Evaluation of As-Needed Intravenous Antihypertensive Use
Favorite
11:00 AM – 12:00 PM
(10-111) Time Study and Cost Analysis Evaluating the Usage of Mini Bags plus Preparation in the IV Room
Favorite
11:00 AM – 12:00 PM
(10-112) Timing of Subsequent Extended-Infusion Piperacillin/tazobactam After Employing an Initial 30-minute Standard Infusion.
Favorite
11:00 AM – 12:00 PM
(10-113) Appropriateness of Long-Acting Opioid Use at an Academic Medical Center
Favorite
11:00 AM – 12:00 PM
(10-114) Evaluating the Use of Tbo-filgrastim in Lung Transplant Recipients with Neutropenia
Favorite
11:00 AM – 12:00 PM
(10-115) Sugammadex Use in the Operating Room
Favorite
11:00 AM – 12:00 PM
(10-116) Evaluating the Usage of as Needed Antihypertensives in the Setting of Inpatient Acute Hypertension Management
Favorite
11:00 AM – 12:00 PM
(10-117) Appropriateness of blood culture ordering in non-hospital admitted patients presenting to the emergency department and the impact of a pharmacist-led education intervention.
Favorite
11:00 AM – 12:00 PM
(10-118) Optimizing Management of Seizures in Post-Cardiac Arrest Anoxic Encephalopathy
Favorite
11:00 AM – 12:00 PM
(10-119) Evaluation of Alcohol Withdrawal Syndrome Management in an Urban Safety Net Hospital
Favorite
11:00 AM – 12:00 PM
(10-120) Comparison of Factor Eight Inhibitor Bypassing Activity and Recombinant Coagulation Factor VIIa for Refractory Bleeding in Cardiothoracic Surgery Patients
Favorite
11:00 AM – 12:00 PM
(10-121) Evaluation of Statin Use in Patients with Diabetes at a Community Health Center
Favorite
11:00 AM – 12:00 PM
(10-122) Evaluation of a Pharmacist-Driven Pilot Workflow to Improve Oral Oncolytic Consent Completion at a Multi-Site Ambulatory Oncology Center
Favorite
11:00 AM – 12:00 PM
(10-123) Evaluation of the impact of two carboplatin dose calculation methods on overall treatment tolerability in gynecologic oncology patients
Favorite
11:00 AM – 12:00 PM
(10-124) Effect of Vitamin K on Correcting INR in Patients with Cirrhosis at a Community Health System
Favorite
11:00 AM – 12:00 PM
(10-125) Evaluation of Intravenous Antihypertensive Use and Monitoring Compliance in Medicine Patients at a Community Health System
Favorite
11:00 AM – 12:00 PM
(10-126) Evaluation of Filgrastim Product Use and Associated Costs within a Community Health Care System
Favorite
11:00 AM – 12:00 PM
(10-127) Evaluation of Outpatient Prescribing of Fosfomycin for Acute Uncomplicated Cystitis
Favorite
11:00 AM – 12:00 PM
(10-128) Utilization of P2Y12 Inhibitors for Percutaneous Coronary Intervention Within a CYP2C19 Tested Population in a Community Health System
Favorite
11:00 AM – 12:00 PM
(10-129) Evaluation of Tenecteplase Use in Acute Ischemic Stroke
Favorite
11:00 AM – 12:00 PM
(10-130) Evaluating Tolvaptan’s Utilization in Hyponatremia Management
Favorite
11:00 AM – 12:00 PM
(10-131) Antiepileptic Drug Use for Seizure Prophylaxis in Patients with Subarachnoid Hemorrhage
Favorite
11:00 AM – 12:00 PM
(10-132) Defining the Use of Midazolam and Fentanyl Administered for Moderate Sedation in the Gastroenterology (GI) Lab
Favorite
11:00 AM – 12:00 PM
(10-133) Evaluation of Periprocedural Management for Elective Procedures in Pharmacist-Managed Anticoagulation Clinics in a Multi-Hospital Health System
Favorite
11:00 AM – 12:00 PM
(10-134) Assessment of 3% Hypertonic Saline for the Treatment of Hyponatremia
Favorite
11:00 AM – 12:00 PM
(10-135) Effects of pharmacy-driven MRSA nasal PCR swab protocol on length of anti-MRSA antibiotic use and length of contact precautions among patients with pneumonia
Favorite
11:00 AM – 12:00 PM
(10-136) Optimal Midodrine Dosing In Critically Ill Patients Requiring Intravenous Vasopressors
Favorite
11:00 AM – 12:00 PM
(10-137) Evaluation of a Report for Empiric Therapy Appropriateness for Cystitis and Pyelonephritis at Northwestern Medicine Hospitals
Favorite
11:00 AM – 12:00 PM
(10-138) Evaluation of a System-Wide Vancomycin Dosing Protocol at a Single Non-Teaching Community Hospital Site
Favorite
11:00 AM – 12:00 PM
(10-139) Assessing the Influence of Specialized Pharmacist Education on Pediatric Cardiopulmonary Arrest: Prospective Interventional Investigation
Favorite
11:00 AM – 12:00 PM
(10-140) Impact of Emergency Medicine (EM) Pharmacist on Door-to-Needle Time of Tenceteplase Administration in Patients with Acute Ischemic Stroke within a Health System
Favorite
11:00 AM – 12:00 PM
(10-141) Comparison of Length of Stay in Community-Acquired Pneumonia Patients Who Fit Protocol for Pharmacy Driven De-escalation of Ceftriaxone to Standard of Care
Favorite
11:00 AM – 12:00 PM
(10-142) A Retrospective Analysis of Anti-Diabetic Medication Regimens in Kidney and Heart Transplant Patients
Favorite
11:00 AM – 12:00 PM
(10-143) Effect of an Insulin Basal-Bolus Order Set Update on Insulin Prescribing Practices in General Internal Medicine Patients with Type 2 Diabetes Mellitus
Favorite
11:00 AM – 12:00 PM
(10-144) Impact of Pharmacist Intervention on Oral Antimicrobial Prescribing at Hospital Discharge: Assessing Adherence to Guidelines
Favorite
11:00 AM – 12:00 PM
(10-145) Impact of symptom reporting on antibiotic appropriateness
Favorite
11:00 AM – 12:00 PM
(10-146) Impact of MRSA Nares Screening on De-escalation of Empiric Vancomycin Therapy in Patients with Proven or Suspected Pneumonia
Favorite
11:00 AM – 12:00 PM
(10-147) Impact of a Pharmacist-Managed Quality Improvement Initiative on the Cost Savings Associated with Dose Rounding Oncology Medications
Favorite
11:00 AM – 12:00 PM
(10-148) Assessing the Appropriateness of Aminoglycoside Utilization at Rush Copley Medical Center (RCMC)
Favorite
11:00 AM – 12:00 PM
(10-149) Development and Implementation of a Heart Failure Guideline-directed Medical Therapy (GDMT) Scoring Tool to Improve Outcomes
Favorite
11:00 AM – 12:00 PM
(10-150) Evaluation of Appropriate Anti-Thymocyte Globulin (ATGAM) use at Rush University Medical Center (RUMC)
Favorite
11:00 AM – 12:00 PM
(10-151) Medication Use Evaluation of Rush’s Enoxaparin Pharmacy to Dose Consult Service
Favorite
11:00 AM – 12:00 PM
(10-152) Rapid Intravenous Administration of Minimally Diluted Levetiracetam in Infants and Toddlers
Favorite
11:00 AM – 12:00 PM
(10-153) Intravenous Lorazepam Dosing for Treatment of Acute Seizures in Pediatric Patients
Favorite
11:00 AM – 12:00 PM
(10-154) Unveiling the Impact of MRSA PCR Testing on Anti-MRSA Therapy Duration for Pneumonia
Favorite
11:00 AM – 12:00 PM
(10-155) Comparison of Blood Pressure Fluctuations on Hematoma Expansion in Hemorrhagic Stroke
Favorite
11:00 AM – 12:00 PM
(10-156) Analysis of Community Acquired Pneumonia Prescribing Practices with Pre- and Post-intervention at a Community Teaching Hospital
Favorite
11:00 AM – 12:00 PM
(10-157) Evaluating the Impact of Best Practice Education and Weekly Controlled Substance Inventory on Drug Diversion Prevention and Detection in a Community Teaching Hospital
Favorite
11:00 AM – 12:00 PM
(10-158) Assessing Staff Competency and Compliance with United States Pharmacopeia Updates for Chapters 795, 797, 800
Favorite
11:00 AM – 12:00 PM
(10-159) Implementation of Guideline Directed Empiric Antipseudomonal Beta-Lactam De-escalation
Favorite
11:00 AM – 12:00 PM
(10-160) Evaluation of a Pharmacist Directed Treat to Target Approach in Patients with Inflammatory Bowel Disease Receiving Upadacitinib or Risankizumab
Favorite
11:00 AM – 12:00 PM
(10-161) Achievement of Guideline Recommended Goals for Hypertension, Diabetes, and Dyslipidemia in People with HIV in the Illinois Department of Corrections
Favorite
11:00 AM – 12:00 PM
(10-162) Comparison of direct-acting oral anticoagulation versus warfarin following kidney transplantation: A single center experience
Favorite
11:00 AM – 12:00 PM
(10-163) Evaluation of Empiric Vancomycin Guideline in the Neonatal Intensive Care Unit for Late-Onset Sepsis and Necrotizing Enterocolitis
Favorite
11:00 AM – 12:00 PM
(10-164) Clinical Outcomes of De Novo LCP-Tacrolimus vs Immediate Release Tacrolimus in Adult Liver Transplant Recipients
Favorite
11:00 AM – 12:00 PM
(10-165) Comparing In-person vs. Telehealth Kidney/Pancreas Transplant Suitability Evaluation by Pharmacist
Favorite
11:00 AM – 12:00 PM
(10-166) Risk Factors for Acute Kidney Injury Follow Liver Transplantation
Favorite
11:00 AM – 12:00 PM
(10-167) Assessing the Impact of a Pharmacist-Driven Consult Service on Safety and Efficacy of Medications for Opioid Use Disorder Utilization in the Inpatient Setting
Favorite
11:00 AM – 12:00 PM
(10-168) Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients on Belatacept-Based Versus Calcineurin Inhibitor-Based Immunosuppression
Favorite
11:00 AM – 12:00 PM
(10-169) Assessing Hepatitis A Virus and Hepatitis B Virus Screening, Immunity, and Vaccination in People Living With HIV in the Illinois Department of Corrections
Favorite
11:00 AM – 12:00 PM
(10-170) Effect of Home Antihypertensive Regimen on Hemodynamic and Clinical Outcomes While Using Angiotensin II in Kidney Transplant Recipients
Favorite
11:00 AM – 12:00 PM
(10-171) Impact of Utilization of Phenobarbital Order Set in Severe Alcohol Withdrawal
Favorite
11:00 AM – 12:00 PM
(10-172) Outcomes of Concentrated Furosemide Infusion on Atrial Fibrillation Rate Post-Kidney Transplant, a Single Center Experience
Favorite
11:00 AM – 12:00 PM
(10-173) Evaluating Institutional Lipid-Lowering Intensification in Patients Post Atherosclerotic Cardiovascular Disease Revascularization
Favorite
11:00 AM – 12:00 PM
(10-174) Evaluating the Impact of High Versus Low Kidney Donor Profile Index Kidneys on Post-Transplant Clinical Outcomes
Favorite
11:00 AM – 12:00 PM
(10-175) Impact of Pharmacist Intervention on the Prescribing Rate of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction
Favorite
11:00 AM – 12:00 PM
(10-176) Impact of Pharmacist Integration into the Denosumab Infusion Services Workflow
Favorite
11:00 AM – 12:00 PM
(10-177) Evaluation of Phenobarbital Use for Treatment of Alcohol Withdrawal Syndrome in Intensive Care Patients
Favorite
11:00 AM – 12:00 PM
(10-178) Implementation and Evaluation of Standardized Pharmacist Review of Prior to Admission Medication Lists
Favorite
11:00 AM – 12:00 PM
(10-179) Justification of a Pharmacist Managed Intranasal Esketamine Clinic
Favorite
11:00 AM – 12:00 PM
(10-180) Evaluation of Time to Administration of Levetiracetam for Seizures after Transition to Intravenous Push from Infusion in the Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-181) Implementation of a Pharmacy Driven Culture Callback Program at a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-182) Evaluating the Use of Nasal MRSA PCR Testing on Vancomycin Utilization in the Treatment of Pneumonias in a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-183) Comparison of the Incidence of Hypoglycemia Following Insulin-Dextrose Administration for Hyperkalemia Treatment in Patients With and Without a History of Diabetes in a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-184) Comparison of Tigecycline in Combination with Standard of Care versus Standard of Care in the Treatment of Clostridioides Difficile Infections in the Community Hospital Setting
Favorite
11:00 AM – 12:00 PM
(10-185) Evaluating Effectiveness of Anti-Factor Xa Assay Versus Activated Partial Thromboplastin Clotting Time (aPTT) Monitoring for Pharmacist-Managed Heparin Dosing
Favorite
11:00 AM – 12:00 PM
(10-186) Forty-Eight Hour Broad-Spectrum Antibiotic De-Escalation and Antibiotic Optimization in Inpatient Hospital Stays
Favorite
11:00 AM – 12:00 PM
(10-187) A Retrospective Study of Obesity and Overweight Treatment and Outcomes in Primary Care
Favorite
11:00 AM – 12:00 PM
(10-188) Assessment of Electrocardiogram Monitoring and QT Interval Prolongation with Ribociclib
Favorite
11:00 AM – 12:00 PM
(10-189) Time of Prior Authorization Decision Compared to Literature at Community Health Network
Favorite
11:00 AM – 12:00 PM
(10-190) Evaluating the Impact of Pharmacist Management of Osteoporosis in the Ambulatory Care Setting
Favorite
11:00 AM – 12:00 PM
(10-191) Impact of Hydrocortisone Regimen on Reversal of Shock in Hospitalized Patients with Septic Shock: A Retrospective Review
Favorite
11:00 AM – 12:00 PM
(10-192) Retrospective Study on the Effectiveness of an Institution Specific Patient Risk Stratification Tool for Scheduling of Medicare Annual Wellness Visits with a Pharmacist
Favorite
11:00 AM – 12:00 PM
(10-193) Examination of Changes in Clinical Outcomes for Patients Living with Human Immunodeficiency Virus (HIV) before and after Conversion to Injectable Cabotegravir/rilpivirine
Favorite
11:00 AM – 12:00 PM
(10-194) Mental Healthcare Utilization Among Transgender Individuals in a Community Psychiatric Hospital
Favorite
11:00 AM – 12:00 PM
(10-195) Assessment of Low Fixed-Dose Protocol of Activated Human Prothrombin Complex Concentrate (FEIBA) for Reversal of Warfarin-Induced Life-Threatening Hemorrhages at Community Healthcare System
Favorite
11:00 AM – 12:00 PM
(10-196) Buprenorphine reinitiation rates in hospitalized patients diagnosed with opioid use disorder
Favorite
11:00 AM – 12:00 PM
(10-197) Diabetic Ketoacidosis Quality Improvement to Decrease Length of Stay
Favorite
11:00 AM – 12:00 PM
(10-198) Assessment of Benzodiazepine Dosing in Toxicology Patients
Favorite
11:00 AM – 12:00 PM
(10-199) Percent change in weight after three months of medical weight management in adult patients by primary care provider versus co-managed by a clinical pharmacist.
Favorite
11:00 AM – 12:00 PM
(10-200) Evaluation of insulin/dextrose management for the treatment of hypertriglyceridemia-induced acute pancreatitis
Favorite
11:00 AM – 12:00 PM
(10-201) Assessment of Vancomycin Trough Levels Before and After Implementation of an Area Under the Curve (AUC) Dosing Calculator
Favorite
11:00 AM – 12:00 PM
(10-202) Real-world Incidence of Depression and Impact on Adherence in Patients Taking Oral Oncolytics
Favorite
11:00 AM – 12:00 PM
(10-203) Intravenous Only Therapy Versus Oral Step-Down Therapy in Simple Source Gram Positive Bacteremia
Favorite
11:00 AM – 12:00 PM
(10-204) Evaluation of the Role of a Pharmacist in the Management of Gestational Hypertension in an Obstetrics and Gynecology Clinic
Favorite
11:00 AM – 12:00 PM
(10-205) Enhancing Heart Failure Care: Implementation of Clinical Pharmacy Services Within an Existing Heart Failure Clinic
Favorite
11:00 AM – 12:00 PM
(10-206) Impact of a Pharmacist-Led Initiative on Antibiotic Use for Asymptomatic Urinary Tract Infection in the Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-207) Initiation of a Pharmacy-Driven Medication History Program
Favorite
11:00 AM – 12:00 PM
(10-208) The Effect of Pharmacist Interventions on Chronic Kidney Disease in an Ambulatory Care Setting
Favorite
11:00 AM – 12:00 PM
(10-209) The effect of pharmacist driven empiric vancomycin de-escalation in methicillin resistant staphylococcus aureus (MRSA) pneumonia with the utilization of MRSA nasal swabs
Favorite
11:00 AM – 12:00 PM
(10-210) Post Anesthesia Care Unit (PACU) Length of Stay with Sugammadex versus Neostigmine and Glycopyrrolate in Patients recovering from Intra-abdominal Surgery
Favorite
11:00 AM – 12:00 PM
(10-211) Overview of Pharmacist Diabetes Outcomes in the Primary Care Setting
Favorite
11:00 AM – 12:00 PM
(10-212) A Review of Guideline Directed Medication Therapy Adherence for Patients with Asthma
Favorite
11:00 AM – 12:00 PM
(10-213) Heading Towards Relief: A Headache Medication Evaluation in a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-214) Evaluation of Ambulatory Care Proton Pump Inhibitor Use
Favorite
11:00 AM – 12:00 PM
(10-215) Community Acquired Pneumonia Order Set Utilization Evaluation: A Retrospective Chart Review
Favorite
11:00 AM – 12:00 PM
(10-216) Evaluation of Diabetic Ketoacidosis Management: Comparing the Effectiveness of Computer Program-Directed vs Physician-Directed Intravenous to Subcutaneous Insulin Transition
Favorite
11:00 AM – 12:00 PM
(10-217) Reducing 30-day Readmission Rates for Admitted Patients on Inhalers Through the Use of Education and Improved Medication Accessibility
Favorite
11:00 AM – 12:00 PM
(10-218) Evaluation of the Impact of Pharmacist-Driven Management of Positive Blood Culture Results on Effective Antimicrobial Therapy within a Community Hospital Setting.
Favorite
11:00 AM – 12:00 PM
(10-219) Culturally Tailored, Pharmacist-Led Diabetes Education Intervention for Uninsured Hispanic Patients: Evaluation of Diabetes Knowledge Enhancement and A1c Improvement.
Favorite
11:00 AM – 12:00 PM
(10-220) Safety and Efficacy of an Updated Diabetic Ketoacidosis-Hyperglycemic Hyperosmolar State Protocol
Favorite
11:00 AM – 12:00 PM
(10-221) Impact of a Transition from Alteplase to Tenecteplase for Acute Ischemic Stroke on Door-to-Needle Time
Favorite
11:00 AM – 12:00 PM
(10-222) Impact of a Pharmacist-Led Nephrotoxin Stewardship Initiative on the Appropriate Use of Nephrotoxins and Renally Eliminated Drugs in Adult Patients at a Tertiary Care Hospital
Favorite
11:00 AM – 12:00 PM
(10-223) Impact of Pharmacist-Led Antimicrobial Stewardship Initiative on the Use of Antibiotics in the Emergency Department at a Lebanese Tertiary Care Hospital: A Pre-Post Study
Favorite
11:00 AM – 12:00 PM
(10-224) Effectiveness, safety and tolerability of dolutegravir+rilpivirine in pretreated HIV patients in a real-life cohort
Favorite
11:00 AM – 12:00 PM
(10-225) Study on Adverse Effects of Inhaled Antibiotherapy in Patients with Chronic Obstructive Pulmonary Disease and/or Bronchiectasis
Favorite
11:00 AM – 12:00 PM
(10-226) Ixekizumab as an alternative for the treatment of Pityriasis Rubra Pilaris: A Case Report
Favorite
11:00 AM – 12:00 PM
(10-227) Development of providing Drug Information for safe parenteral medication
Favorite
11:00 AM – 12:00 PM
(10-228) Satisfaction Toward Virtual Pharmacy-led Clinic in Renal Transplant Recipients: A Cross-Sectional Study
Favorite
11:00 AM – 12:00 PM
(10-229) Impact of Hypoalbuminemia on Ertapenem Treatment Failure in Patients with ESBL Enterobacterales Infection: Retrospective Cohort Study
Favorite
11:00 AM – 12:00 PM
(10-230) Exploring the Role of Antithrombotic Stewardship Program Led by Clinical Pharmacist in Optimizing Direct Oral Anticoagulants Prescribing in a Tertiary Care Hospital
Favorite
11:00 AM – 12:00 PM
(10-231) Clinical Outcomes of Carbapenem Resistant Pseudomonas Aeruginosa Treated with Cephalosporins or Piperacillin/Tazobactam
Favorite
11:00 AM – 12:00 PM
(10-232) Surgical Site Infections Occurrence and Associated Risk Factors: A Matched Case-Control Study
Favorite
11:00 AM – 12:00 PM
(10-233) Evaluation of the Treatment of Febrile Neutropenia in a Tertiary Care Center
Favorite
11:00 AM – 12:00 PM
(10-234) Assessing the quality of medication reconciliation process in the medical ward, A retrospective study
Favorite
11:00 AM – 12:00 PM
(10-235) Assessing the Adherence to Antibiotic Prophylaxis in Selected Surgical Procedures at Tawam Hospital
Favorite
11:00 AM – 12:00 PM
(10-236) Implementation of a penicillin allergy de-labeling workflow in a community hospital setting
Favorite
11:00 AM – 12:00 PM
(10-237) Assessment of Local Risk Factors for Resistant Organisms in Community-Acquired Pneumonia
Favorite
11:00 AM – 12:00 PM
(10-238) A Retrospective Study Investigating Solid Tumor Cancer Patients That Developed VTE Who Would Have Benefitted From Proactive Anticoagulation Initiation Using Their Khorana Risk Score.
Favorite
11:00 AM – 12:00 PM
(10-239) Impact of Pharmacist Intervention on Reduction in Subsequent Hypoglycemic Events in Hospitalized Patients
Favorite
11:00 AM – 12:00 PM
(10-240) Evaluation of Pre-Hospital and Emergency Department Benzodiazepine Dosing for Seizure Management
Favorite
11:00 AM – 12:00 PM
(10-241) Assessment and Characterization of Inpatient Naloxone Administration for Opioid Related Adverse Drug Events
Favorite
11:00 AM – 12:00 PM
(10-242) Evaluation of the Appropriate Use of Rapid Antigen Detection Tests for Diagnosis of Streptococcus Pharyngitis in Pediatric Patients in the Outpatient Setting
Favorite
11:00 AM – 12:00 PM
(10-243) Implementation of Specialty Pharmacy Service On-Site to Improve Quality of Care to Cancer Center Patients
Favorite
11:00 AM – 12:00 PM
(10-244) Pharmacist Lead Education Regarding the Treatment of Urinary Tract Infections versus Asymptomatic Bacteriuria
Favorite
11:00 AM – 12:00 PM
(10-245) Implementation of a Validated Screening Tool (TAPS) to Improve Screening Rates of Substance Use Disorders in a Family Practice Clinic
Favorite
11:00 AM – 12:00 PM
(10-246) Chronic Coronary Disease in Black Hawk County Iowa: Provider Education for Better Disease Management
Favorite
11:00 AM – 12:00 PM
(10-247) Implementation of a guided algorithm for dalbavancin usage in the emergency department
Favorite
11:00 AM – 12:00 PM
(10-248) Stepwise Approach to Reducing Antibiotic Prescribing for Catheter Associated Asymptomatic Bacteriuria in the Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-249) Comparing the Effectiveness of a Tenecteplase vs Alteplase in Reducing Door to Needle Time for Treatment of Acute Ischemic Stroke
Favorite
11:00 AM – 12:00 PM
(10-250) Evaluation of Pharmacist Driven Enoxaparin Anti-Xa Monitoring
Favorite
11:00 AM – 12:00 PM
(10-251) Influence of Electronic Medical Record Optimization on Empiric Utilization of Daptomycin at a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-252) Comparison of Droperidol and Haloperidol in the Management of Acute Agitation in the Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-253) Impact of an Insulin Order Set Complemented by a Multilayered Therapeutic Interchange on Severe Hypoglycemia Incidence
Favorite
11:00 AM – 12:00 PM
(10-254) Pharmacist Impact on 30-day Hospital Encounters in Patients with Diabetes Managed in a Transitional Care Clinic
Favorite
11:00 AM – 12:00 PM
(10-255) The Impact of Clinical Pharmacist Intervention on the Rates of Gestational Diabetes Complications
Favorite
11:00 AM – 12:00 PM
(10-256) Cefazolin versus Nafcillin for the Treatment of MSSA Bacteremia
Favorite
11:00 AM – 12:00 PM
(10-257) Comparing Weight Based Norepinephrine Dosing to Non-Weight Based Norepinephrine Dosing at the Time of Vasopressin Initiation in Septic Shock Patients
Favorite
11:00 AM – 12:00 PM
(10-258) The Effects of Scheduled Atypical Antipsychotics on Duration of Mechanical Ventilation
Favorite
11:00 AM – 12:00 PM
(10-259) Optimization of 5-fluorouracil preparation and the impact on pharmacy workflow
Favorite
11:00 AM – 12:00 PM
(10-260) Effect of Implementing Pharmacist-Driven Methicillin-Resistant Staphylococcus Aureus Nasal Polymerase Chain Reaction Screenings on Vancomycin Use in Patients With Community-Acquired Pneumonia
Favorite
11:00 AM – 12:00 PM
(10-261) Efficacy of Tirzepatide on Weight Loss in Adult Patients of Lawrence Memorial Hospital (LMH) Health Primary Care Clinics
Favorite
11:00 AM – 12:00 PM
(10-262) Post-Implementation Analysis of Tenecteplase Compared to Alteplase for Acute Ischemic Stroke at a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-263) Enhancing Chronic Care Management: Exploring the Impact of Pharmacist Involvement on Patient Care
Favorite
11:00 AM – 12:00 PM
(10-264) Penicillin Allergy De-Labeling in an Elective Surgery Setting at a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-265) Medication Use Evaluation of Buprenorphine at a Rural Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-266) Implementation of a Pharmacist Managed Warfarin Protocol in a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-267) Efficacy and Safety of Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Retrospective Study
Favorite
11:00 AM – 12:00 PM
(10-268) Safety and Efficacy of Fixed-Dose 4-Factor Prothrombin Complex Concentrate for Anticoagulation Reversal Following Institutional Policy Change
Favorite
11:00 AM – 12:00 PM
(10-269) Evaluating the HFA-ICOS Cardiovascular Risk Assessment Tool for Predicting Cardiotoxicity in Breast Cancer Patients
Favorite
11:00 AM – 12:00 PM
(10-270) Exploring Fentanyl Dosing Following Otolaryngology Surgery in Pediatric Patients
Favorite
11:00 AM – 12:00 PM
(10-271) Comparing the Incidence of Cefepime-Induced Neurotoxicity in Prolonged-Infusion versus Standard-Infusion Administrations
Favorite
11:00 AM – 12:00 PM
(10-272) Enhancing Antimicrobial Stewardship Through Health-System Integration: A Multidisciplinary Approach
Favorite
11:00 AM – 12:00 PM
(10-273) Retrospective Analysis of the Safety of Alteplase versus Tenecteplase in Ischemic Stroke
Favorite
11:00 AM – 12:00 PM
(10-274) Utilization assessment of fixed-ratio insulin/GLP-1RA combination products versus insulin and GLP1-RAs individually in Medicare beneficiaries
Favorite
11:00 AM – 12:00 PM
(10-275) Incidence of Immune Checkpoint-Inhibitor Related Thyroid Dysfunction: A Retrospective Analysis
Favorite
11:00 AM – 12:00 PM
(10-276) Evaluation of a Cyclophosphamide Rapid Hydration Protocol and Specific Gravity Requirements
Favorite
11:00 AM – 12:00 PM
(10-277) Incidence of Hypotension Post Rapid Sequence Intubation
Favorite
11:00 AM – 12:00 PM
(10-278) Rebound Hypertension after Prolonged Nicardipine Infusion
Favorite
11:00 AM – 12:00 PM
(10-279) Frontline Febrile Neutropenia Antibiotic Treatment across Institution Types: A Multicenter Survey Study
Favorite
11:00 AM – 12:00 PM
(10-280) Early Intravenous Magnesium Sulfate Administration in Acute Pediatric Asthma Exacerbations
Favorite
11:00 AM – 12:00 PM
(10-281) Impact of an Oral Dextrose Gel Protocol on Neonatal Hypoglycemia
Favorite
11:00 AM – 12:00 PM
(10-282) Hospital Response to Prolonged Hyperglycemia in the Medical Intensive Care Unit
Favorite
11:00 AM – 12:00 PM
(10-283) Monitoring Effectiveness and Safety of Implementing Pharmacist Guided Heparin Management in Achieving Time to Therapeutic Anti-Xa Levels Versus Nursing Protocol per aPTT Levels
Favorite
11:00 AM – 12:00 PM
(10-284) The Creation and Implementation of a Supportive Care Protocol for Head and Neck Cancer Populations
Favorite
11:00 AM – 12:00 PM
(10-285) Evaluating the Effect of an Antibiotic Pocket Guide on Rates of Guideline-Directed Empiric Antibiotic Regimens for Inpatients with Community Acquired Pneumonia
Favorite
11:00 AM – 12:00 PM
(10-286) Evaluation of Heart Failure Readmissions and Goal Directed Medical Therapy in a Rural Kentucky Hospital
Favorite
11:00 AM – 12:00 PM
(10-287) Assessment of Pharmacist-led Opioid Stewardship Workflow and Its Impact on Hospitalist Opioid Ordering Habits in a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-288) Compliance with Two Level Kinetics when Dosing Vancomycin in Obesity Based on Bayesian Models in a Community Hospital Setting
Favorite
11:00 AM – 12:00 PM
(10-289) Incidence of pump and medication errors in intermittent infusion utilizing proprietary vial and bag system in a community hospital.
Favorite
11:00 AM – 12:00 PM
(10-290) Impact of a Decentralized Clinical Pharmacist Service on Time-to-Administration of Antibiotics in Sepsis Patients at a Community Hospital Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-291) Evaluating the clinical and financial impacts of integrating a clinical pharmacy team in an ambulatory endocrinology clinic
Favorite
11:00 AM – 12:00 PM
(10-292) Effects of Pharmacist Continuity of Care on Medication Event Reporting in a Large Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-293) Impact of Adjunct Phenobarbital in Management of Alcohol Withdrawal Syndrome
Favorite
11:00 AM – 12:00 PM
(10-294) Comparison of Dexamethasone-Sparing and Olanzapine-Sparing Nausea Prevention Versus Standard of Care for Highly Emetogenic Chemotherapy
Favorite
11:00 AM – 12:00 PM
(10-295) Clostridioides difficile Infection Incidence Before and After Initiating a Two-step Testing Protocol
Favorite
11:00 AM – 12:00 PM
(10-296) Pharmacist Impact on Inpatient Morphine Milligram Equivalents (MME) through Automatic Intravenous to Oral Conversion of Opioids.
Favorite
11:00 AM – 12:00 PM
(10-297) Assessing the Impact of Midodrine on Intensive Care Unit Length of Stay in Refractory Septic Shock
Favorite
11:00 AM – 12:00 PM
(10-298) Evaluation of Empiric Coverage of Previously Cultured Multidrug Resistant Organisms in Critically Ill Patients Admitted with Sepsis
Favorite
11:00 AM – 12:00 PM
(10-299) Impact of pharmacist-driven patient education on all-cause readmissions in patients with heart failure
Favorite
11:00 AM – 12:00 PM
(10-300) Olanzapine for Highly Emetic Chemotherapy Regimens (O-HER): Implementing Evidence-Based Guideline Directed Therapy
Favorite
11:00 AM – 12:00 PM
(10-301) Impact of a Pharmacist-Involved Sepsis Alert on Time to Antimicrobial Administration in the Emergency Department at a Rural Community Health-System
Favorite
11:00 AM – 12:00 PM
(10-302) Implementation of a Pharmacy Driven Rapid Blood Stream Infection Response Protocol
Favorite
11:00 AM – 12:00 PM
(10-303) Evaluating the Effects of a Nursing-Driven Diabetic Ketoacidosis Protocol
Favorite
11:00 AM – 12:00 PM
(10-304) Impact of Rapid Blood Culture Identification Panels on Antimicrobial Selection
Favorite
11:00 AM – 12:00 PM
(10-305) Impact of a Urinalysis Order Panel Change on Emergency Department Reflex Cultures and Treatment of Asymptomatic Bacteriuria
Favorite
11:00 AM – 12:00 PM
(10-306) Evaluation of Guideline-Directed Medication Therapy at Discharge in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) in a Community Teaching Hospital
Favorite
11:00 AM – 12:00 PM
(10-307) Assessing Appropriateness of Vancomycin Population Kinetics in Adults with BMI-Adjusted Volume of Distribution
Favorite
11:00 AM – 12:00 PM
(10-308) Presumed Augmented Renal Clearance and Antibiotic Treatment Failure
Favorite
11:00 AM – 12:00 PM
(10-309) Impact of Using Actual Body Weight for Obese Compared to Non-Obese Breast Cancer Patients Receiving Carboplatin Dosed Using the Cockcroft-Gault Equation
Favorite
11:00 AM – 12:00 PM
(10-310) Inpatient Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Administration During Admission for Heart Failure Exacerbation
Favorite
11:00 AM – 12:00 PM
(10-311) Assessing National Institutes of Health Stroke Scale (NIHSS) Improvement in Patients Presenting with Acute Ischemic Stroke after Receiving Alteplase or Tenecteplase
Favorite
11:00 AM – 12:00 PM
(10-312) Pharmacist-Driven Evaluation on the Use of Post-Operative Pain Medications at Discharge in a Rural Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-313) Evaluation of Phenobarbital Loading Dose Series in an Alcohol Withdrawal Protocol in a Rural Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-314) Retrospective Evaluation of Heparin Syringe Protocol for Anticoagulation in Patients Receiving Continuous Renal Replacement Therapy
Favorite
11:00 AM – 12:00 PM
(10-315) Comparing the Lilo-Le-Louet (3L) Score to the 4T Score in Predicting Heparin-Induced Thrombocytopenia (HIT) in Cardiothoracic Surgery Patients Receiving Cardiopulmonary Bypass
Favorite
11:00 AM – 12:00 PM
(10-316) Implementation of a Buprenorphine Induction Program in a Community Health System
Favorite
11:00 AM – 12:00 PM
(10-317) Addition of Vitamin C Supplementation for the Prevention of Post-Operative Atrial Fibrillation Following Cardiothoracic Surgery
Favorite
11:00 AM – 12:00 PM
(10-318) Efficacy of Basal versus Prandial Insulin Transition after Diabetic Ketoacidosis Resolution
Favorite
11:00 AM – 12:00 PM
(10-319) Implementation of Khorana Score for Venous Thromboembolism (VTE) Prophylaxis in Oncology Patients; A Retrospective Review
Favorite
11:00 AM – 12:00 PM
(10-320) Retrospective Evaluation of Interruptive Pharmacogenomic Best Practice Alerts (BPAs) and their Association with Medication Therapy Changes
Favorite
11:00 AM – 12:00 PM
(10-321) Modelling Study Examining Opioid Poisoning in the Emergency Department of an Academic Based Community Medical Center
Favorite
11:00 AM – 12:00 PM
(10-322) Incidence of Inappropriate Midodrine Continuation Post Discharge from Intensive Care Units at an Academic Based Community Medical Center
Favorite
11:00 AM – 12:00 PM
(10-323) Impact of Pharmacist Transitions of Care Services for Patients with Chronic Obstructive Pulmonary Disease in a Rural Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-324) Effects of Typical Antipsychotic Administration in Methamphetamine-Related Agitation in the Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-325) CIWA-later: phenobarbital versus standard of care for moderate to severe alcohol withdrawal syndrome
Favorite
11:00 AM – 12:00 PM
(10-326) Evaluation of levetiracetam loading dose in adult patients with benzodiazepine-refractory status epilepticus
Favorite
11:00 AM – 12:00 PM
(10-327) Evaluation of Patient Satisfaction with Anti-CD20 B-cell Depletion Therapy in Multiple Sclerosis
Favorite
11:00 AM – 12:00 PM
(10-328) Valproic Acid for Treatment of Agitation and Delirium in Neurosurgical Intensive Care Unit Patients
Favorite
11:00 AM – 12:00 PM
(10-329) Impact of Doxycycline Discharge Kits on Appropriate Treatment of Sexually Transmitted Infections Among Patients in the Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-330) Naloxegol vs. Methylnaltrexone for Opioid-Induced Constipation in Hospitalized Patients with an Inadequate Response to Traditional Laxatives
Favorite
11:00 AM – 12:00 PM
(10-331) Impact of Low Dose Phenobarbital on Emergency Department Return Encounters for Patients with Acute Alcohol Withdrawal
Favorite
11:00 AM – 12:00 PM
(10-332) Performance of Molecular Diagnostic Panels for Bloodstream Infections During Febrile Neutropenia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation
Favorite
11:00 AM – 12:00 PM
(10-333) Aspirin and clopidogrel duration of therapy for secondary stroke prevention
Favorite
11:00 AM – 12:00 PM
(10-334) Evaluation of Cefepime IV Push Medication Administration
Favorite
11:00 AM – 12:00 PM
(10-335) Effect of Prophylactic Fluconazole on the Incidence of Candidemia in Patients Receiving Total Parenteral Nutrition (TPN)
Favorite
11:00 AM – 12:00 PM
(10-336) Negative Predictive Value of Methicillin-resistant Staphylococcus aureus Nares Screening in Adults Following Nasal Decolonization Swab
Favorite
11:00 AM – 12:00 PM
(10-337) Impact of Changing Migraine Outcome from Quality of Life to Objective Outcome on Pharmacist Interventions for Patients in a Health-System Specialty Pharmacy
Favorite
11:00 AM – 12:00 PM
(10-338) Evaluation of Beta-Lactam Antibiotics in Patients with Hypoalbuminemia and Enterobacterales Bacteremia
Favorite
11:00 AM – 12:00 PM
(10-339) Patient Outcomes from Using Depression Screening in Oncology Patient Consultations in a Community-Based Setting
Favorite
11:00 AM – 12:00 PM
(10-340) Assessing the Impact of a Standardized Pharmacy to Dose/Monitor Consult in Patients Receiving Vancomycin
Favorite
11:00 AM – 12:00 PM
(10-341) Assessing the Benefit of Daptomycin and Linezolid in Place of Vancomycin in Therapy
Favorite
11:00 AM – 12:00 PM
(10-342) Appropriateness of Bacterial Urinary Tract Infection Treatment: a Retrospective Chart Review
Favorite
11:00 AM – 12:00 PM
(10-343) Rates of Broad-Spectrum Antibiotic De-escalation Based on Positive Blood Cultures and Biofire Data
Favorite
11:00 AM – 12:00 PM
(10-344) Comparing Clinical Outcomes Between Phenobarbital and Benzodiazepines for the Management of Alcohol Withdrawal Syndrome: A Retrospective Review
Favorite
11:00 AM – 12:00 PM
(10-345) Safety of Ibuprofen in Infants Aged 28 days to 6 months: A Retrospective Chart Review
Favorite
11:00 AM – 12:00 PM
(10-346) Evaluation of the incidence of hypotension for patients with septic shock related to the order of vasopressor discontinuation
Favorite
11:00 AM – 12:00 PM
(10-347) Evaluation of Nicardipine vs Clevidipine for Non-Traumatic Intracerebral Hemorrhage Patients
Favorite
11:00 AM – 12:00 PM
(10-348) Assessing Sepsis Protocol Compliance: A Retrospective, Before-After Study in Determining Appropriate Empiric Antibiotic Therapy in Hospitalized Patients
Favorite
11:00 AM – 12:00 PM
(10-349) Effectiveness of sugammadex to reduce time-to-extubation following cardiac artery bypass graft procedure
Favorite
11:00 AM – 12:00 PM
(10-350) Bridging the Gap: NICU Utilization of Antibiotics, Indication, Duration and Appropriateness
Favorite
11:00 AM – 12:00 PM
(10-351) Impact of a Pharmacy-Led Pain Management Team on Adults in a Louisiana Medical Center
Favorite
11:00 AM – 12:00 PM
(10-352) Evaluating the Use of Aminoglycosides at a Large Academic Medical Center in Southeastern Louisiana
Favorite
11:00 AM – 12:00 PM
(10-353) Evaluation of Symptom-Triggered Phenobarbital versus Benzodiazepines Initiated in the Intensive Care Unit for Alcohol Withdrawal Symptoms
Favorite
11:00 AM – 12:00 PM
(10-354) Retrospective Evaluation of Hypoglycemia in the Perioperative Setting in Non-cardiac Surgical Patients Receiving Long-acting Insulin
Favorite
11:00 AM – 12:00 PM
(10-355) Appropriateness of Intravenous Iron use in Heart Failure
Favorite
11:00 AM – 12:00 PM
(10-356) Measuring Adherence to Best Practices When Dispensing Liquid Medications for Children
Favorite
11:00 AM – 12:00 PM
(10-357) Impact of rapid diagnostic tests to improve time to definitive antimicrobial therapy for bacteremia
Favorite
11:00 AM – 12:00 PM
(10-358) The Attitudes and Perceptions of Community Pharmacists Towards the Over the Counter (OTC) Birth Control Pill in Louisiana
Favorite
11:00 AM – 12:00 PM
(10-359) Assessing Prescribing Patterns in the Management of Diabetic Peripheral Neuropathy
Favorite
11:00 AM – 12:00 PM
(10-360) Clinical Outcome of Combination of Ceftaroline and Vancomycin versus Monotherapy for Treatment of Methicillin Resistant Staphylococcus aureus Bacteremia
Favorite
11:00 AM – 12:00 PM
(10-361) Guanfacine for the Management of Delirium in Hospitalized Older Adults
Favorite
11:00 AM – 12:00 PM
(10-362) Safety of Intermittent Intravenous and Intramuscular Midazolam Injection in Hospitalized Patients in Non-Intensive Care Nursing Units
Favorite
11:00 AM – 12:00 PM
(10-363) Characterization of Pharmacist Review of Emergency Department Discharge Prescriptions for Geriatric Patients
Favorite
11:00 AM – 12:00 PM
(10-364) Evaluation of Albumin Prescribing Practices in the Intensive Care Unit (ICU)
Favorite
11:00 AM – 12:00 PM
(10-365) Evaluation of Prescribing Patterns Among Surgical Unit Patients with Intra-abdominal Infections
Favorite
11:00 AM – 12:00 PM
(10-366) Utilization of the Clinical Process Improvement Program Framework to Improve Quality of Inpatient Pharmacist Warfarin Management in A Community Hospital Setting.
Favorite
11:00 AM – 12:00 PM
(10-367) Optimization of pharmacist managed warfarin therapy in a community hospital using the Clinical Process Improvement Leadership Program
Favorite
11:00 AM – 12:00 PM
(10-368) Integrating Current Prescription Software with OutcomesMTM and Expanding the Roles of Pharmacy Technicians and Interns to Improve Medication Therapy Management Services for Retail Pharmacies
Favorite
11:00 AM – 12:00 PM
(10-369) The Influence of a Pharmacist Driven Protocol on Hemoglobin A1C in Overbasalized Patients with Type 2 Diabetes at a Federally Qualified Health Care Organization
Favorite
11:00 AM – 12:00 PM
(10-370) The evaluation of proper inhaler use with the implementation of In-Check Dial in the management of COPD and asthma at a Federally Qualified Health Center
Favorite
11:00 AM – 12:00 PM
(10-371) Pre-exposure Prophylaxis Difference in Treatment before and after Provider Education in Penobscot Community Health Center Patients
Favorite
11:00 AM – 12:00 PM
(10-372) Questions Asked to Specialty Pharmacists During the COVID-19 Pandemic: A Retrospective Review
Favorite
11:00 AM – 12:00 PM
(10-373) Assessing the Appropriateness of Ceftriaxone Utilization in Urinary Tract Infections, Community-Acquired Pneumonia, and Intra-Abdominal Infections at a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-374) Design and Implementation of a Direct Oral Anticoagulant To-Go Program for Venous Thromboembolism in a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-375) Appropriateness of Darbepoetin Alfa Usage in an Inpatient Setting at Frederick Health Hospital
Favorite
11:00 AM – 12:00 PM
(10-376) Analysis of Ipratropium Bromide and Albuterol Inhaler Use in Hospitalized Patients
Favorite
11:00 AM – 12:00 PM
(10-377) Evaluation of Appropriate Piperacillin/Tazobactam Use at a Community Teaching Hospital After Removal of ID Requirement
Favorite
11:00 AM – 12:00 PM
(10-378) Comparing the Efficacy of Liposomal Bupivacaine and Ropivacaine for Adductor Canal Block in Unilateral Total Knee Replacement
Favorite
11:00 AM – 12:00 PM
(10-379) Impact of Pharmacist-Driven Penicillin Allergy De-Labeling on Appropriate Antibiotic Use
Favorite
11:00 AM – 12:00 PM
(10-380) Door-to-Needle Time: Tenecteplase versus Alteplase
Favorite
11:00 AM – 12:00 PM
(10-381) Impact of Pharmacist-Directed Opioid Stewardship on Patient Outcomes
Favorite
11:00 AM – 12:00 PM
(10-382) Impact of Implementation of a Medicaid Lock-in Program on Patients Continued Use of Opioids.
Favorite
11:00 AM – 12:00 PM
(10-383) Real-World Visual and Anatomical Outcomes of Faricimab Use in Ophthalmology Patients with Neovascular Age-Related Macular Degeneration and/or Diabetic Macular Edema
Favorite
11:00 AM – 12:00 PM
(10-384) Evaluation of the impact of pharmacist-led medication reconciliations post-hospital discharge on readmissions in a select high-risk population
Favorite
11:00 AM – 12:00 PM
(10-385) Evaluation of the Use of Procalcitonin Levels in Patients Receiving Antibiotics for Pneumonia or Sepsis
Favorite
11:00 AM – 12:00 PM
(10-386) Use of Concomitant Gram-Negative Coverage in Patients on Vancomycin for Skin and Soft Tissue Infections
Favorite
11:00 AM – 12:00 PM
(10-387) Metoprolol versus Diltiazem: Management of Atrial Fibrillation with Rapid Ventricular Response in Patients with Heart Failure with Reduced Ejection Fraction in the Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-388) Medication Use Evaluation of Intravenous Hydrocortisone for Septic Shock in a Community Hospital’s Intensive Care Unit
Favorite
11:00 AM – 12:00 PM
(10-389) Retrospective Evaluation of Clinical Outcomes Associated with Adjunctive Nebulized Antibiotics Compared to Intravenous Antibiotic Monotherapy for Pneumonia in Adult Patients at a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-390) Development of a Pharmacist Managed Outpatient Oral Oncology Clinic
Favorite
11:00 AM – 12:00 PM
(10-391) Evaluation of the perception and assessment of pain to bridge the gap of opioid administration disparities among patients
Favorite
11:00 AM – 12:00 PM
(10-392) Evaluation of ICU Delirium Antipsychotic Use and Transitions of Care Practices
Favorite
11:00 AM – 12:00 PM
(10-393) Evaluation of Tolvaptan Safety and Efficacy at LifeBridge Health
Favorite
11:00 AM – 12:00 PM
(10-394) Evaluation of sodium zirconium cyclosilicate efficacy in acute hyperkalemia in the Emergency Department at LifeBridge Health (LBH)
Favorite
11:00 AM – 12:00 PM
(10-395) Retrospective Review of a Community Hospital’s Massive Transfusion Protocol for Traumatic Hemorrhage
Favorite
11:00 AM – 12:00 PM
(10-396) Characterization of Newly Prescribed DOACs on Discharge From BWMC Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-397) Short Duration versus Long Duration Beta-Lactam Therapy for Acute Uncomplicated Pyelonephritis in Patients Discharged from a Community Hospital Emergency Department
Favorite
11:00 AM – 12:00 PM
(10-398) Evaluating the Impact of Pharmacist Intervention on Medication Reconciliation and Counseling
Favorite
11:00 AM – 12:00 PM
(10-399) Enhancing Sepsis Care: Improving Facility Antibiotic Administration Time in Sepsis
Favorite
11:00 AM – 12:00 PM
(10-400) Optimization of a Diabetic Ketoacidosis (DKA) Protocol in Medical ICU Patients
Favorite
11:00 AM – 12:00 PM
(10-401) Assessing Pharmacist’s Role in Direct Oral Anticoagulant Management in the Ambulatory Care Setting
Favorite
11:00 AM – 12:00 PM
(10-402) Effects of a High-Touch Specialty Pharmacy Care Model on Annualized Relapse Rates in Patients with Multiple Sclerosis
Favorite
11:00 AM – 12:00 PM
(10-403) Development of a competency-based orientation (CBO) model to assess education, training, and proficiency in order verification for inpatient pharmacists
Favorite
11:00 AM – 12:00 PM
(10-404) Implementation of a Direct Oral Anticoagulant (DOAC) Stewardship program: A Quality Improvement Initiative
Favorite
11:00 AM – 12:00 PM
(10-405) Rates of Cytomegalovirus (CMV) Viremia Post-Kidney Transplant Using Lower Than Recommended Doses of Prophylactic Valganciclovir
Favorite
11:00 AM – 12:00 PM
(10-406) Impact of Pharmacist-Led Medication Reconciliation on HIV Patient Outcomes in an Interprofessional Outpatient HIV Clinic
Favorite
11:00 AM – 12:00 PM
(10-407) Comparison of Tenecteplase Versus Alteplase in Patients With Acute Ischemic Stroke
Favorite
11:00 AM – 12:00 PM
(10-408) Development of a Standardized Clinical Opioid Withdrawal protocol and algorithm for initiating opioid agonist therapy.
Favorite
11:00 AM – 12:00 PM
(10-409) Evaluating the Hemodynamic Effects of Pharmacologic Agents Utilized in Rapid Sequence Intubation
Favorite
11:00 AM – 12:00 PM
(10-410) Evaluation of Inpatient Community Acquired Pneumonia Treatment at a Large Academic Medical Center
Favorite
11:00 AM – 12:00 PM
(10-411) Evaluation of Institutional Practices for Albumin Infusions in Surgical and Trauma ICUs
Favorite
11:00 AM – 12:00 PM
(10-412) Evaluation of Inpatient Prescribing Practices for Rituximab
Favorite
11:00 AM – 12:00 PM
(10-413) Improvement of Glucose Control in Non-Intensive Care Unit (ICU) Patients: A Quality Improvement Project
Favorite
11:00 AM – 12:00 PM
(10-414) Impact of Phenobarbital Versus Benzodiazepines on Length of Stay and Readmission Rate in Patients With Alcohol Withdrawal Syndrome
Favorite
11:00 AM – 12:00 PM
(10-415) Role of the Pharmacist in Clinical Trials Research: Current State and Future Direction
Favorite
11:00 AM – 12:00 PM
(10-416) Evaluating the Impact of a Transition of Care Service in Clinical Outcomes of Patients with Diabetes
Favorite
11:00 AM – 12:00 PM
(10-417) Evaluation of Antibiotic Treatment Durations in Hospitalized Patients with Community Acquired Pneumonia
Favorite
11:00 AM – 12:00 PM
(10-418) Impact of a Hyperkalemia Order Set on Improving Outcomes and Safety at a Community Teaching Institution
Favorite
11:00 AM – 12:00 PM
(10-419) Targeted Medication Reviews to Increase Clozapine Prescribing
Favorite
11:00 AM – 12:00 PM
(10-420) Delabeling Penicillin Allergies at an Urban Community Teaching Hospital
Favorite
11:00 AM – 12:00 PM
(10-421) Analysis of Mass General Brigham Antimicrobial Dosing Guidelines and Incidence of Acute Kidney Injury In Hospitalized Patients
Favorite
11:00 AM – 12:00 PM
(10-422) Descriptive Study To Evaluate The Time to Therapeutic AUC level When Utilizing Vancomycin Loading Dose for The Treatment of MRSA Infections
Favorite
11:00 AM – 12:00 PM
(10-423) Evaluation of romiplostim use for adults with chemotherapy-induced thrombocytopenia
Favorite
11:00 AM – 12:00 PM
(10-424) Assessing and improving first-line antibitoics usage in obstetric patients in a community hospital
Favorite
11:00 AM – 12:00 PM
(10-425) Impact of inpatient empagliflozin initiation on post-discharge diuretic doses in patients with heart failure
Favorite
11:00 AM – 12:00 PM
(10-426) Impact of Semaglutide versus Dulaglutide on Weight in Patients with Diabetes and Obesity at a Federally Qualified Health Center within a Predominantly Hispanic Community
Favorite
11:00 AM – 12:00 PM
(10-427) Comparison of Metabolic Profiles of Low-Dose Quetiapine versus Mirtazapine for Individuals with Insomnia at a Federally Qualified Health Center
Favorite
11:00 AM – 12:00 PM
(10-428) Implementation of a Clinical Practice Guideline for Venous Thromboembolism Prophylaxis in Trauma Patients at a Community Hospital
Favorite
11:00 AM – 12:00 PM
(10-429) Time to Diabetic Ketoacidosis Resolution with Lactated Ringers Versus Normal Saline for Fluid Resuscitation
Favorite
11:00 AM – 12:00 PM
(10-430) Implementation of Increased Pharmacist-Led Gradual Dose Reductions for Off-Label Antipsychotics in the Geriatric Population
Favorite
11:00 AM – 12:00 PM
(10-431) Implementation of Strategies to Guide Management of QT Prolonging Medications
Favorite
11:00 AM – 12:00 PM
(10-432) Impact of the Addition of Virtual Care in Ambulatory Care Clinical Pharmacy Diabetes Clinics on HgbA1c
Favorite
11:00 AM – 12:00 PM
(10-433) Evaluating the Accuracy of Area Under the Curve (AUC) Vancomycin Dosing Through an Online Pharmacokinetic Calculator with Bayesian Modeling Compared to First-Order Pharmacokinetic Equations
Favorite
11:00 AM – 12:00 PM
(10-434) Efficacy, Safety, and Appropriateness of Pharmacological Venous Thromboembolism Prophylaxis Practice in Non-Surgical Hospitalized Patients with Extreme Weight in a Community Teaching Hospital
Favorite
11:00 AM – 12:00 PM
(10-435) Quality improvement project to improve documentation of Patient-Controlled Analgesia (PCA)
Favorite
11:00 AM – 12:00 PM
(10-436) Pharmacy-Led Admission Medication Reconciliation
Favorite
11:00 AM – 12:00 PM
(10-437) Impact of Pharmacist-led Interventions Targeting Modifiable Risk Factors on Pneumonia Readmission Rates
Favorite
11:00 AM – 12:00 PM
(10-438) Evaluation of Unfractionated Heparin Weight Based Dosing Protocols in Obese vs. Non-Obese Critically Ill Patients
Favorite
11:00 AM – 12:00 PM
(10-439) Reduction of Days of Therapy of Broad-Spectrum Antibiotic Use to Treat Intra-abdominal Infections in an Urban Community Teaching Hospital
Favorite
11:00 AM – 12:00 PM
(10-440) Impact of Pharmacy Interventions in Improving Surgical Prophylaxis Antimicrobial Selection and Administration Time
Favorite
11:00 AM – 12:00 PM
(10-441) Use of Phenobarbital Protocol for Treatment of Alcohol Withdrawal Syndrome in Non-Critically Ill Patients
Favorite
11:00 AM – 12:00 PM
(10-442) Fidaxomicin: A Quality Improvement Analysis for its Utilization and Compliance Across a Health-System
Favorite
11:00 AM – 12:00 PM
(10-443) Optimizing Antibiotic Administration Time in the Emergency Department: Analysis of Time to First Dose of Antibiotics upon Order Entry across a Health System
Favorite
11:00 AM – 12:00 PM
(10-444) Long-Acting Antipsychotics: A Multi-Hospital System Medication Use Evaluation
Favorite
11:00 AM – 12:00 PM
(10-445) Evaluation of Perioperative Antibiotic Compliance among Hospitals in a Health-System
Favorite
11:00 AM – 12:00 PM
(10-446) Continuous Renal Replacement Therapy (CRRT) anticoagulation with heparin protocol.
Favorite
11:00 AM – 12:00 PM
(10-447) Impact of Targeted Opioid Education on Increasing the Instance of Multimodal Pain Management and Pain Reassessment
Favorite
11:00 AM – 12:00 PM
(10-448) Evaluation of Clonidine Utilization for Dexmedetomidine Discontinuation in the Intensive Care Unit
Favorite
11:00 AM – 12:00 PM
(10-449) Community-Pharmacy Resident Led Diabetes Injection Technique Education and Disease State Optimization
Favorite
11:00 AM – 12:00 PM
(10-450) Impact of Retail Pharmacy Meds to Beds with Ambulatory Pharmacotherapy Clinic Services on 30 Day Readmission Rates at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-001) Clinical Efficacy Evaluation of Step-Down Oral Antibiotic Therapy for Streptococcal and Enterococcal Bloodstream Infections
Favorite
12:30 PM – 1:30 PM
(11-002) Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients With Severe Renal Impairment: A Multicenter Study
Favorite
12:30 PM – 1:30 PM
(11-003) Optimizing Healthcare: Implementation of a Pharmacist-Driven Transitions of Care Pilot Program
Favorite
12:30 PM – 1:30 PM
(11-004) Cisatracurium versus Atracurium in the Management of Non-COVID-19 Acute Respiratory Distress Syndrome
Favorite
12:30 PM – 1:30 PM
(11-005) The CoNSequences of Blood Culture Contamination with Coagulase Negative Staphylococcus
Favorite
12:30 PM – 1:30 PM
(11-006) Evaluation of Niche Gram Negative Agents in the Treatment of Multidrug Resistant Infections
Favorite
12:30 PM – 1:30 PM
(11-007) Prevention of Acute Kidney Injury in Cardiothoracic Surgery Patients with Urinary Biomarker-Guided Management
Favorite
12:30 PM – 1:30 PM
(11-008) Evaluation of Fluconazole Prophylaxis in the Neonatal Intensive Care Unit (NICU)
Favorite
12:30 PM – 1:30 PM
(11-009) Characterization of Procalcitonin Use at a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-010) Characterization of early long-acting insulin in adult diabetic ketoacidosis
Favorite
12:30 PM – 1:30 PM
(11-011) Intraoperative Glucose Management in Patients Undergoing Cardiac Surgery
Favorite
12:30 PM – 1:30 PM
(11-012) Safety and efficacy of early antibiotic discontinuation in febrile neutropenic patients at a tertiary medical center
Favorite
12:30 PM – 1:30 PM
(11-013) Characterizing Sodium-Glucose Cotransporter-2 Inhibitor Use in Heart Failure Patients at an Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-014) Time to Sepsis Treatment Before and After Implementation of a Protocolized Sepsis Resuscitation Program
Favorite
12:30 PM – 1:30 PM
(11-015) Evaluation of Screening and Treatment of Asymptomatic Bacteriuria
Favorite
12:30 PM – 1:30 PM
(11-016) Evaluation of Peri-Operative Antibiotic Prophylaxis in Patients Undergoing Total Hip or Knee Arthroplasty
Favorite
12:30 PM – 1:30 PM
(11-017) Assessment of the Value of Anticoagulant Interventions Initiated by Pharmacists
Favorite
12:30 PM – 1:30 PM
(11-018) Evaluation of a pharmacist-led intervention to optimize beta-lactam allergy reporting
Favorite
12:30 PM – 1:30 PM
(11-019) Evaluation of Efficacy and Safety of 4-Factor Prothrombin Complex Concentrate in the Reversal of Apixaban and Rivaroxaban Related Acute Bleed
Favorite
12:30 PM – 1:30 PM
(11-020) An Assessment of Pharmacist-Driven Antimicrobial Pre-Operative Prophylaxis
Favorite
12:30 PM – 1:30 PM
(11-021) Pharmacist Led Management of Glucagon-Like Peptide 1 Receptor Agonists
Favorite
12:30 PM – 1:30 PM
(11-022) Monitoring Heparin Continuous Infusions and the Time to Achieve Therapeutic Anti-Xa Levels in the NICU
Favorite
12:30 PM – 1:30 PM
(11-023) Comparing the Safety and Efficacy of the Utilization of SMOF vs Intralipid in the Neonatal Population
Favorite
12:30 PM – 1:30 PM
(11-024) The Sweet Truth: Optimizing Insulin Infusion Protocols for Enhanced Glycemic Control Across a Health System
Favorite
12:30 PM – 1:30 PM
(11-025) Retrospective Institutional Evaluation of the Appropriateness of Therapy for Bacteremia with Early versus Late Multiplex PCR Panel Detection
Favorite
12:30 PM – 1:30 PM
(11-026) A Retrospective Institutional Evaluation of the Use of Procalcitonin in the De-escalation of Antibiotics in Lower Respiratory Tract Infections
Favorite
12:30 PM – 1:30 PM
(11-027) Retrospective Institutional Evaluation of the Incidence of Thrombocytopenia in Patients Undergoing Continuous Renal Replacement Therapy and Prolonged Intermittent Renal Replacement Therapy
Favorite
12:30 PM – 1:30 PM
(11-028) Impact of Timing of Four-Factor Prothrombin Complex Concentrate Administration on Outcomes in Oral Factor Xa Inhibitor-associated Intracranial Hemorrhage
Favorite
12:30 PM – 1:30 PM
(11-029) The Impact of an Ambulatory Care Elective: Evaluating Student’s Perceptions and Entry-Level Competencies Post-Ambulatory Care APPE
Favorite
12:30 PM – 1:30 PM
(11-030) Effect of Time to Therapeutic Vancomycin Area Under the Curve on Clinical Outcomes in Hospitalized Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
Favorite
12:30 PM – 1:30 PM
(11-031) Incidence of Acute Kidney Injury with Hydroxocobalamin Administration
Favorite
12:30 PM – 1:30 PM
(11-032) Efficacy of Inpatient Sodium-glucose Cotransporter-2 Inhibitor Initiation in Heart Failure
Favorite
12:30 PM – 1:30 PM
(11-033) Ceftriaxone Plus Doxycycline or Azithromycin for Inpatient Treatment of Community-Acquired Pneumonia
Favorite
12:30 PM – 1:30 PM
(11-034) Impact of Prescriber Education on Empagliflozin Prescribing and Adverse Reactions in an inpatient setting at the DMC
Favorite
12:30 PM – 1:30 PM
(11-035) Addition of Antibiotic End Dates Prior to ICU Discharge
Favorite
12:30 PM – 1:30 PM
(11-036) Serum magnesium associated with atrial fibrillation rates in cardiothoracic surgery (CTS)
Favorite
12:30 PM – 1:30 PM
(11-037) Milrinone Use and Complications in Critically Ill Adults With and Without Kidney Failure
Favorite
12:30 PM – 1:30 PM
(11-038) Evaluation of half-dose prothrombin complex concentrate in Cardiac Surgery
Favorite
12:30 PM – 1:30 PM
(11-039) Stewardship Opportunities for a Hospital Philanthropic Fund for Patient Medication Access
Favorite
12:30 PM – 1:30 PM
(11-040) Lung cancer screening in patients prescribed smoking cessation therapy at an integrated health system
Favorite
12:30 PM – 1:30 PM
(11-041) Rhythm and Rhyme Behind "POEM" Pharmacist Involvement with Oral Anticancer Agents
Favorite
12:30 PM – 1:30 PM
(11-042) Oops! Did we miss it? Missed opportunities for oral antibiotic therapy in bone and joint infections
Favorite
12:30 PM – 1:30 PM
(11-043) Observation of Anti-Infective Use in Esophageal Perforations
Favorite
12:30 PM – 1:30 PM
(11-044) Characterization of Dose-dense Doxorubicin and Cyclophosphamide within the Keynote-522 Trial Regimen for Triple Negative Breast Cancer
Favorite
12:30 PM – 1:30 PM
(11-045) Insulin Prescribing and Glycemic Control in Response to a Steroid-Induced Hyperglycemia Best Practice Alert
Favorite
12:30 PM – 1:30 PM
(11-046) I-C-U Continuing Antipsychotics at Discharge
Favorite
12:30 PM – 1:30 PM
(11-047) Cost Savings and Clinical Evaluation of Sugammadex Utilization at Henry Ford Health System
Favorite
12:30 PM – 1:30 PM
(11-048) Ketamine Use in the Hospital Setting
Favorite
12:30 PM – 1:30 PM
(11-049) Evaluation of Inpatient Opioid Administration and Outpatient Opioid Prescribing Following Intraoperative Bupivacaine/meloxicam Use in Unilateral Primary Total Knee Arthroplasty
Favorite
12:30 PM – 1:30 PM
(11-050) Evaluation of Initial Antibiotic(s) Use in Patients with Community Acquired Pneumonia at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-051) Establishing an Emergency Medicine Pharmacist Position at a Community Teaching Hospital with a Focus on Anticoagulation-Related Interventions
Favorite
12:30 PM – 1:30 PM
(11-052) Lorazepam Oral Solution Evaluation of Preparation and Administration of Medication (LOraSEPAM)
Favorite
12:30 PM – 1:30 PM
(11-053) Evaluation of Post-Intubation Sedation Following Rocuronium Versus Succinylcholine in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-054) Utilization of a Carbapenem Request Form and Its Impact on Empiric Prescribing
Favorite
12:30 PM – 1:30 PM
(11-055) Breaking Free from Opioids: ESP Catheters Leading the Way in Rib Fracture Pain Management
Favorite
12:30 PM – 1:30 PM
(11-056) Raising the Barb: Evaluating the Impact of the Updated Alcohol Withdrawal Management Order Panel on Escalation of Care
Favorite
12:30 PM – 1:30 PM
(11-057) Shockingly Vague: Evaluating the Timing of Adjunct Therapy to Norepinephrine in Septic Shock
Favorite
12:30 PM – 1:30 PM
(11-058) Clinical Outcomes in Severe Trauma Patients Requiring Emergent Surgery while on Anticoagulants and Antiplatelets
Favorite
12:30 PM – 1:30 PM
(11-059) Effects of Early Venous Thromboembolism Prophylaxis on Intracranial Hemorrhage Outcomes in Traumatic Brain Injury Patients
Favorite
12:30 PM – 1:30 PM
(11-060) Evaluation of pediatric antimicrobial dosing in primary care and emergency settings to identify opportunities to optimize prescribing
Favorite
12:30 PM – 1:30 PM
(11-061) Comparison of Warfarin Management Between Primary Care Provider and Pharmacist-Led Anticoagulation Clinics Within a Primary Care Network
Favorite
12:30 PM – 1:30 PM
(11-062) Evaluation of Time in Therapeutic Range Using Provider to Dose Warfarin for Hospitalized Patients
Favorite
12:30 PM – 1:30 PM
(11-063) Evaluation of Time in Therapeutic Range with Pharmacist to Dose Warfarin for Hospitalized Patients
Favorite
12:30 PM – 1:30 PM
(11-064) Evaluation of Naloxone Use for Inpatient Opioid Reversal at a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-065) Evaluation of Naloxone Use for Inpatient Opioid Reversal at a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-066) Retrospective Review of Guideline Concordance with Perioperative Anticoagulation Practices
Favorite
12:30 PM – 1:30 PM
(11-067) Evaluation of Oral Pre-exposure Prophylaxis Therapy in Primary Care Clinics
Favorite
12:30 PM – 1:30 PM
(11-068) Four Factor Prothrombin Complex Concentrate (4F-PCC) for the Reversal of Direct-Acting Oral Anticoagulants (DOACs) at a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-069) Evaluation of Inpatient IV Iron in a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-070) Factors associated with hypoglycemia in critically ill patients at a community teaching hospital
Favorite
12:30 PM – 1:30 PM
(11-071) Evaluation of Appropriate Use and Safety of SGLT2 Inhibitor Therapy in the Inpatient Setting
Favorite
12:30 PM – 1:30 PM
(11-072) Factors associated with hypoglycemia in non-critically ill patients at a community teaching hospital
Favorite
12:30 PM – 1:30 PM
(11-073) Prescribing of Intravenous Pantoprazole at a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-074) Evaluation of perioperative tranexamic acid (TXA) use in orthopedic procedures
Favorite
12:30 PM – 1:30 PM
(11-075) Osteoporosis Treatment and the Use of a Collaborative Practice Agreement: Does Pharmacist Clinician Intervention Lead to Better Patient Outcomes?
Favorite
12:30 PM – 1:30 PM
(11-076) Evaluation of Pharmacist-led GLP-1 Utilization and Management of Type 2 Diabetic Patients Compared to Primary Care
Favorite
12:30 PM – 1:30 PM
(11-077) Cost Savings of Intermittent Pantoprazole Intravenous Push Versus Continuous Infusion Strategies
Favorite
12:30 PM – 1:30 PM
(11-078) Intravenous Piggyback Versus Intravenous Push Levetiracetam: A Case-Control Study of Time to Antiepileptic Drug Administration in an Acute Care Setting
Favorite
12:30 PM – 1:30 PM
(11-079) More than One Solution: Savings Opportunities for Enteral Dose Formulations
Favorite
12:30 PM – 1:30 PM
(11-080) Go Broad or Go Home: Meropenem Prescribing Patterns for Empiric Antibiotic Choice in Patients with a Penicillin or Cephalosporin Allergy
Favorite
12:30 PM – 1:30 PM
(11-081) To Err is Human: A Comparison of Heparin Administration Errors in Nurse-Driven Versus Pharmacy-Managed Heparin Protocols
Favorite
12:30 PM – 1:30 PM
(11-082) Effects of Chart Review and Pharmacist Interventions on Diabetes Gap Scores in the Rural Ambulatory Care Setting
Favorite
12:30 PM – 1:30 PM
(11-083) Outcomes associated with PCC weight-based and fixed dosing strategies for factor Xa reversal in the setting of emergent surgery
Favorite
12:30 PM – 1:30 PM
(11-084) Evaluation of Long-Acting Injectable Reimbursement at a Hospital Based Mental Health Clinic
Favorite
12:30 PM – 1:30 PM
(11-085) Pharmacist Interventions in Discharge Medication Reconciliation for Mental Health Patients
Favorite
12:30 PM – 1:30 PM
(11-086) Creation of an Intensive Care Unit-Specific Combination Antibiogram to Enhance Empiric Antimicrobial Treatment Decisions
Favorite
12:30 PM – 1:30 PM
(11-087) Safety, Efficacy and Usage of Tranexamic Acid in a Level 1 Trauma Center
Favorite
12:30 PM – 1:30 PM
(11-088) Standardization of Uterotonic Agent Administration in the Surgical Suite after Elective Cesarean Section: Impacts on Cost and Care
Favorite
12:30 PM – 1:30 PM
(11-089) Evaluating the Safety and Efficacy of Algorithm-Based Versus Fixed-Rate Insulin Infusions for the Treatment of Diabetic Ketoacidosis in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-090) Evaluation and Expansion of Push Dose Antibiotics in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-091) Evaluating the use of Droperidol in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-092) What is with the Doxy Moxie? Reviewing Prescriber Preferences and the Use of Doxycycline at a Large Tertiary Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-093) Feasibility of Transitioning EPOCH-containing Chemotherapy Regimens to Ambulatory Settings at CentraCare Health System
Favorite
12:30 PM – 1:30 PM
(11-094) Medication Use Evaluation of Clevidipine at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-095) Medication Use Evaluation of Palonosetron, Aprepitant and Fosaprepitant in Post Operative Nausea and Vomiting (PONV) Prevention
Favorite
12:30 PM – 1:30 PM
(11-096) Review of Direct Oral Anticoagulants Dosing and Associated Indications at a Central Minnesota Health System
Favorite
12:30 PM – 1:30 PM
(11-097) Review of Analgesics Therapeutic Duplication in Order Sets
Favorite
12:30 PM – 1:30 PM
(11-098) Review of off-label semaglutide prescribing at two Central Minnesota weight loss clinics
Favorite
12:30 PM – 1:30 PM
(11-099) Impact of Rapid MSSA Identification and Stewardship Interventions on Length of Anti-MRSA Therapy in Patients with S. aureus Bacteremia
Favorite
12:30 PM – 1:30 PM
(11-100) Assessment of the Efficacy of Semaglutide and Tirzepatide in the Management of Weight Loss in a Rural Internal Medicine Ambulatory Clinic in Mississippi
Favorite
12:30 PM – 1:30 PM
(11-101) Evaluation of Rabies Post-Exposure Prophylaxis Biologic Utilization at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-102) Fournier’s gangrene in a patient taking a sodium-glucose transporter-2 inhibitor: a case report
Favorite
12:30 PM – 1:30 PM
(11-103) Tenecteplase versus Alteplase for Thrombolytic Therapy in Acute Ischemic Stroke: A Retrospective Multicenter Cohort Study
Favorite
12:30 PM – 1:30 PM
(11-104) A Retrospective Review Assessing the Utilization of Phenobarbital Based on Documented CIWA-Ar Scores in Patients Admitted for Alcohol Withdrawal
Favorite
12:30 PM – 1:30 PM
(11-105) Retrospective Analysis of Aspiration Events in Elective Surgical Procedures in Patients Prescribed Glucagon-Like Peptide-1 Agonists
Favorite
12:30 PM – 1:30 PM
(11-106) Outcomes Associated with the Concurrent Use of Beta Blockers and Continuous Inotropic Infusions
Favorite
12:30 PM – 1:30 PM
(11-107) Readmission for Community-Acquired Pneumonia Based on Antibiotic Utilized at Previous Discharge
Favorite
12:30 PM – 1:30 PM
(11-108) Impact of Steripath, an Initial Specimen Diversion Device on Blood Culture Contamination
Favorite
12:30 PM – 1:30 PM
(11-109) Trends in Adverse Drug Events Related to Sedation in Post-Operative Settings
Favorite
12:30 PM – 1:30 PM
(11-110) Evaluation of MRSA Nasal Screening Use and the Impact on Therapy Modification
Favorite
12:30 PM – 1:30 PM
(11-111) Implementation of Automated Dispensing System Regulated Insulin at Mississippi Baptist Medical Center
Favorite
12:30 PM – 1:30 PM
(11-112) Evaluation of the impact of a diabetes management team on glycemic control in the intensive care unit
Favorite
12:30 PM – 1:30 PM
(11-113) Your Satisfaction Has Our Heart: Evaluating the Impact of Community Pharmacy-Led Prior Authorization, Patient Assistance and Medication Shipping on Clinic Staff Satisfaction
Favorite
12:30 PM – 1:30 PM
(11-114) Evaluating the Impact of The Mississippi Department of Health’s Opioid and Substance Misuse Disorder Program on Incidence of Non-fatal Opioid-related Overdoses
Favorite
12:30 PM – 1:30 PM
(11-115) Health Outcomes of MS AIDS Drug Assistance Program Patients with Insurance Assistance Compared to Those Without Insurance Assistance
Favorite
12:30 PM – 1:30 PM
(11-116) Daily vs Intermittent Tuberculosis Therapy in Patients with Active Tuberculosis in Mississippi
Favorite
12:30 PM – 1:30 PM
(11-117) Assessing the Knowledge of and Attitudes Toward HIV Pre-Exposure Prophylaxis (PrEP) among Primary Care Prescribers
Favorite
12:30 PM – 1:30 PM
(11-118) A Comparison of Sodium Polystyrene Sulfonate and Sodium Zirconium Cyclosilicate for the Treatment of Acute Hyperkalemia
Favorite
12:30 PM – 1:30 PM
(11-119) Emergency Department Pharmacist-Driven Outpatient Culture Reconciliation Program at a Large Rural Tertiary Medical Center
Favorite
12:30 PM – 1:30 PM
(11-120) Implementation of Real-Time BioFire® Pneumonia Panel Result Notification to Decentralized Clinical Pharmacy Staff to Evaluate Effects on Antibiotic Use
Favorite
12:30 PM – 1:30 PM
(11-121) Use of Tenecteplase as an Alternative Thrombolytic Agent to Alteplase for Acute Ischemic Stroke
Favorite
12:30 PM – 1:30 PM
(11-122) Opioid Stewardship in Postoperative Care
Favorite
12:30 PM – 1:30 PM
(11-123) Assessing Adherence to Current Hospital Sugammadex Restrictions
Favorite
12:30 PM – 1:30 PM
(11-124) Patient Perceptions Regarding Shortages of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
Favorite
12:30 PM – 1:30 PM
(11-125) Assessing Mississippi Community Pharmacists' Knowledge, Perceptions, and Availability of Medications for Opioid Use Disorder
Favorite
12:30 PM – 1:30 PM
(11-126) Identifying Social Determinants of Health in North Mississippi
Favorite
12:30 PM – 1:30 PM
(11-127) Pharmacists’ Perceptions of Cognitive Screening of Older Adults in the Community Pharmacy Setting
Favorite
12:30 PM – 1:30 PM
(11-128) Compassionate Care and Medication Adherence in the Community Pharmacy Setting
Favorite
12:30 PM – 1:30 PM
(11-129) Decreasing 30-day Readmission Rates for Community Acquired Pneumonia by Improving Antibiotic Selection at Discharge
Favorite
12:30 PM – 1:30 PM
(11-130) Impact of Scheduled Gabapentin on Opioid Consumption in Surgery Patients
Favorite
12:30 PM – 1:30 PM
(11-131) IV Acetaminophen utilization and adherence to institutional restrictions at an academic pediatric hospital
Favorite
12:30 PM – 1:30 PM
(11-132) Evaluation of Leuprolide Depot Utilization at an Academic Pediatric Hospital
Favorite
12:30 PM – 1:30 PM
(11-133) Pediatric Albumin Utilization: Effect of Education and Medication Shortage
Favorite
12:30 PM – 1:30 PM
(11-134) Assessing the Incidence of Antibiotic Therapy Escalation after New Onset Fever in Patients on Dexmedetomidine
Favorite
12:30 PM – 1:30 PM
(11-135) Impact of Phytonadione Administration on INR in Patients with Chronic Liver Disease
Favorite
12:30 PM – 1:30 PM
(11-136) Comparative Analysis of Diltiazem and Adenosine for Supraventricular Tachycardia Conversion Efficacy in Community Hospital Emergency Departments
Favorite
12:30 PM – 1:30 PM
(11-137) Impact of a Pharmacy Technician in a Pharmacist-led Diabetes Clinic
Favorite
12:30 PM – 1:30 PM
(11-138) Developing a Prioritization Algorithm for Inpatient Pharmacist Discharge-Counseling
Favorite
12:30 PM – 1:30 PM
(11-139) Evaluating the Efficacy and Safety of Tranexamic Acid for Traumatic Hemorrhage in Patients Admitted from the Pre-Hospital Setting
Favorite
12:30 PM – 1:30 PM
(11-140) Effect of Provider Education on Naloxone Co-Prescribing Habits at Discharge from Freeman Health System
Favorite
12:30 PM – 1:30 PM
(11-141) Evaluation of Inpatient Hypoglycemic Control with D10 vs D50
Favorite
12:30 PM – 1:30 PM
(11-142) Retrospective Chart Review Comparing Critically Ill Patients Pre and Post Implementation of an Intensive Care Unit Bowel Regimen Protocol Assessing Time to First Bowel Movement
Favorite
12:30 PM – 1:30 PM
(11-143) Safety and Efficacy of a Novel Two-Bag Dosing Regimen Compared to Traditional Dosing of N-acetylcysteine for Treatment of Acetaminophen Toxicity
Favorite
12:30 PM – 1:30 PM
(11-144) Impact of Pneumonia Pathogen Polymerase Chain Reaction (PCR) Implementation with Expedited Lab-to-Pharmacist Communication on Antimicrobial Optimization
Favorite
12:30 PM – 1:30 PM
(11-145) Is Enoxaparin 30mg Twice Daily Enough? Retrospective Chart Review Comparing Rates of Venous Thromboembolisms at a Level One Community Hospital Trauma Center
Favorite
12:30 PM – 1:30 PM
(11-146) Impact on Prescribing Rates of SGLT2-Inhibitors Through Pharmacist Interventions in Patients with Diabetes and Heart Failure
Favorite
12:30 PM – 1:30 PM
(11-147) Expanding Formulary Access to Dalbavancin: Impact on Hospital Length of Stay and Clinical Outcomes
Favorite
12:30 PM – 1:30 PM
(11-148) Evaluation of Albumin Use Before & After Education with Computerized Provider Order Entry (CPOE) Optimization
Favorite
12:30 PM – 1:30 PM
(11-149) Development and Evaluation of a Pharmacist Driven Transitions of Care Protocol Upon Transfer Out of an Intensive Care Unit
Favorite
12:30 PM – 1:30 PM
(11-150) Refining Granulocyte-Colony Stimulating Factor Utilization Through Protocol Implementation: A Comprehensive Evaluation
Favorite
12:30 PM – 1:30 PM
(11-151) Evaluation of a 2-bag versus 3-bag N-acetylcysteine Protocol in the Treatment of Acetaminophen Toxicity
Favorite
12:30 PM – 1:30 PM
(11-152) The Impact of a Pharmacist Driven MRSA Nares Protocol on Antibiotic De-escalation in Diabetic Foot Infections
Favorite
12:30 PM – 1:30 PM
(11-153) Evaluation of Patient Outcomes in the Setting of Asymptomatic Bacteriuria Treatment
Favorite
12:30 PM – 1:30 PM
(11-154) Evaluating the use of fixed versus variable dosing of 4-factor prothrombin complex concentrate in anticoagulant-related major bleeding
Favorite
12:30 PM – 1:30 PM
(11-155) Evaluation of Desmopressin for Antiplatelet Reversal and the Impact on Intracranial Hemorrhage Expansion
Favorite
12:30 PM – 1:30 PM
(11-156) Incidence of hemorrhagic transformation associated with treatment of acute ischemic stroke using tenecteplase compared to alteplase
Favorite
12:30 PM – 1:30 PM
(11-157) Assessing the Safety and Efficacy of Treatment of Hyperkalemia at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-158) Evaluation of Appropriate Administration Time of Second Antibiotic Dose in Sepsis Patients in a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-159) Drug Use Evaluation of Ceftaroline in Pediatric Populations
Favorite
12:30 PM – 1:30 PM
(11-160) Medication Use Evaluation of Products for Bowel Disimpaction in Pediatric Refractory Constipation
Favorite
12:30 PM – 1:30 PM
(11-161) Time to Sedation Following Rapid Sequence Intubation
Favorite
12:30 PM – 1:30 PM
(11-162) Amiodarone: Medication Use Evaluation
Favorite
12:30 PM – 1:30 PM
(11-163) Evaluation of Verification Order Time to Administration Time for Pre-Procedural Medications Dispensed from Central Pharmacy
Favorite
12:30 PM – 1:30 PM
(11-164) Evaluation of Sugammadex for Neuromuscular Blockade Reversal in Intraoperative Use
Favorite
12:30 PM – 1:30 PM
(11-165) Evaluating the effectiveness, treatment response, safety, and cost of IV iron replacement products at the SSM Health infusion centers
Favorite
12:30 PM – 1:30 PM
(11-166) The Use of Methylnaltrexone for Opioid-Induced Constipation
Favorite
12:30 PM – 1:30 PM
(11-167) Remifentanil Use in Pediatric Patients with Severe Traumatic Brain Injury: A Retrospective Cohort Study
Favorite
12:30 PM – 1:30 PM
(11-168) Ceftaroline Use in Premature Neonates: A Case Series
Favorite
12:30 PM – 1:30 PM
(11-169) Assessing barriers to mental health medication adherence in college students with depression and anxiety transitioning to collegiate life.
Favorite
12:30 PM – 1:30 PM
(11-170) Intravenous Insulin Not for Diabetic Ketoacidosis Use in an Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-171) Evaluation of the safe transition between methotrexate formulations in a pharmacist-supported rheumatology clinic
Favorite
12:30 PM – 1:30 PM
(11-172) Evaluation of sedation practices in the intensive care unit
Favorite
12:30 PM – 1:30 PM
(11-173) Assessing Patient Adherence to Clinic-Administered Cabotegravir/Rilpivirine Versus Clinic-Initiated Bictegravir/Emtricitabine/Tenofovir Alafenamide
Favorite
12:30 PM – 1:30 PM
(11-174) Appropriate use of Antifungal Agents in Patients Admitted to the ICU
Favorite
12:30 PM – 1:30 PM
(11-175) Assessing Appropriateness of Seizure Management in the Emergency Department of an Urban Safety-Net Hospital
Favorite
12:30 PM – 1:30 PM
(11-176) Suboxone Clinic Patient Perceptions on Clinical Pharmacist Intervention at a Federally Qualified Health Center
Favorite
12:30 PM – 1:30 PM
(11-177) Impact of Pharmacy-led Asthma Clinic on Asthma Control in the Primary Care Setting
Favorite
12:30 PM – 1:30 PM
(11-178) Assessing Current Practice Concerning the Usage of Phytonadione for Non-Vitamin K Antagonist Associated Bleeding and Laboratory Identified Coagulopathy
Favorite
12:30 PM – 1:30 PM
(11-179) Comparison of Acute Kidney Injury Incidence with the Concomitant Use of Vancomycin with Cefepime or Piperacillin/tazobactam
Favorite
12:30 PM – 1:30 PM
(11-180) Intravenous Haloperidol and Olanzapine: An Evaluation of Appropriate Use in Adults with Acute Agitation
Favorite
12:30 PM – 1:30 PM
(11-181) Benzodiazepine Utilization in Patients with Status Epilepticus: Dosing Patterns and Implications for Clinical Practice
Favorite
12:30 PM – 1:30 PM
(11-182) Symptom-Monitored Loading: An Evaluation of Prophylactic Medications in Patients with Severe Alcohol Withdrawal
Favorite
12:30 PM – 1:30 PM
(11-183) Evaluation of Routine Assessment of Patient Index Data 3 (RAPID3) Scores in Patients with Rheumatoid Arthritis Using the Health-System's Specialty Pharmacy versus Usual Care
Favorite
12:30 PM – 1:30 PM
(11-184) Assessing and Optimizing the Treatment of Hyponatremia in a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-185) Towards a Safer System: Evaluation and Optimization of Adverse Drug Reaction Reporting at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-186) Evaluation of Therapy Selection in the Treatment of Bronchitis and Community Acquired Pneumonia (CAP) in the Pediatric Population at a Small Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-187) Evaluating the Impact of Continuous Glucose Monitoring on Patients with Malignancies at Risk of Steroid Induced Hyperglycemia
Favorite
12:30 PM – 1:30 PM
(11-188) Expansion of interchange for penicillin allergy in preop patients to all surgery types
Favorite
12:30 PM – 1:30 PM
(11-189) Use of Phenobarbital in setting of Acute Alcohol withdrawal Symptoms (AAWS) Management
Favorite
12:30 PM – 1:30 PM
(11-190) Evaluation of Provider-Led Inpatient Digoxin Dosing
Favorite
12:30 PM – 1:30 PM
(11-191) Thiamine Drug Use Evaluation
Favorite
12:30 PM – 1:30 PM
(11-192) Evaluation of an Endocrinology Specialty Pharmacist, an Expansion of Health System Based Specialty Pharmacy Services
Favorite
12:30 PM – 1:30 PM
(11-193) Implementation of the Severity of Ethanol Withdrawal Scale (SEWS) for Inpatient Monitoring of Alcohol Withdrawal at a Small Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-194) Evaluation of Appropriate Ketamine Usage Within a Rural Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-195) Narcan Discharge Prescribing Practices at a Small Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-196) Comparison of Antimicrobial Prescribing in Pneumonia Before and After the Implementation of a Pneumonia Clinical Guidance Document
Favorite
12:30 PM – 1:30 PM
(11-197) Treatment of Beta-blocker and Calcium Channel Blocker Overdose at Bryan Medical Center
Favorite
12:30 PM – 1:30 PM
(11-198) Comparison of Pre and Post Implementation of a Pharmacist Driven Protocol for Discontinuation of Quetiapine Prescribed for ICU Delirium
Favorite
12:30 PM – 1:30 PM
(11-199) Retrospective Evaluation of Factors Leading to Emergency Department or Hospital Admission Within 30 Days of Chemotherapy Treatment in the Outpatient Infusion Center
Favorite
12:30 PM – 1:30 PM
(11-200) Serum Sodium Concentration Correction Rates Following Hypertonic Saline Treatment
Favorite
12:30 PM – 1:30 PM
(11-201) Enhancing Patient Care: Pharmacists’ Vital Role in Navigating Transitions of Care to Post-Acute Settings
Favorite
12:30 PM – 1:30 PM
(11-202) Implementation of the BioFire FilmArray Blood Culture Identification 2 (BCID2) Panel and the Clinical Impact in Patients with Extended Spectrum Beta Lactamase-producing Enterobacterales (ESBL-E) Bacteremia
Favorite
12:30 PM – 1:30 PM
(11-203) Characterization of Prescribing Habits Surrounding Sacubitril-Valsartan Dose Titration in Patients With Heart Failure
Favorite
12:30 PM – 1:30 PM
(11-204) A Retrospective Comparison of Nomogram Dosing and Bayesian Models for Dosing Vancomycin in a Level III Neonatal Intensive Care Unit at an Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-205) Impact of Pharmacist Transition of Care Interventions on 30-Day Readmissions in a Cardiac Unit
Favorite
12:30 PM – 1:30 PM
(11-206) Impact of an Enhanced Clinical Pharmacy Service on Medication Optimization in Hospitalized Patients With Heart Failure
Favorite
12:30 PM – 1:30 PM
(11-207) Assessing Pharmacist Clinical Performance After Adopting a Vancomycin Area Under the Curve (AUC) Dosing Protocol in a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-208) Difference Between Alteplase and Tenecteplase Time to Therapy Completion in Acute Ischemic Stroke
Favorite
12:30 PM – 1:30 PM
(11-209) Impact of a Community Pharmacist on Continuous Glucose Monitoring Adoption and Use by Medicaid Patients
Favorite
12:30 PM – 1:30 PM
(11-210) A Pharmacist-Led Intervention to Support Medication Optimization During Hospital-to-Home Transitions of Care
Favorite
12:30 PM – 1:30 PM
(11-211) Impact of potentially inappropriate prescribing trends in older adults admitted to internal medicine and trauma services
Favorite
12:30 PM – 1:30 PM
(11-212) Use of Scheduled Acetaminophen as Part of an ERAS-CD Protocol and Its Effect on Reducing Post-Cesarean Pain Scores and Opioid Administration
Favorite
12:30 PM – 1:30 PM
(11-213) The Effect of Previous Sodium-Glucose Transporter 2 Inhibitor Therapy on the Time to Resolution of Diabetic Ketoacidosis
Favorite
12:30 PM – 1:30 PM
(11-214) Evaluation of Outpatient Antibiotics for the Treatment of Urinary Tract Infections in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-215) Appropriate Renal Dose Adjustment for Apixaban in Patients with Nonvalvular Atrial Fibrillation
Favorite
12:30 PM – 1:30 PM
(11-216) Evaluation of Compliance and Outcomes Associated with the Acute Care Surgery Inpatient Thromboprophylaxis Guidelines
Favorite
12:30 PM – 1:30 PM
(11-217) Impact of Continuous Infusion Antibiotics Through an Outpatient Infusion Center
Favorite
12:30 PM – 1:30 PM
(11-218) Evaluation of clinical pharmacist review of discharge prescriptions in a tertiary medical center
Favorite
12:30 PM – 1:30 PM
(11-219) Impact of a Pharmacist-Driven Ambulatory Care Clinic on Cure of Hepatitis C
Favorite
12:30 PM – 1:30 PM
(11-220) Implementation of best practice when collecting blood cultures in the emergency department (ED)
Favorite
12:30 PM – 1:30 PM
(11-221) Educational intervention for delirium assessment in intensive care units using the Confusion Assessment Method
Favorite
12:30 PM – 1:30 PM
(11-222) Evaluation of Warfarin Patient Readmissions: A Retrospective Study
Favorite
12:30 PM – 1:30 PM
(11-223) Analysis of Trends for Patients with a 30-day Readmission as Focal Points for Targeted Pharmacist Intervention in Transitions of Care
Favorite
12:30 PM – 1:30 PM
(11-224) Evaluation of Appropriate Usage of Four-Factor Prothrombin Complex Concentrate
Favorite
12:30 PM – 1:30 PM
(11-225) Evaluation of Efficacy of Standard Heparin Protocol in Obese Patients
Favorite
12:30 PM – 1:30 PM
(11-226) Retrospective Analysis of Pharmacy Driven Phenobarbital Protocol in Patients with Alcohol Withdrawal Syndrome
Favorite
12:30 PM – 1:30 PM
(11-227) Identifying Treatment Gaps and Disparities in Patients with Non-Valvular Atrial Fibrillation Within a Community Hospital Ambulatory Setting: Opportunity to Improve Ambulatory Anticoagulation Practices
Favorite
12:30 PM – 1:30 PM
(11-228) Impact of a pharmacist-driven protocol for extended-infusion dosing of beta-lactam antibiotics in a community hospital; pre and post implementation
Favorite
12:30 PM – 1:30 PM
(11-229) Implementation of a continuous glucose monitor wear-experience in a pharmacy school didactic curriculum
Favorite
12:30 PM – 1:30 PM
(11-230) Evaluation of Prescribing Patterns of Apixaban and Rivaroxaban Initial Doses Post Parental Anticoagulation for the Treatment of Venous Thromboembolism
Favorite
12:30 PM – 1:30 PM
(11-231) Bulk Medication Secured Storage and Transfer Process Improvement in the ED
Favorite
12:30 PM – 1:30 PM
(11-232) Evaluation of atypical antipsychotic and stress ulcer prophylaxis continuation after transfer from the intensive care unit
Favorite
12:30 PM – 1:30 PM
(11-233) Evaluation of Fentanyl Patch Use for Weaning of Intravenous Opioid Infusions
Favorite
12:30 PM – 1:30 PM
(11-234) Retrospective analysis and guideline development for albumin 25% use in pediatric patients
Favorite
12:30 PM – 1:30 PM
(11-235) Evaluation of Nicardipine versus Clevidipine for Blood Pressure Management in Intracranial Hemorrhage
Favorite
12:30 PM – 1:30 PM
(11-236) Applicability of Urinary Nitrites to Predict Pathogen Type in Bacterial Urinary Tract Infections
Favorite
12:30 PM – 1:30 PM
(11-237) Implementing the Process for Fecal Microbiota Administration to Prevent Recurrent Clostridioides Difficile Infection in an Outpatient Setting
Favorite
12:30 PM – 1:30 PM
(11-238) Assessment of Inpatient Admissions and Readmissions Following One Hour Intravenous Oritavancin Administration in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-239) Rates of Extravasation Reactions with Vasopressors in Ultrasound Guided (USG) Lines versus Peripheral Lines in Hospitalized Patients: A Retrospective Study
Favorite
12:30 PM – 1:30 PM
(11-240) Fentanyl Infusion as Analgosedation in a Regional Hospital System
Favorite
12:30 PM – 1:30 PM
(11-241) Droperidol Safety and Efficacy in Emergency Departments in a Two Hospital System
Favorite
12:30 PM – 1:30 PM
(11-242) Identification and Optimization of Guideline Directed Chronic Obstructive Pulmonary Disease Inhaler Therapy
Favorite
12:30 PM – 1:30 PM
(11-243) Retrospective Medication Use Evaluation of Benzodiazepines and Phenobarbital for the Management of Alcohol Withdrawal Syndrome
Favorite
12:30 PM – 1:30 PM
(11-244) Incidence of inappropriate aspirin use for primary prevention of cardiovascular disease in older adults
Favorite
12:30 PM – 1:30 PM
(11-245) Cefazolin plus Metronidazole Compared to Cefoxitin for Surgical Site Infection Prophylaxis in Hysterectomy
Favorite
12:30 PM – 1:30 PM
(11-246) Outcomes of Induction Immunosuppression Therapy in a Geriatric Renal Transplant Population
Favorite
12:30 PM – 1:30 PM
(11-247) Assessing the appropriateness of antimicrobials prescribed at discharge for treatment of pneumonia and urinary tract infection
Favorite
12:30 PM – 1:30 PM
(11-248) Implementation of Phenobarbital Protocol for Alcohol Withdrawal Syndrome in Critically-Ill Patients
Favorite
12:30 PM – 1:30 PM
(11-249) Evaluation of time to initiation of antiresorptive agents for patients newly diagnosed with multiple myeloma (ET-IAM)
Favorite
12:30 PM – 1:30 PM
(11-250) Evaluation of Operational and Financial expenditure of premixed versus compounded Vasopressin
Favorite
12:30 PM – 1:30 PM
(11-252) Incidence, Treatment, and Outcomes of Urinary Tract Infections caused by extended-spectrum beta-lactamase producing bacteria in kidney transplant recipients
Favorite
12:30 PM – 1:30 PM
(11-253) Assessment of Metabolic Outcomes in Kidney Transplant Recipients: Tacrolimus vs Belatacept
Favorite
12:30 PM – 1:30 PM
(11-254) Impact of Bendamustine as an Alternative Lymphodepletion Regimen on Chimeric Antigen Receptor T-Cell Therapy Outcomes
Favorite
12:30 PM – 1:30 PM
(11-255) Effect of Adding Venetoclax to Intensive Chemotherapy for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Favorite
12:30 PM – 1:30 PM
(11-256) Optimizing Patient Care: A Pharmacist-Led De-labeling Initiative for Penicillin Allergy by Assessing Reaction Severity
Favorite
12:30 PM – 1:30 PM
(11-257) A Retrospective Safety Analysis of Kcentra Dosing For Direct Oral factor Xa Inhibitors Related Life-Threatening Bleed.
Favorite
12:30 PM – 1:30 PM
(11-258) Evaluation of preoperative antibiotic selection in patients with documented penicillin allergy undergoing elective surgery at a community hospital
Favorite
12:30 PM – 1:30 PM
(11-259) Evaluation of an Oral Oncolytic Therapy Program in a Community Cancer Center
Favorite
12:30 PM – 1:30 PM
(11-260) Evaluating Zolpidem Utilization in Elderly Patients in the Outpatient Setting
Favorite
12:30 PM – 1:30 PM
(11-261) Appropriateness of statin therapy as primary prevention in elderly patients
Favorite
12:30 PM – 1:30 PM
(11-262) Evaluating the Appropriate Use of Direct Oral Anticoagulants in the Ambulatory Care Setting
Favorite
12:30 PM – 1:30 PM
(11-263) Assessment of sugammadex versus neostigmine with glycopyrrolate on postoperative nausea and vomiting
Favorite
12:30 PM – 1:30 PM
(11-264) Insulin Detemir Versus Insulin Glargine: Evaluation of Hypoglycemic Events in the Intensive Care Unit Setting
Favorite
12:30 PM – 1:30 PM
(11-265) Impact of Pharmacist Led Parenteral Nutrition Ordering on Electrolyte Management
Favorite
12:30 PM – 1:30 PM
(11-266) Impacts of Sacubitril/valsartan vs Lisinopril on All-Cause Hospital Admissions
Favorite
12:30 PM – 1:30 PM
(11-267) Comparison of Droperidol and Haloperidol for Acute Agitation in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-268) Incidence of Hypoglycemic Events in Hospitalized Patients Receiving Insulin Glargine versus Insulin Detemir
Favorite
12:30 PM – 1:30 PM
(11-269) Impact of Pharmacist Addition to the Adult Code Team (ImPACT)
Favorite
12:30 PM – 1:30 PM
(11-270) Improving Inpatient Management of Steroid Induced Hyperglycemia in Hospitalized Adults
Favorite
12:30 PM – 1:30 PM
(11-271) Transitioning Admitted Patients from Intravenous to Enteral Potassium: A Cost-Effectiveness Analysis
Favorite
12:30 PM – 1:30 PM
(11-272) Evaluation of patients prescribed warfarin who can be converted to a DOAC in a medically underserved, family medicine clinic
Favorite
12:30 PM – 1:30 PM
(11-273) Evaluation of Dapagliflozin and Empagliflozin Use in a Multi-Center Health System
Favorite
12:30 PM – 1:30 PM
(11-274) Evaluation of endocrine function testing for immune checkpoint inhibitors
Favorite
12:30 PM – 1:30 PM
(11-275) Safety of rapid intravenous push administration of levetiracetam in an academic children’s hospital
Favorite
12:30 PM – 1:30 PM
(11-276) Retrospective Comparison of Short and Prolonged Treatment Strategies for Neutropenic Enterocolitis Patients
Favorite
12:30 PM – 1:30 PM
(11-277) An Evaluation of Education on Alert Override Rates for Pharmacists
Favorite
12:30 PM – 1:30 PM
(11-278) Targeted Interventions to Improve Antibiotic Administration Timing in Patients with Presumed Sepsis
Favorite
12:30 PM – 1:30 PM
(11-279) Simultaneous administration of broad-spectrum antibiotics in sepsis and impact on outcomes
Favorite
12:30 PM – 1:30 PM
(11-280) Evaluation of the Impact of Concomitant Valproic Acid and Lorazepam Administration on Sedation and Fall Risk
Favorite
12:30 PM – 1:30 PM
(11-281) Evaluation of the Use and Barriers to Use of Intranasal Esketamine for Treatment-Resistant Depression in Psychiatric Outpatients
Favorite
12:30 PM – 1:30 PM
(11-282) Implementation of a High-Dose Buprenorphine Induction Protocol for the Treatment of Opioid Use Disorder at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-283) Reducing Chemotherapy Waste Through Vial Sharing Single-Dose Non-Reimbursable Chemotherapy Medications
Favorite
12:30 PM – 1:30 PM
(11-284) Put the Post-Exposure Prophylaxis (PEP) in Your Patient's Step
Favorite
12:30 PM – 1:30 PM
(11-285) Evaluation of Safety, Efficiency, and Cost of Intravenous Push Versus Intravenous Piggyback Administration of Levetiracetam and Lacosamide at a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-286) Impact of Pharmacist-Led Intervention on Prescribing of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Hospitalized Patients with Heart Failure with Reduced Ejection Fraction (HFrEF)
Favorite
12:30 PM – 1:30 PM
(11-287) Interventions for Improved Time to Antibiotic Administration in Pediatric Patients with Febrile Neutropenia
Favorite
12:30 PM – 1:30 PM
(11-288) High-Dose Atorvastatin Loading in ST-Elevation Myocardial Infarction Patients Before Primary Percutaneous Coronary Intervention
Favorite
12:30 PM – 1:30 PM
(11-289) Prescribing practices at a community teaching hospital of anticoagulation for VTE prophylaxis after orthopedic surgery
Favorite
12:30 PM – 1:30 PM
(11-290) Quality Improvement Initiative to Implement Eat, Sleep, Console for Management of Neonatal Opioid Withdrawal Syndrome in a Level IV Neonatal Intensive Care Unit
Favorite
12:30 PM – 1:30 PM
(11-291) Evaluation of Autoverification of Antibiotics in the Emergency Department at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-292) Efficacy and Safety of Vancomycin AUC Monitoring with a Single Trough Level
Favorite
12:30 PM – 1:30 PM
(11-293) The Safety and Efficacy of Direct Oral Anticoagulants in Patients with Bioprosthetic Heart Valves
Favorite
12:30 PM – 1:30 PM
(11-294) Assessment of Antiretroviral Prescribing Practices for Non-Occupational Post Exposure Prophylaxis in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-295) Readmission Rates of Patients Who Attend Patient Medication Education Groups
Favorite
12:30 PM – 1:30 PM
(11-296) Optimization of Pharmacotherapy to Improve Renal Outcomes in Patients with Diabetes and Chronic Kidney Disease Receiving Care at a Community Clinic
Favorite
12:30 PM – 1:30 PM
(11-297) Methicillin-resistant Staphylococcus aureus Nares Utility in Non-Pneumonia Related Infections
Favorite
12:30 PM – 1:30 PM
(11-298) Medication Use Evaluation of Rabies Vaccine and Immune Globulin in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-299) Evaluation of the Utilization of Sugammadex in the Operating Room at a Non-Teaching Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-300) Drug Use Evaluation of Non-Formulary Medications for Therapeutic Interchange Opportunities at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-301) Assessing the Applicability of Medication Possession Ratio in Measuring the Medication Adherence Rate for Specialty Pharmacy Patients
Favorite
12:30 PM – 1:30 PM
(11-302) Impact of Clindamycin Shortage and Updated Penicillin Allergy Guidance on Appropriateness of Surgical Antibiotic Prophylaxis
Favorite
12:30 PM – 1:30 PM
(11-303) Characterization of Current Health System Prescribing for Analgesia and Sedation of Intubated ICU Patients
Favorite
12:30 PM – 1:30 PM
(11-304) Impact of Cardioprotective Medications on Mitigating Cardiotoxicity During Cancer Treatment
Favorite
12:30 PM – 1:30 PM
(11-305) Self-perceived Changes in Sexual Behaviors of Patients Taking PrEP for HIV
Favorite
12:30 PM – 1:30 PM
(11-306) Smart Infusion Pump with Dose Error Reduction System Adherence Improvement
Favorite
12:30 PM – 1:30 PM
(11-307) Follow-Up Study on Pharmacist-driven Initiation of Buprenorphine/Naloxone Program in the ED at a community hospital
Favorite
12:30 PM – 1:30 PM
(11-308) Improvement of Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Score through Pharmacist Medication Education during Hospital Stay at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-309) Evaluation of the Effect of Inappropriate Apixaban Dosing Among Patients Admitted for Adverse Thrombotic or Bleeding Events
Favorite
12:30 PM – 1:30 PM
(11-310) Review of implementation of micro-dosed buprenorphine in high withdrawal risk patients for opioid use disorder.
Favorite
12:30 PM – 1:30 PM
(11-311) Evaluation of Appropriate Use of Paxlovid and Remdesivir in an Inpatient Setting and Respective Outcomes in Patients During the COVID-19 Pandemic
Favorite
12:30 PM – 1:30 PM
(11-312) Examining primary care prescribing patterns of inhaled asthma reliever therapies among adult patients at a federally qualified health center
Favorite
12:30 PM – 1:30 PM
(11-313) Evaluation of computerized provider order entry impact on direct oral anticoagulant prescribing
Favorite
12:30 PM – 1:30 PM
(11-314) Review of Electrolyte Abnormalities in Pediatric Diabetic Ketoacidosis
Favorite
12:30 PM – 1:30 PM
(11-315) Safety and Efficacy of Non Standard Ticagrelor Dosing with the Utilization of Platelet Function Testing Post Neuroendovascular Stenting
Favorite
12:30 PM – 1:30 PM
(11-316) Evaluation of Laboratory Monitoring Frequencies for Unfractionated Heparin Infusions
Favorite
12:30 PM – 1:30 PM
(11-317) Evaluation of Antibiotic Appropriateness at Hospital Discharge in an Inner-city Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-318) Evaluation of Inpatient Use of Empagliflozin on Glycemic Control and Patient Safety
Favorite
12:30 PM – 1:30 PM
(11-319) Assessment of Prescriber Use of Opioid Agreement in Chronic Opioid Users at BronxCare Health System
Favorite
12:30 PM – 1:30 PM
(11-320) Review of Emergency Department Urine Culture Results and Susceptibilities to Guide Antibiotic Use for Urinary Tract Infections
Favorite
12:30 PM – 1:30 PM
(11-322) Dexmedetomidine as a Sedative Agent: An Analysis of Usage and Adherence to Current Clinical Protocols
Favorite
12:30 PM – 1:30 PM
(11-323) Evaluation of Vancomycin De-escalation Using Negative Methicillin-resistant Staphylococcus aureus Nasal Swab in Patients with Skin and Soft Tissue Infections
Favorite
12:30 PM – 1:30 PM
(11-324) Comparing the Outcomes of Fixed-Tapering Dose Regimen versus Symptom-Triggered Regimen of Lorazepam for Alcohol Withdrawal in a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-325) Sustainability of an Allergy Referral Process for Pregnant Patients with Penicillin Allergy
Favorite
12:30 PM – 1:30 PM
(11-326) Evaluation of Haloperidol Use for Agitation in Older Adults in the Emergency Department at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-327) Increasing Appropriate Usage of Intravenous (IV) Hydromorphone in Elderly Opioid Naïve Medical/Surgery Patients at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-328) Drug Use Evaluation of Inhaled Tobramycin in Non-Cystic Fibrosis Pediatric Patients at a Children's Hospital
Favorite
12:30 PM – 1:30 PM
(11-329) Evaluation of the Use of Sliding Scale Insulin as Primary Antihyperglycemic Agent in Non-Critically Ill Hospitalized Patients
Favorite
12:30 PM – 1:30 PM
(11-330) Evaluation of Antipsychotic Use in Hospitalized Older Adults
Favorite
12:30 PM – 1:30 PM
(11-331) Evaluation of Potentially Inappropriate Medication Therapies Present after Transition from Intensive Care Unit
Favorite
12:30 PM – 1:30 PM
(11-332) Evaluation of Adherence to the Nurse-Driven Standard Unfractionated Heparin Protocol at an Academic Teaching Hospital.
Favorite
12:30 PM – 1:30 PM
(11-333) Evaluation of Argatroban Order Set Utilization for Management of Heparin-Induced Thrombocytopenia
Favorite
12:30 PM – 1:30 PM
(11-334) Evaluation of Early versus Late Initiation of Corticosteroids in Adults with Septic Shock
Favorite
12:30 PM – 1:30 PM
(11-335) Assessing the Ceiling Dose of Ketorolac in Emergency Department Patients
Favorite
12:30 PM – 1:30 PM
(11-336) Evaluation of Fentanyl Patch Use in a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-337) The Use of Ampicillin/Sulbactam for Carbapenem-Resistant Acinetobacter baumannii (CRAB) Bacteremia: Does Combination Therapy Improve Clinical Outcomes?
Favorite
12:30 PM – 1:30 PM
(11-338) Assessment of Insulin and Dextrose Infusion Requirements in Euglycemic Diabetic Ketoacidosis Due to Sodium- Glucose Co-transporter-2 Inhibitors
Favorite
12:30 PM – 1:30 PM
(11-339) Effect of ketamine continuous infusion on vasopressor requirements in mechanically ventilated critically ill patients
Favorite
12:30 PM – 1:30 PM
(11-340) Impact of Pharmacist-Led-Interventions on Corticosteroid Utilization in Hospitalized Patients for Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
Favorite
12:30 PM – 1:30 PM
(11-341) Retrospective Analysis of Ceftriaxone 1 Gram or 2 Grams for Bacteremia
Favorite
12:30 PM – 1:30 PM
(11-342) Effect of Glucose-Dependent Insulinotropic Polypeptide (GIP)/Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist and GLP-1 Receptor Agonists on Renal Outcomes in Patients with Type 2 Diabetes Mellitus
Favorite
12:30 PM – 1:30 PM
(11-343) Evaluation of Heparin Venous Thromboembolism Prophylaxis at a Large Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-344) Hypoglycemia Prevention in Hospitalized Patients: A Quality Improvement Project of Insulin Glargine Use
Favorite
12:30 PM – 1:30 PM
(11-345) Evaluation of Fluconazole Use for Candidemia at a Large Urban Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-346) Effect of Optimizing Guideline-Directed Medical Therapy before Discharge on Heart Failure Readmission in Patients Hospitalized with Heart Failure with Reduced Ejection Fraction
Favorite
12:30 PM – 1:30 PM
(11-347) Evaluation of Initial Heparin Infusion Dose Maximums on Goal Anti-Xa Levels
Favorite
12:30 PM – 1:30 PM
(11-348) Evaluation of Safety of the Co-Administration of Parenteral Olanzapine and Benzodiazepines in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-349) Compliance with the Advanced Cardiac Life Support (ACLS) Guidelines During Cardiac Arrest Associated with Pharmacist Presence
Favorite
12:30 PM – 1:30 PM
(11-350) Effect of In-Hospital Pneumococcal Vaccine and Readmissions for Pulmonary Diseases
Favorite
12:30 PM – 1:30 PM
(11-351) Evaluation of Perioperative Bridging with Parenteral Anticoagulation Therapy in Patients with Atrial Fibrillation on an Oral Anticoagulant
Favorite
12:30 PM – 1:30 PM
(11-352) Intravenous Acetaminophen Induction of Hypotension in Critically Ill Patients
Favorite
12:30 PM – 1:30 PM
(11-353) Comparison of tenecteplase versus alteplase in acute ischemic stroke: a retrospective, longitudinal cohort study to evaluate safety and establish non-inferiority
Favorite
12:30 PM – 1:30 PM
(11-354) Evaluating the Impact of Penicillin Allergy Alert Removal on Cephalosporin Ordering
Favorite
12:30 PM – 1:30 PM
(11-355) Assessing the benefits of a standardized electrolyte repletion protocol in an academic surgical intensive care unit
Favorite
12:30 PM – 1:30 PM
(11-356) Evaluating the outcomes of nursing staff in timely tacrolimus level monitoring for lung transplant recipients in a large academic medical center
Favorite
12:30 PM – 1:30 PM
(11-357) Evaluation of Protocol-driven Heparin Utilization in the Inpatient Setting at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-358) Evaluation of systemic corticosteroid use and prescribing patterns for patients admitted with an acute exacerbation of chronic obstructive pulmonary disease (COPD) at a community hospital
Favorite
12:30 PM – 1:30 PM
(11-359) Assessment of Treatment of Asymptomatic Bacteriuria in a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-360) Examining the Effect of Prospective Medication Review and Selective Autoverification on Medication Error Rates in the Emergency Department (ED) at a 242-bed Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-361) Evaluating the Safety of Administering Tamsulosin Capsules via Feeding Tube in Intensive Care Unit Patients
Favorite
12:30 PM – 1:30 PM
(11-362) Evaluating the Appropriateness of Trimethobenzamide at a Large Health System
Favorite
12:30 PM – 1:30 PM
(11-363) Assessment of Sedation Practices Following Rapid Sequence Intubation with Rocuronium
Favorite
12:30 PM – 1:30 PM
(11-364) Evaluating the Appropriateness of Tdap Prescribing in the Emergency Department at a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-365) Nebulized Naloxone Utilization in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-366) Utilization of Intravenous Insulin in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-367) Comparing the Safety and Efficacy of IV Push Lacosamide vs Levetiracetam
Favorite
12:30 PM – 1:30 PM
(11-368) Evaluation of Cangrelor Usage at Mount Sinai Health Systems (MSHS)
Favorite
12:30 PM – 1:30 PM
(11-369) Assessing the Appropriateness of Enoxaparin Dosing for Venous Thromboembolism (VTE) Prevention in a Community Hospital: A Pharmacy Resident-Centered Approach
Favorite
12:30 PM – 1:30 PM
(11-370) Assessing the Cost Savings and Safety of Thiamine Intravenous Push (IVP) 200 mg and 500 mg Across a Hospital Health System: A Pharmacy Resident-Centered Approach
Favorite
12:30 PM – 1:30 PM
(11-371) Time to Shock Resolution in Urosepsis Patients on β lactams with and without Aminoglycosides
Favorite
12:30 PM – 1:30 PM
(11-372) Comparison of Functional Outcomes in Acute Ischemic Stroke Patients Receiving Intravenous Alteplase With and Without Diabetes.
Favorite
12:30 PM – 1:30 PM
(11-373) The Effect of Intravenous versus Oral Antibiotic Use in Uncomplicated Infections on Emergency Department Length of Stay
Favorite
12:30 PM – 1:30 PM
(11-374) Assessing Appropriateness of Enoxaparin Standard Treatment Dose in Obesity
Favorite
12:30 PM – 1:30 PM
(11-375) Identification of Areas for Pharmacist Interventions Through the Lens of Hypoglycemic Correction
Favorite
12:30 PM – 1:30 PM
(11-376) Social Determinants of Health in Guideline-Directed Medical Therapy Post-Percutaneous Coronary Intervention Prescribing Patterns
Favorite
12:30 PM – 1:30 PM
(11-377) Under-Recognized Medication Loss with Small-Volume Intermittent Infusions
Favorite
12:30 PM – 1:30 PM
(11-378) Effects of an Automated Dispensing Cabinet Inventory Optimization Tool on Missing Medication Requests in Hospital Inpatient Units
Favorite
12:30 PM – 1:30 PM
(11-379) Assessing the Real World Use of Direct Oral Anticoagulants Versus Warfarin for the Treatment of Left Ventricular Thrombus
Favorite
12:30 PM – 1:30 PM
(11-380) Evaluating the Inpatient Use and Efficacy of Droxidopa for Orthostatic Hypotension
Favorite
12:30 PM – 1:30 PM
(11-381) Antimicrobial Stewardship Evaluation of Fidaxomicin Use at NYU Langone Health
Favorite
12:30 PM – 1:30 PM
(11-382) Comparing Valproic Acid Delivery Strategies at a Large Academic Medical Center: IV Push versus Intravenous Piggyback
Favorite
12:30 PM – 1:30 PM
(11-383) Intravenous Push versus Intermittent Infusion Beta-lactams in Pediatrics: Safety and Time to First Dose
Favorite
12:30 PM – 1:30 PM
(11-384) Evaluation of the Administration of Undiluted IV Push Levetiracetam in Pediatrics
Favorite
12:30 PM – 1:30 PM
(11-385) Evaluation of Cytomegalovirus Immune Globulin Use at a Large Academic Health System
Favorite
12:30 PM – 1:30 PM
(11-386) Evaluation of Voriconazole Therapeutic Drug Monitoring (TDM) at a Large Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-387) Safety Evaluation of Pegaspargase vs Calaspargase in Pediatric Patients with Acute Lymphoblastic Leukemia
Favorite
12:30 PM – 1:30 PM
(11-388) Medication Use Evaluation of Haloperidol, Quetiapine, Risperidone, and Olanzapine in the Treatment of ICU Delirium
Favorite
12:30 PM – 1:30 PM
(11-389) Medication use evaluation of cangrelor at a large academic medical center
Favorite
12:30 PM – 1:30 PM
(11-390) Tranexamic Acid Utilization Review in Level 1 Trauma Patients in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-391) Evaluation of Antibiotic Utilization within the NYU Langone Hospital – Long Island Home Hospital Program
Favorite
12:30 PM – 1:30 PM
(11-392) Effect of Carboplatin and Cisplatin Drug Shortage on Patient Care at NYU Langone Hospital
Favorite
12:30 PM – 1:30 PM
(11-393) Evaluation of Clinical Outcomes of Albumin Use in patients with Sepsis/Septic Shock
Favorite
12:30 PM – 1:30 PM
(11-394) Evaluation of Melatonin Use in Patients with Delirium in Surgical Intensive Care Unit
Favorite
12:30 PM – 1:30 PM
(11-395) Evaluation of Starter Total Parenteral Nutrition Use in the Neonatal Intensive Care Unit
Favorite
12:30 PM – 1:30 PM
(11-396) Real-World Incidence of Hypersensitivity Reactions in Patients Receiving Rituximab or Rituximab-biosimilar
Favorite
12:30 PM – 1:30 PM
(11-397) Evaluation of Glucose Management in Hospitalized Patients with Type 2 Diabetes Mellitus Being Treated with Oral Antihyperglycemics Versus Insulin
Favorite
12:30 PM – 1:30 PM
(11-398) Efficacy and safety of clindamycin vs cefazolin based regimens for antimicrobial prophylaxis in surgery
Favorite
12:30 PM – 1:30 PM
(11-399) Evaluation of Patients Discharged From Pharmacist-Led Collaborative Drug Therapy Management (CDTM) Primary Care Clinic
Favorite
12:30 PM – 1:30 PM
(11-400) Association between Obesity and Venous Thromboembolism (VTE) Incidence in Hospitalized Patients on Apixaban or Rivaroxaban.
Favorite
12:30 PM – 1:30 PM
(11-401) Effect of Dapagliflozin Initiation on Hospital Readmission Rates for Heart Failure with Reduced Ejection Fraction
Favorite
12:30 PM – 1:30 PM
(11-402) Effect of Dapagliflozin Initiation on Renal Outcomes for Hospitalized Patients with Type 2 Diabetes Mellitus and Patients with Chronic Heart Failure
Favorite
12:30 PM – 1:30 PM
(11-403) Efficacy of Early Random Serum Drug Concentration Levels on Vancomycin Dosing Recommendations in Bayesian Kinetic Modeling
Favorite
12:30 PM – 1:30 PM
(11-404) Pharmacy- Directed De-escalation of Proton Pump Inhibitor Use
Favorite
12:30 PM – 1:30 PM
(11-405) Impact of Enhanced Targeted Alerts to Improve Weight Documentation and Clinical Outcomes
Favorite
12:30 PM – 1:30 PM
(11-406) A Comparison of Tenecteplase versus Alteplase in the Treatment of Acute Ischemic Stroke in a Community Hospital
Favorite
12:30 PM – 1:30 PM
(11-407) The Impact of Compliance with Methicillin Resistant and Methicillin Susceptible Staphylococcus Aureus Testing and Decolonization Protocol in the Intensive Care Unit
Favorite
12:30 PM – 1:30 PM
(11-408) Impact of Pharmacist Intervention on Hospital Readmission Rates Among a Target Population
Favorite
12:30 PM – 1:30 PM
(11-409) Evaluation of Apixaban Use for Venous Thromboembolism Prophylaxis in Post-Bariatric Surgery Patients at a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-410) Optimizing Guideline Directed Therapy for Asthma Management and Reduce Asthma Inhaler Polypharmacy
Favorite
12:30 PM – 1:30 PM
(11-411) Evaluation of the Use and Cost-Effectiveness of Rabies Immune Globulin Standard Weight-Based Dosing Versus a Dose Rounding Strategy for Post-Exposure Prophylaxis in the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-412) Preliminary evaluation of change in asthma symptom control after starting tezepelumab-ekko in patients with severe asthma in an urban health system clinic
Favorite
12:30 PM – 1:30 PM
(11-413) Evaluation of Appropriate Use of Albumin at SBH Health System
Favorite
12:30 PM – 1:30 PM
(11-414) Evaluation of cabotegravir-rilpivirine use in patients with human immunodeficiency virus at an urban healthcare system
Favorite
12:30 PM – 1:30 PM
(11-415) The Effect of Glucagon-like Peptide-1 Receptor Agonists and Mounjaro on Patients' Insulin Requirements
Favorite
12:30 PM – 1:30 PM
(11-416) Role of Long-acting Semisynthetic Lipoglycopeptides for the Treatment of Complicated Gram Positive Infections: A Retrospective Study Evaluating Patient Outcomes and Safety in Outpatient Antimicrobial Therapy
Favorite
12:30 PM – 1:30 PM
(11-417) Evaluation of Conventional Versus Reduced-Dose Insulin in the Treatment of Hyperkalemia
Favorite
12:30 PM – 1:30 PM
(11-418) Evaluation of Intravenous Push Versus Intermittent Infusion Administration of Antibiotics for the Treatment of Gram-Negative Bacteremia
Favorite
12:30 PM – 1:30 PM
(11-419) Comparison of Oritavancin vs. Dalbavancin in the Outpatient Setting: Patient Selection, Adverse Effects and Outcomes
Favorite
12:30 PM – 1:30 PM
(11-420) Assessment of Guideline-Directed Medical Therapy (GDMT) for Heart Failure: Focus on 30-day Readmission for Patients Discharged on Dapagliflozin Following Heart Failure Admission
Favorite
12:30 PM – 1:30 PM
(11-421) Evaluation of the Impact of a Clinical Pharmacist-led Diabetes Management Program at an Ambulatory Care Clinic
Favorite
12:30 PM – 1:30 PM
(11-422) Evaluation of the Two-Bag Protocol for Management of Diabetic Ketoacidosis
Favorite
12:30 PM – 1:30 PM
(11-423) Metformin-Associated Lactic Acidosis and Diabetic Ketoacidosis Case Report
Favorite
12:30 PM – 1:30 PM
(11-424) Effects of Early Sodium Bicarbonate Administration in Acidotic Patients - a Safety and Efficacy Evaluation.
Favorite
12:30 PM – 1:30 PM
(11-425) Evaluation of the Diagnostic Markers and Empiric Treatment of Urinary Tract Infections Among Ambulatory Patients Discharged from the Emergency Department
Favorite
12:30 PM – 1:30 PM
(11-426) Assessing Respiratory Syncytial Virus (RSV) Vaccine Interest in an Urban Geriatrics Clinic
Favorite
12:30 PM – 1:30 PM
(11-427) Evaluation of Cefiderocol Usage in the Treatment of Multi-Drug Resistant Gram-Negative Infections at an Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-428) Evaluation of the Appropriateness of Dual Anaerobic Coverage with Metronidazole
Favorite
12:30 PM – 1:30 PM
(11-429) Evaluation of the Incidence of Acute Kidney Injury with the use of Intravenous Ibuprofen at Stony Brook Children’s Hospital
Favorite
12:30 PM – 1:30 PM
(11-430) Evaluation of Intravenous Amiodarone Use in Post-Cardiac Surgery Patients at Stony Brook University Hospital
Favorite
12:30 PM – 1:30 PM
(11-431) Medical Use evaluation of prophylaxis Heparin Post Intracranial Procedures in Patients over 100 Kg
Favorite
12:30 PM – 1:30 PM
(11-432) Pharmacoeconomic analysis of ceftaroline use for confirmed or suspected Methicillin-resistant Staphylococcus aureus infections at an urban teaching hospital
Favorite
12:30 PM – 1:30 PM
(11-433) Small Cell Carcinoma of the Prostate after Brachytherapy and ADT for Treatment of Adenocarcinoma of the Prostate
Favorite
12:30 PM – 1:30 PM
(11-434) Sulbactam-durlobactam use in a hemodialysis-dependent patient with carbapenem-resistant Acinetobacter baumannii (CRAB) ventilator-associated pneumonia: a case report
Favorite
12:30 PM – 1:30 PM
(11-435) Corticosteroid Induced Bradycardia
Favorite
12:30 PM – 1:30 PM
(11-436) Evaluate the Real-World Use of Long Acting Injectable Catotegravir for HIV Pre-Exposure Prophylaxis
Favorite
12:30 PM – 1:30 PM
(11-437) Cefazolin + ertapenem in combination for rapid clearance of Methicillin-susceptible Staphylococcus aureus bloodstream infection
Favorite
12:30 PM – 1:30 PM
(11-438) Comparison of Sugammadex to Neostigmine within Guideline-based Reversal of Neuromuscular Blockade in a multi-site urban health system
Favorite
12:30 PM – 1:30 PM
(11-439) Vancomycin in Pediatric Cardiac Surgery Prophylaxis: Evaluation of Institutional Protocol Compliance and Associated Nephrotoxicity
Favorite
12:30 PM – 1:30 PM
(11-440) Evaluating the Effectiveness of an apixaban Order Set on the Selection of an Appropriate Dosing Regimen for Inpatients
Favorite
12:30 PM – 1:30 PM
(11-441) Therapeutic Drug Monitoring (TDM) of Posaconazole in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplant (allo-HSCT)
Favorite
12:30 PM – 1:30 PM
(11-442) Evaluation of Two Vancomycin Bayesian Dosing Software Programs; Comparing Rates of Acute Kidney Injury at a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-443) Evaluation of compliance with an antimicrobial stewardship restriction for ceftazidime-avibactam at a large academic medical center
Favorite
12:30 PM – 1:30 PM
(11-444) Effects of Pharmacist Medication Interventions on Delirium in Geriatric Patients Admitted for Traumatic Injury
Favorite
12:30 PM – 1:30 PM
(11-445) Assessment of heparin drip errors following implementation of a pharmacist driven aPTT protocol
Favorite
12:30 PM – 1:30 PM
(11-446) Impact of Pharmacist Interventions on Clostridioides difficile Testing in a Rural Hospital Setting
Favorite
12:30 PM – 1:30 PM
(11-447) Impact of Ambulatory Care Pharmacists on Heart Failure Patients in an Outpatient Setting
Favorite
12:30 PM – 1:30 PM
(11-448) Evaluation of the Adherence to the Clinical Practice Policy for Piperacillin-Tazobactam Extended Infusion Dosing at a Community Teaching Hospital
Favorite
12:30 PM – 1:30 PM
(11-449) Assessment of Psychiatric Patients’ Actual QTc Intervals vs. Predicted QTc Prolongation Risk
Favorite
12:30 PM – 1:30 PM
(11-450) Evaluation of calcimimetic therapy in post-renal transplant recipients at an urban teaching hospital
Favorite
12:30 PM – 1:30 PM
(11-451) Evaluation of Remdesivir Utilization and Cost for the Treatment and Prophylaxis of SARS-CoV-2 at a Large Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-452) Safety of IV Push Administration of Iron Sucrose in Adult Inpatients
Favorite
12:30 PM – 1:30 PM
(11-453) Evaluation of Pharmacist Lead Age-Friendly Health System Pilot Program for Identifying Potentially Inappropriate Benzodiazepine use in the Elderly at a Large Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-454) Evaluating the Frequency of Co-prescribing of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Glucagon Like Peptide-1 (GLP-1) Agonists Among Patients with Type 2 Diabetes Mellitus
Favorite
12:30 PM – 1:30 PM
(11-455) Bone Modifying Agent Utilization: Evaluation of Use Pre and Post Implementation of an Indication-Directed Policy in Cancer Patients
Favorite
12:30 PM – 1:30 PM
(11-456) Evaluation of Cangrelor Use at a Tertiary Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-457) Evaluation of Factor VIIa (recombinant) Use in Adult and Pediatric Patients at a Tertiary Academic Medical Center
Favorite
12:30 PM – 1:30 PM
(11-458) Utilization of and Costs Associated with Injectable Calcitonin in Hypercalcemia
Favorite
12:30 PM – 1:30 PM
(11-459) Title: Direct oral anticoagulants treatment failure for venous thromboembolism in the setting of thrombophilic conditions
Favorite
12:30 PM – 1:30 PM
(11-460) Description of a pharmacy-driven medication reconciliation process at a mid-sized community hospital
Favorite
12:30 PM – 1:30 PM
(11-461) Evaluation of Staphylococcus Bacteremia Patient Outcomes with Tele-Infectious Disease at Baptist Memorial Hospital – Golden Triangle
Favorite
12:30 PM – 1:30 PM
(11-462) Necessity of an emergency department-based outpatient infusion service as a stewardship initiative
Favorite
2:00 PM – 3:00 PM
(12-001) Evaluation of Intravenous Sotalol
Favorite
2:00 PM – 3:00 PM
(12-002) Evaluation of Dalbavancin at Atrium Health
Favorite
2:00 PM – 3:00 PM
(12-003) Evaluation of the Impact on Weight Loss with Glucagon-like Peptide-1 Receptor Agonists or Glucose-dependent Insulinotropic Polypeptide/Glucagon-like Peptide-1 Receptor Agonist at Doses Not Indicated for Obesity
Favorite
2:00 PM – 3:00 PM
(12-004) Subcutaneous versus intravenous insulin for the treatment of mild-to-moderate diabetic ketoacidosis in the emergency department
Favorite
2:00 PM – 3:00 PM
(12-005) Medication Use Evaluation of Phenobarbital Treatment for Alcohol Withdrawal in the Intensive Care Unit
Favorite
2:00 PM – 3:00 PM
(12-006) Medication Use Evaluation of Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors in Patients Without Diabetes
Favorite
2:00 PM – 3:00 PM
(12-007) Impact of metagenomic next-generation sequencing of plasma cell-free DNA on infectious diseases management
Favorite
2:00 PM – 3:00 PM
(12-008) Evaluation of Safety Outcomes with Transitioning Obinutuzumab from Standard Rate to Short Duration Infusion in Patients with B-cell Lymphomas
Favorite
2:00 PM – 3:00 PM
(12-010) Evaluation of the Appropriateness of Erythropoietin-stimulating Agent Use in a Hospital Setting
Favorite
2:00 PM – 3:00 PM
(12-011) Documentation of Rationale for Omission of Bone-Modifying Agents in Solid Tumor Oncology Patients
Favorite
2:00 PM – 3:00 PM
(12-012) Review of Corticosteroid-Induced Adrenal Insufficiency in the Neonatal Intensive Care Unit (NICU)
Favorite
2:00 PM – 3:00 PM
(12-013) Use and Real-World Experience with Novel Janus Kinase Inhibitors in Myelofibrosis
Favorite
2:00 PM – 3:00 PM
(12-014) Evaluation of Thyroid Function Monitoring in Patients on Tyrosine Kinase inhibitor (TKI) for Oncology Indications
Favorite
2:00 PM – 3:00 PM
(12-015) Time to Administration of Alteplase Versus Tenecteplase for Acute Ischemic Stroke in the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-016) Evaluation of Alcohol Withdrawal Syndrome Following Implementation of the Modified Minnesota Detoxification Scale
Favorite
2:00 PM – 3:00 PM
(12-017) Effect of pharmacist driven methicillin resistant staphylococcus aureus polymerase chain reaction screening on vancomycin therapy duration in patients with community acquired pneumonia
Favorite
2:00 PM – 3:00 PM
(12-018) Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban or rivaroxaban associated bleeding
Favorite
2:00 PM – 3:00 PM
(12-019) Efficacy of Single-Syringe Adenosine Administration for Termination of Supraventricular Tachycardia in the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-020) Implementation of a pediatric intravenous infusion smart pump drug library in a community hospital
Favorite
2:00 PM – 3:00 PM
(12-021) Ketamine for Acute Pain Management in a Community Hospital Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-022) Assessing Efficacy and Safety of Patient Controlled Analgesia (PCA) in Opioid-Tolerant vs. Opioid-Naive Patients
Favorite
2:00 PM – 3:00 PM
(12-023) Time to Administration of Tenecteplase versus Alteplase in Acute Ischemic Stroke Patients
Favorite
2:00 PM – 3:00 PM
(12-024) Impact of Community Pharmacists Completing Transitions of Care Follow-up Calls to Recently Hospitalization Patients
Favorite
2:00 PM – 3:00 PM
(12-025) Analysis of Patients with Penicillin Allergy Reconciliation > 1 Year After Pharmacist Intervention on Allergy
Favorite
2:00 PM – 3:00 PM
(12-026) Effect of Dual Antiplatelet Therapy versus Single Antiplatelet Therapy on Bleeding Outcomes Following Transcatheter Aortic Valve Replacement
Favorite
2:00 PM – 3:00 PM
(12-027) Impact of Pharmacist Targeted Interventions in the Management of Chronic Kidney Disease in Patients with Hypertension
Favorite
2:00 PM – 3:00 PM
(12-028) Appropriate use of GLP1-RAs, SGLT2 Inhibitors, and Statins in Patients with Managed Medicaid Insurance
Favorite
2:00 PM – 3:00 PM
(12-029) Evaluation of the Adherence and Tolerability of Treprostinil DPI in Patients with WHO Groups 1 and 3 Pulmonary Hypertension
Favorite
2:00 PM – 3:00 PM
(12-030) Evaluation of Antibiotic Administration Surrounding Interventional Radiology Procedures
Favorite
2:00 PM – 3:00 PM
(12-031) Evaluation of the Utilization and Dosing of Intraoperative Digoxin at ECU Health Medical Center
Favorite
2:00 PM – 3:00 PM
(12-032) Incidence of hypoglycemia with the use of a paper-based protocol compared to Glucommander-driven intravenous insulin management in the emergency department
Favorite
2:00 PM – 3:00 PM
(12-033) Use of Sodium Bicarbonate Boluses in Neonatal Patients
Favorite
2:00 PM – 3:00 PM
(12-034) Time to Antimicrobial Administration in Patients Presenting with Shock in Intensive Care Units
Favorite
2:00 PM – 3:00 PM
(12-035) Glycemic Management During the Rewarming Phase of Targeted Temperature Management Following Cardiac Arrest
Favorite
2:00 PM – 3:00 PM
(12-036) Pharmacist Involvement in a Provider-Driven Culture Call-Back Program in a Community Based Hospital Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-037) Impact of Pharmacist-Driven Medication Review Post-Discharge on Hospital Readmission Rates
Favorite
2:00 PM – 3:00 PM
(12-038) If There is Nothing in the Pee, Let it be: Diagnostic Stewardship for Urinary Testing in Hospitalized Patients
Favorite
2:00 PM – 3:00 PM
(12-039) Analysis of Prosthetic Joint Infections in a Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-040) Assessing the Usefulness of Rechallenging Carboplatin, Docetaxel, and Paclitaxel versus Switching Therapies in Cancer Patients at an Outpatient Setting
Favorite
2:00 PM – 3:00 PM
(12-041) Evaluation of Trazodone Utilization for Insomnia in Hospitalized Patients in a Rural Teaching Hospital.
Favorite
2:00 PM – 3:00 PM
(12-042) Evaluation of Current Utilization of Intravenous (IV) Albumin based on Appropriate Indications for Use in Hospitalized Patients in a Rural Community Teaching Hospital
Favorite
2:00 PM – 3:00 PM
(12-043) Evaluation of Bevacizumab-Induced Proteinuria Monitoring and Management
Favorite
2:00 PM – 3:00 PM
(12-044) Assessment of Inpatient Sotalol Initiation Dosing for Atrial Fibrillation and Atrial Flutter
Favorite
2:00 PM – 3:00 PM
(12-045) Assessment of drug-drug interactions in hospitalized patients receiving direct oral anticoagulants
Favorite
2:00 PM – 3:00 PM
(12-046) Evaluation of Prescribing and Monitoring Practices for Direct Oral Anticoagulants By Providers and Outpatient Clinics
Favorite
2:00 PM – 3:00 PM
(12-047) Impact of a Dedicated Pediatric Emergency Department on Pediatric Care
Favorite
2:00 PM – 3:00 PM
(12-048) Comparison of Opioid Utilization After Selective Orthopedic Surgery in the 24 Hours Prior to Discharge Versus Discharge Prescription
Favorite
2:00 PM – 3:00 PM
(12-049) Effect of Decreased Dose Nimodipine Use in Subarachnoid Hemorrhage
Favorite
2:00 PM – 3:00 PM
(12-050) Assessment of Direct Oral Anticoagulant Prescribing at Discharge from a Community Teaching Hospital
Favorite
2:00 PM – 3:00 PM
(12-051) Alpha-1 Adrenergic Antagonists for the Management of Acute Urinary Retention in the Intensive Care Unit
Favorite
2:00 PM – 3:00 PM
(12-052) Assessment of Pharmacist Sustainability and Qualitative Impact in a Rural Health Clinic
Favorite
2:00 PM – 3:00 PM
(12-053) Alteplase vs Tenecteplase in Acute Ischemic Stroke at Moses Cone Hospital
Favorite
2:00 PM – 3:00 PM
(12-054) Impact of High-Dose Levetiracetam for Neonatal Seizures
Favorite
2:00 PM – 3:00 PM
(12-055) Evaluation of a Nurse and Pharmacist Driven Phenobarbital Protocol for Alcohol Withdrawal Syndromes
Favorite
2:00 PM – 3:00 PM
(12-056) The Impact of Pharmacist-Driven Insulin Management in the Intensive Care Unit
Favorite
2:00 PM – 3:00 PM
(12-057) Assessment of Medication Switching and Cycling in Spondylarthritis
Favorite
2:00 PM – 3:00 PM
(12-058) Evaluation of Dalbavancin Use in a Community Hospital System
Favorite
2:00 PM – 3:00 PM
(12-059) Comparison of Patient Monitoring and Follow-up on Direct Oral Anticoagulant Therapy Following Pharmacist Intervention versus Standard Care
Favorite
2:00 PM – 3:00 PM
(12-060) Timing of Inpatient Renin-Angiotensin-Aldosterone System Inhibitor Administration Prior to Cardiac Surgery
Favorite
2:00 PM – 3:00 PM
(12-061) Development of a Local Gram-Negative Multidrug Resistant Organism Antibiogram
Favorite
2:00 PM – 3:00 PM
(12-062) Optimization and Compliance of Medications with Risk Evaluation and Mitigation Strategies (REMS) Program Designation at Novant Health
Favorite
2:00 PM – 3:00 PM
(12-063) Evaluation of cytarabine consolidation strategies in acute myeloid leukemia
Favorite
2:00 PM – 3:00 PM
(12-064) Assessing Appropriate Dosing of Apixaban and Rivaroxaban for Extended Treatment of VTE: A Retrospective Chart Review
Favorite
2:00 PM – 3:00 PM
(12-065) Evaluation of patients on warfarin transitioned to direct oral anticoagulants enrolled in an Ambulatory Pharmacy Medication Management Care Clinic
Favorite
2:00 PM – 3:00 PM
(12-066) Evaluation and Characterization of the Incidence of Acute Kidney Injury After Switching to Area Under the Curve/Minimum Inhibitory Concentration Dosing and Monitoring of Vancomycin
Favorite
2:00 PM – 3:00 PM
(12-067) Clinical Impact of Nirmatrelvir/Ritonavir in Patients Incidentally Found to Have Coronavirus Disease 2019 (COVID-19) After Admission
Favorite
2:00 PM – 3:00 PM
(12-068) Evaluation of Nitazoxanide Criteria of Use at a Large, Community Healthcare System
Favorite
2:00 PM – 3:00 PM
(12-069) Assessing Appropriate Use of Naloxone and Flumazenil in Procedural Areas at Three Community Hospitals
Favorite
2:00 PM – 3:00 PM
(12-070) Evaluation and Management of Iron Deficiency in Patients Hospitalized for Heart Failure
Favorite
2:00 PM – 3:00 PM
(12-071) Clinical and Financial Evaluation of the Use of Mitomycin for Pyelocalyceal Instillation
Favorite
2:00 PM – 3:00 PM
(12-072) Medication Use Evaluation: Calcitonin Injection Use
Favorite
2:00 PM – 3:00 PM
(12-073) Assessing Use of Peripherally Acting Mu-Opioid Receptor Antagonists (PAMORAs) Based on Established Criteria
Favorite
2:00 PM – 3:00 PM
(12-074) Evaluation of Compliance to Retinal Toxicity Monitoring in Patients Receiving Hydroxychloroquine
Favorite
2:00 PM – 3:00 PM
(12-075) Evaluating the effectiveness of a pharmacist-driven program for the de-escalation of vancomycin in patients with potential MRSA pneumonia utilizing a nasal MRSA screen
Favorite
2:00 PM – 3:00 PM
(12-076) Prescribing Trends for Perioperative Tranexamic Acid in Adults at a Community Teaching Hospital
Favorite
2:00 PM – 3:00 PM
(12-077) Evaluating the use of metronidazole at a community teaching hospital
Favorite
2:00 PM – 3:00 PM
(12-078) Evaluation of the safety of iron sucrose administration as slow intravenous injection versus intravenous infusion in adults with iron deficiency anemia in an outpatient setting
Favorite
2:00 PM – 3:00 PM
(12-079) Comparison of HFrEF GDMT Prescribing with Pharmacist Intervention versus Usual Care
Favorite
2:00 PM – 3:00 PM
(12-080) Evaluation of Severe Hyperglycemia Post-Subcutaneous Insulin Order Set Implementation
Favorite
2:00 PM – 3:00 PM
(12-081) Assessing Appropriate Use of Low Dose Rivaroxaban as an Alternative to Prophylactic Enoxaparin
Favorite
2:00 PM – 3:00 PM
(12-082) Impact of Clinical Pharmacist Practitioner-managed discharge medication reconciliation on medication discrepancies
Favorite
2:00 PM – 3:00 PM
(12-083) Evaluation of Antimicrobial Agents in Bone Cement for Orthopedic Joint Revision
Favorite
2:00 PM – 3:00 PM
(12-084) Cost Effect of Rabies Immune Globulin Dose Rounding in a Community Health System
Favorite
2:00 PM – 3:00 PM
(12-085) Inclisiran Efficacy and Financial Impact for Outpatient Use
Favorite
2:00 PM – 3:00 PM
(12-086) Assessment of Long-Acting Opioid Use Within a Community Health System
Favorite
2:00 PM – 3:00 PM
(12-087) Evaluation of Valproic Acid, Phenytoin and Fosphenytoin Loading Doses in Achieving Therapeutic Levels and Seizure Control
Favorite
2:00 PM – 3:00 PM
(12-088) Comparative Efficacy of Evolocumab and Alirocumab in Patients with Hyperlipidemia
Favorite
2:00 PM – 3:00 PM
(12-089) Evaluating the use and safety monitoring of denosumab in the outpatient setting
Favorite
2:00 PM – 3:00 PM
(12-090) Evaluation of Compliance to Select Specialty Medication Lab Monitoring in the Ambulatory Care Setting
Favorite
2:00 PM – 3:00 PM
(12-091) Assessing the impact on disease progression in Rheumatoid Arthritis patients on biologic therapy
Favorite
2:00 PM – 3:00 PM
(12-092) Overdiagnosis of Urinary Tract Infections at a Multicenter Health System
Favorite
2:00 PM – 3:00 PM
(12-093) Evaluating the Impact of Scripted Pharmacist Opioid and Narcan Education on Narcan Prescribing and Distribution Among Patients Receiving Opioid Prescriptions
Favorite
2:00 PM – 3:00 PM
(12-094) The Impact of Consult Driven Medication Reconciliation Completed by Pharmacists
Favorite
2:00 PM – 3:00 PM
(12-095) Evaluation of a Pharmacist-led Erythropoietin Stimulating Agent Standard Work Protocol in the Hospital Setting
Favorite
2:00 PM – 3:00 PM
(12-096) Evaluation of a Pharmacist-led Emergency Department Culture Review Program in an Upper Midwest Mid-Sized Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-097) A retrospective study comparing opioid medication choice for the treatment of neonatal iatrogenic withdrawal syndrome (IAWS)
Favorite
2:00 PM – 3:00 PM
(12-098) Examining the Impact of a Pharmacist-Managed Diabetes Program in an Internal Medicine Clinic: A Retrospective Matched Cohort Study
Favorite
2:00 PM – 3:00 PM
(12-099) Impact of Ongoing Provider Feedback and Education on Antibiotic Prescribing for Upper Respiratory Tract Infections in the Urgent Care Setting
Favorite
2:00 PM – 3:00 PM
(12-100) Phenylephrine vs. Norepinephrine in ICU Shock Patients in Atrial Fibrillation with Rapid Ventricular Rate
Favorite
2:00 PM – 3:00 PM
(12-101) Glucagon-Like Peptide 1 Agonist Impact on Inflammatory Bowel Disease
Favorite
2:00 PM – 3:00 PM
(12-102) Evaluation of the Neuro Heparin Protocol
Favorite
2:00 PM – 3:00 PM
(12-103) Medication Use Evaluation: Assessing the Impact of Conversion from Clevidipine to Nicardipine in Hypertensive Patients at a 200-bed Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-104) Evaluation of Continuous Glucose Monitoring (CGM) Managed by Pharmacists Compared to Primary Care Providers (PCP): Impact on Hemoglobin A1c% (HgA1c%)
Favorite
2:00 PM – 3:00 PM
(12-105) Evaluation of Scanning Failures on Compliance of Barcode Medication Administration (BCMA) within a Rural Health System
Favorite
2:00 PM – 3:00 PM
(12-106) Effects of tirzepatide on HbA1c and body weight after switching from semeglutide or dulaglutide
Favorite
2:00 PM – 3:00 PM
(12-107) Implementation of Pharmacist Led Inpatient Warfarin Management Within a Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-108) After-hours In-person Versus After-hours Telestroke Response: How Do They Compare In Door-to-needle (DTN) Time?
Favorite
2:00 PM – 3:00 PM
(12-109) Effectiveness of Emergency Department Overdose PowerPlan in Preventing Patient-Directed Discharges in Patients with Opioid Use Disorder
Favorite
2:00 PM – 3:00 PM
(12-110) Fentanyl Patch Use in the Inpatient and Post-Acute Care Setting
Favorite
2:00 PM – 3:00 PM
(12-111) Evaluation of Appropriate Use for Antibiotics on the Automated Renal Dosing Policy at Aultman Hospital.
Favorite
2:00 PM – 3:00 PM
(12-112) Evaluation of Vancomycin Protocol Utilization by Pharmacists in a Large Hospital Setting
Favorite
2:00 PM – 3:00 PM
(12-113) Implementation of a Pharmacist-Led Cabotegravir HIV Pre-Exposure Prophylaxis (PrEP) Program within an Established Collaborative Practice Agreement
Favorite
2:00 PM – 3:00 PM
(12-114) Evaluation of Sodium-Glucose Cotransporter 2 Inhibitors in Preventing Hospital Readmission due to Acute Heart Failure Exacerbations
Favorite
2:00 PM – 3:00 PM
(12-115) Discharge Opioid Prescribing Patterns for Opioid-Naïve Post-Surgical Patients at a Level III Community-Based Hospital
Favorite
2:00 PM – 3:00 PM
(12-116) Retrospective Study of the Safety and Efficacy of Enoxaparin in Laparoscopic Sleeve Gastrectomy
Favorite
2:00 PM – 3:00 PM
(12-117) Pharmacist-Led Pain Management Interventions in the Critically Ill
Favorite
2:00 PM – 3:00 PM
(12-118) Determining the degree of International Normalized Ratio (INR) response to vitamin K dosing in critically ill children
Favorite
2:00 PM – 3:00 PM
(12-119) Impact of a pharmacy technician in an outpatient clinic on hospital cost reductions and patient outcomes
Favorite
2:00 PM – 3:00 PM
(12-120) Safety and efficacy of intravenous posaconazole in pediatric HSCT patients
Favorite
2:00 PM – 3:00 PM
(12-121) Association of Neutropenia with Valganciclovir Prophylaxis Dosing Practices within Pediatric Solid Organ Transplant Recipients
Favorite
2:00 PM – 3:00 PM
(12-122) Blood is Not an Option Order Set Evaluation
Favorite
2:00 PM – 3:00 PM
(12-123) Characterization of Calcium Supplementation in Trauma Patients Receiving Packed Red Blood Cells at a Level 1 Trauma Center
Favorite
2:00 PM – 3:00 PM
(12-124) Beta-lactam Monotherapy vs Combination Regimens For Empiric Gram Negative Coverage in Sepsis
Favorite
2:00 PM – 3:00 PM
(12-126) Desmopressin Use in the Critically Ill
Favorite
2:00 PM – 3:00 PM
(12-127) Introduction of an ambulatory care pharmacist team in a pediatric asthma clinic
Favorite
2:00 PM – 3:00 PM
(12-128) Evaluation of Benzodiazepine Administration for Delirium in Non-Intensive Care Unit Patients Aged 65 Years or Older
Favorite
2:00 PM – 3:00 PM
(12-129) Migraine Treatment in the Emergency Department: Droperidol, Prochlorperazine, & Metoclopramide
Favorite
2:00 PM – 3:00 PM
(12-130) Effects of Pharmacist Education on Antibiotics at Discharge for Patient Satisfaction and Antibiotic Knowledge
Favorite
2:00 PM – 3:00 PM
(12-131) Impact of Lumbar Puncture Performance on Antimicrobial Stewardship Outcomes in Suspected Community-Acquired Meningitis
Favorite
2:00 PM – 3:00 PM
(12-132) Impact of Nasal Staphylococcus aureus Decolonization with Intranasal Mupirocin on ICU-acquired Blood Stream Infections
Favorite
2:00 PM – 3:00 PM
(12-133) Health System Specialty Pharmacist Interventions Related to Patient Reported Outcome Measures
Favorite
2:00 PM – 3:00 PM
(12-134) Descriptive Analysis of the Development of Transitional Care Management Services Within an Inpatient Pediatric Neurology Service
Favorite
2:00 PM – 3:00 PM
(12-135) Phenytoin Prescribing and Monitoring Practices Pre-Implementation of the Dayton Children’s Hospital Phenytoin Standard Monitoring Procedure
Favorite
2:00 PM – 3:00 PM
(12-136) Evaluation of the Rates of Cholestasis in Patients Receiving Intravenous Lipid Emulsion (IVLE) in a Neonatal Intensive Care Unit (NICU): A Pre- and Post-implementation Study
Favorite
2:00 PM – 3:00 PM
(12-137) Implementation and evaluation of a medication loss prevention protocol in a rural community hospital
Favorite
2:00 PM – 3:00 PM
(12-138) Weight Loss Outcomes Associated with Semaglutide Treatment for Patients with Overweight or Obesity in a Rural Ambulatory Clinic
Favorite
2:00 PM – 3:00 PM
(12-139) Droperidol Prescribing Patterns in the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-140) Tirzepatide on Renal Outcomes, an Equivalency Study
Favorite
2:00 PM – 3:00 PM
(12-141) COPD Exacerbation Rate Between Dual Combination Inhaler Therapy Compared to Triple Combination Therapy
Favorite
2:00 PM – 3:00 PM
(12-142) Impact of N-acetylcysteine on Non-acetaminophen Acute Liver Injury
Favorite
2:00 PM – 3:00 PM
(12-143) Fixed-dose versus Weight-based 4-Factor Prothrombin Complex Concentrate for Direct Oral Anticoagulant Reversal: Impact on Clinical Outcomes in Intracranial Hemorrhage.
Favorite
2:00 PM – 3:00 PM
(12-144) The Impact of Hold Duration of Oral Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors (VEGF TKIs) on Surgical Outcomes and Complications in Cancer Patients
Favorite
2:00 PM – 3:00 PM
(12-145) Clinical Utility of Nasal Methicillin-Resistant Staphylococcus Aureus Polymerase Chain Reaction in Patients with Diabetic Foot Infections
Favorite
2:00 PM – 3:00 PM
(12-146) Electronic Medical Record Order Set Optimization in a Rural Health-System Infusion Center
Favorite
2:00 PM – 3:00 PM
(12-147) Diagnostic Stewardship: Impact on Time to Optimal Therapy in Patients with Staphylococcus aureus Infections Using the Penicillin-Binding Protein 2a Assay
Favorite
2:00 PM – 3:00 PM
(12-148) Development of a Nicotine Cessation Clinic Within a Community Hospital in Rural Ohio
Favorite
2:00 PM – 3:00 PM
(12-149) Retrospective non-inferiority study comparing the incidence of post-operative nausea and vomiting following the administration of aprepitant 32.4mg IV versus 80mg PO in laparoscopic sleeve gastrectomy
Favorite
2:00 PM – 3:00 PM
(12-150) Evaluating the Impact of a Pharmacist on Providing Naloxone in a Pain Management Clinic
Favorite
2:00 PM – 3:00 PM
(12-151) Continuous Glucose Monitoring in the Primary Care Setting and the Risk of Diabetic Emergencies
Favorite
2:00 PM – 3:00 PM
(12-152) Impact of Pharmacist Intervention on Multiple Antipsychotics Prescribing in an Inpatient Psychiatric Facility
Favorite
2:00 PM – 3:00 PM
(12-153) Implementation of a Pharmacist Driven Protocol for Lipid Monitoring and Intervention in Patients Taking Atypical Antipsychotics
Favorite
2:00 PM – 3:00 PM
(12-154) Comparison of a single dose of phenobarbital combined with CIWA protocol versus CIWA protocol alone for the management of acute alcohol withdrawal syndrome
Favorite
2:00 PM – 3:00 PM
(12-155) Effects of a pharmacist-led deprescribing initiative in a family medicine residency clinic
Favorite
2:00 PM – 3:00 PM
(12-156) Vancomycin Therapy Utilizing Bayesian-Estimated Area Under the Curve Dosing Versus Trough Dosing
Favorite
2:00 PM – 3:00 PM
(12-157) Evaluation of Safety Outcomes of 4-Factor Prothrombin Complex Concentrate + Tranexamic Acid Versus 4-Factor Prothrombin Complex Concentrate Alone in Patients Requiring Emergent Anticoagulation Reversal
Favorite
2:00 PM – 3:00 PM
(12-158) Effect of single doses of droperidol or haloperidol on QT prolongation
Favorite
2:00 PM – 3:00 PM
(12-160) Characteristics of adult patients with diabetes admitted to an academic medical center for hypoglycemia events
Favorite
2:00 PM – 3:00 PM
(12-161) Intermittent Bolus Versus Continuous Infusion of Propofol for Procedural Sedation in the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-162) Evaluation of Dextrose 10% versus Dextrose 50% for hypoglycemia management in the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-163) Dofetilide (Tikosyn) New Starts at a Large Academic Medical Center
Favorite
2:00 PM – 3:00 PM
(12-164) Inpatient Initiation of Dalbavancin in a Safety Net Hospital: A Long Half-Life Can Only Get Us So Far
Favorite
2:00 PM – 3:00 PM
(12-165) Evaluation of a Weight-Based Enoxaparin Dosing Protocol for Venous Thromboembolism Prophylaxis in Acute Trauma Patients
Favorite
2:00 PM – 3:00 PM
(12-166) Impact of Continuous Glucose Monitoring on Pharmacist Management of Type 2 Diabetes Mellitus
Favorite
2:00 PM – 3:00 PM
(12-167) Impact of Pharmacist Administration of Long-Acting Injectable Antipsychotics in Community Pharmacies
Favorite
2:00 PM – 3:00 PM
(12-168) Fixed Dose Four-Factor Prothrombin Complex Concentrates for Reversal of Factor Xa Inhibitors in Patients with Intracranial Hemorrhage
Favorite
2:00 PM – 3:00 PM
(12-169) Impact of Penicillin Allergy Skin Testing on Length-of-Stay in GBS Positive Mothers: A Retrospective Cohort
Favorite
2:00 PM – 3:00 PM
(12-170) Evaluating the Impact of Total Duration of Antibiotic Therapy for Community-Acquired Pneumonia on All-Cause Readmission Rates
Favorite
2:00 PM – 3:00 PM
(12-171) Chart Correction of Beta-Lactam Allergies: A Medication Use Evaluation
Favorite
2:00 PM – 3:00 PM
(12-172) Impact of a Pharmacist-Led Employee Wellness Hypertension Program Utilizing Remote Monitoring Devices
Favorite
2:00 PM – 3:00 PM
(12-173) Implementation of an Pharmacist-Led Employer-Based Weight Management Program in a Rural, Ambulatory Care Setting
Favorite
2:00 PM – 3:00 PM
(12-174) Impact of Decentralized Practice on Pharmacist Interventions
Favorite
2:00 PM – 3:00 PM
(12-175) Evaluation of Continuous Heparin Infusion Protocol Safety Improvement
Favorite
2:00 PM – 3:00 PM
(12-176) Evaluating the Efficacy of the Newly Implemented Anticoagulation Order Set Utilizing Enoxaparin vs. Heparin for Indications Such As A-Fib/Flutter, ACS (NSTEMI/ Troponin Elevation) and DVT/PE
Favorite
2:00 PM – 3:00 PM
(12-177) Development of a Pharmacy-Led Anti-Factor Xa Monitoring Protocol for High-Risk Populations on Enoxaparin
Favorite
2:00 PM – 3:00 PM
(12-178) Droperidol for the Treatment of Migraine Headaches in the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-179) RAFTS Study: The Role of ACE in Refractory Septic Shock
Favorite
2:00 PM – 3:00 PM
(12-180) Evaluation of Current Credentialing and Privileging Standards for Inpatient Pharmacists
Favorite
2:00 PM – 3:00 PM
(12-181) Effect of a Limited Enoxaparin Bridging Protocol for Subtherapeutic INR in Patients with HeartMate 3 Left Ventricular Assist Device
Favorite
2:00 PM – 3:00 PM
(12-182) Evaluation of Weight-Based Dosing of Intravenous Diltiazem in Obese Patients in Atrial Fibrillation with Rapid Ventricular Response
Favorite
2:00 PM – 3:00 PM
(12-183) Evaluating the Effect on Total Daily Insulin Dose in Adult Patients with Type 1 Diabetes Managed with Metformin and/or GLP-1 or GLP-1/GIP Receptor Agonists
Favorite
2:00 PM – 3:00 PM
(12-184) Comparison of Potassium Lowering with 5 Units versus 10 Units of Intravenous Insulin for the Treatment of Severe Hyperkalemia
Favorite
2:00 PM – 3:00 PM
(12-185) Utility of Donor Derived Cell-Free DNA in High-Risk Kidney Transplant Monitoring Protocols
Favorite
2:00 PM – 3:00 PM
(12-186) Impact of Lower Dose IV Iron Replacement on Hospital Readmission and Mortality in Heart Failure Patients with Iron Deficiency
Favorite
2:00 PM – 3:00 PM
(12-187) Effect of Continuous Glucose Monitoring on Glycemic Control for Patients with Type 2 Diabetes Enrolled in an Employee Wellness Program
Favorite
2:00 PM – 3:00 PM
(12-188) Evaluation of hemorrhagic conversion in patients receiving tenecteplase for acute ischemic stroke in a community teaching hospital
Favorite
2:00 PM – 3:00 PM
(12-189) Analysis of oral transition to cefdinir versus moderately and highly bioavailable agents for gram-negative bacteremia
Favorite
2:00 PM – 3:00 PM
(12-190) Heparin Monitoring Strategies in Adult Patients Receiving Extracorporeal Membrane Oxygen Support: A Retrospective Chart Review
Favorite
2:00 PM – 3:00 PM
(12-191) Evaluation of Loop Diuretic Efficacy With or Without Concomitant Albumin Administration
Favorite
2:00 PM – 3:00 PM
(12-192) INDUC-DOAC trial: Ischemic stroke and venous thromboembolism (VTE) incidence with Pgp/CYP INDUCtion with concomitant use of Direct Oral AntiCoagulant apixaban, rivaroxaban or dabigatran.
Favorite
2:00 PM – 3:00 PM
(12-193) Impact of fentanyl pushes versus continuous infusion for analgosedation in critically ill patients: a retrospective review
Favorite
2:00 PM – 3:00 PM
(12-194) Retrospective review of asthma control following initiation of inhaler therapy in outpatients with mild asthma
Favorite
2:00 PM – 3:00 PM
(12-195) Comparing Weight Loss Benefit of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide 1 Agonists in Patients with Type 2 Diabetes
Favorite
2:00 PM – 3:00 PM
(12-196) Comparing Glycemic Impact of Mounjaro (tirzepatide) vs. Ozempic (semaglutide) vs. Trulicity (dulaglutide)
Favorite
2:00 PM – 3:00 PM
(12-197) Pharmacist Led Interventions Through Post Discharge Ambulatory Pharmacy Program; The Effectiveness, Outcomes, and Impact of Optimized Type 2 Diabetes Management Reflected by Reduced HbA1c Values
Favorite
2:00 PM – 3:00 PM
(12-198) Utilization of Multi-dose Compliance Packaging to Improve Adherence in Patients with Major Depressive Disorder (MDD)
Favorite
2:00 PM – 3:00 PM
(12-199) Implementation and Evaluation of Subcutaneous (SQ) Insulin Administration for Mild Diabetic Ketoacidosis (DKA) in a Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-200) Establishment of a Warfarin Pharmacy to Dose Protocol in a Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-201) Evaluation of time in therapeutic range of warfarin by physicians in an academic community hospital
Favorite
2:00 PM – 3:00 PM
(12-202) Optimization of MRSA PCR Utilization
Favorite
2:00 PM – 3:00 PM
(12-203) Evaluating Patient Scenarios that Trigger Pharmacy Automatic Consult: Intravenous Opioids Greater than 48 Hours
Favorite
2:00 PM – 3:00 PM
(12-204) Analgesic Regimens With or Without Intravenous Lidocaine for the Treatment of Renal Colic in Patients Presenting to the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-205) Apixaban versus Rivaroxaban for Acute Venous Thromboembolism Treatment in Patients with Obesity
Favorite
2:00 PM – 3:00 PM
(12-206) Adjuvant Growth Hormone Therapy in Poor Responders to In-Vitro Fertilization: A Medication Use Evaluation
Favorite
2:00 PM – 3:00 PM
(12-207) Evaluation of Liver Function in People with Cystic Fibrosis Prescribed elexacaftor, tezacaftor and ivacaftor (ETI)
Favorite
2:00 PM – 3:00 PM
(12-208) Project DAWN Fentanyl Test Strip Distribution, NaloxBox Implementation, and Expansion on Naloxone Distribution throughout University Hospitals
Favorite
2:00 PM – 3:00 PM
(12-209) UH Meds Culture Callback Expedited Partner Therapy
Favorite
2:00 PM – 3:00 PM
(12-210) Assessment of Preceptors’ Preparedness to Effectively Teach APPE Students Before and After Self-Lead Online Training
Favorite
2:00 PM – 3:00 PM
(12-211) Role of the Pharmacist in Comprehensive Management of Heart Failure as an Integral Member of the Interdisciplinary Team
Favorite
2:00 PM – 3:00 PM
(12-212) Improving Care through Community-Based Specialty Pharmacist Intervention
Favorite
2:00 PM – 3:00 PM
(12-213) Evaluating the Safety and Efficacy of a Therapeutic Interchange to Tenecteplase for Acute Ischemic Stroke
Favorite
2:00 PM – 3:00 PM
(12-214) Changes in Albumin Utilization Following Implementation of a 48-hour Automatic Stop Time Protocol
Favorite
2:00 PM – 3:00 PM
(12-215) Retrospective Evaluation of a Pharmacist-Led Renal Dose Adjustment Protocol at a Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-216) Retrospective Drug Utilization Review of Meropenem at Hillcrest Medical Center
Favorite
2:00 PM – 3:00 PM
(12-217) Analyzing Pharmacists’ Impact on Anticoagulation Treatment Interventions within a Healthcare System
Favorite
2:00 PM – 3:00 PM
(12-218) Efficacy of Oral Clonidine and Clonazepam for Sedation of Pediatric Patients Undergoing Magnetic Resonance Imaging.
Favorite
2:00 PM – 3:00 PM
(12-219) Compare the Impact of Tirzepatide on Type 2 Diabetes Mellitus Related Outcomes in a Comprehensive Medication Management Program
Favorite
2:00 PM – 3:00 PM
(12-220) Evaluation of Vancomycin Dosing in Pediatric Patients at a Community Hospital: A Descriptive Analysis
Favorite
2:00 PM – 3:00 PM
(12-221) Evaluation of Antibiotic Appropriateness for the Treatment of Urinary Tract Infections for Patients Discharged from Multi-Campus Community Health System Emergency Departments
Favorite
2:00 PM – 3:00 PM
(12-222) Financial Impact of Clinical-Pharmacist-Led Medication Therapy Management Clinic in the Context of 340B Drug Pricing at a Regional Health System
Favorite
2:00 PM – 3:00 PM
(12-223) Impact of Pharmacist-Verified Oral Anticoagulation on Discharge from an Academic Medical Facility
Favorite
2:00 PM – 3:00 PM
(12-224) Utilization of LACE Index to Identify Gaps in Post-Discharge Transitions of Care Services
Favorite
2:00 PM – 3:00 PM
(12-225) Comparison of Readmission Rates in Patients Newly Prescribed a Long-Acting Injectable Antipsychotic Medication During an Inpatient Admission
Favorite
2:00 PM – 3:00 PM
(12-226) Evaluation of pharmacist to dose vancomycin service utilizing AUC:MIC software compared to trough guided dosing
Favorite
2:00 PM – 3:00 PM
(12-227) Analyzing Perceptions of Oklahoma and Arkansas Pharmacy Professionals in a Large Chain on Over-the-Counter Medication Misuse in the Community
Favorite
2:00 PM – 3:00 PM
(12-228) Comparison of Protocols Used to Manage Neonatal Opioid Withdrawal Syndrome (NOWS) or Neonatal Abstinence Syndrome (NAS) at an Academic Children’s Hospital
Favorite
2:00 PM – 3:00 PM
(12-229) Impact of Social Determinants of Health Barriers on the Initiation and Utilization of Continuous Glucose Monitors (CGMs) for Adults with Type 2 Diabetes.
Favorite
2:00 PM – 3:00 PM
(12-230) Comparing Patient Utilization of Pharmacy-Led Services Based on Geographic Location in the Chain Community Pharmacy Setting
Favorite
2:00 PM – 3:00 PM
(12-231) Assessing Patient Tolerability of Common Janus Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
Favorite
2:00 PM – 3:00 PM
(12-232) Assessment and Validation of Clinical and Operational Pharmacist Workflow and Productivity Model at a Medium-Sized Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-233) Retrospective Evaluation of Pharmacogenomic Tests in Optimizing Mood-Altering Therapy for Behavioral Health Patients
Favorite
2:00 PM – 3:00 PM
(12-234) Evaluation of Select Highly Occurring Poisonings at a Community Medical Center
Favorite
2:00 PM – 3:00 PM
(12-235) Development and Implementation of Vancomycin AUC Protocol for Select Critically Ill Patients in a Mid-Sized Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-236) Low dose sugammadex as a cost saving measure for neuromuscular blockade reversal
Favorite
2:00 PM – 3:00 PM
(12-237) Optimizing Asthma Control by Switching to SMART Therapy in Patients with Uncontrolled Asthma
Favorite
2:00 PM – 3:00 PM
(12-238) Modifying Pharmacist-Led Diabetes Case Management Care Model to Enhance Patient Identification and Expand Care Capacity within a Managed Care Delivery System
Favorite
2:00 PM – 3:00 PM
(12-239) Identifying Pain Management Gaps at Time of Discharge and Potential Pharmacist Interventions to Reduce Barriers to Discharge
Favorite
2:00 PM – 3:00 PM
(12-241) Effect of Direct Oral Anticoagulants on Hospital Length of Stay in Arterial Thrombi
Favorite
2:00 PM – 3:00 PM
(12-242) Knowledge, Attitudes, and Practices of Healthcare Providers Regarding Oral Antibiotic Use in a Health System
Favorite
2:00 PM – 3:00 PM
(12-243) Implementation of High-risk Discharge Prescription Review Alert for Emergency Medicine Pharmacists
Favorite
2:00 PM – 3:00 PM
(12-244) Evaluation of Appropriate Onset and Duration of Sedation in the Setting of Short-term Paralysis for Rapid Sequence Intubation in the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-245) Safety and Practicality of Intravenous Bolus Antiepileptics
Favorite
2:00 PM – 3:00 PM
(12-247) Incidence of Serotonin Toxicity in Patients Receiving Linezolid with and without Serotonergic Agents
Favorite
2:00 PM – 3:00 PM
(12-248) Implementation of an Inventory Management System for Hazardous Drugs
Favorite
2:00 PM – 3:00 PM
(12-249) Implementation of routine CYP2C19 pharmacogenetic testing to guide antiplatelet therapy post-percutaneous coronary intervention
Favorite
2:00 PM – 3:00 PM
(12-250) Impact of injectable calcitonin non-formulary status on treatment of hypercalcemia of malignancy in hospitalized patients
Favorite
2:00 PM – 3:00 PM
(12-251) Exploring Resources to Mitigate Burnout in PGY-1 Pharmacy Residency Programs and Pharmacy Workplaces: A Comprehensive Investigation
Favorite
2:00 PM – 3:00 PM
(12-252) Evaluation of Patients Diagnosed with Atrial Fibrillation not Discharged on Appropriate Anticoagulation
Favorite
2:00 PM – 3:00 PM
(12-253) Evaluation of Single-Dose Gentamicin Therapy for Uncomplicated Urinary Tract Infections in a Community-Based Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-254) Impact of Pharmacist-led Care on Type 2 Diabetes Mellitus Outcomes in a Rural, Primary Care Setting
Favorite
2:00 PM – 3:00 PM
(12-255) Implementation and Impact of Pharmacist-led Urine Culture and Sensitivity Follow-Up After Discharge from a Rural Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-256) Outcomes of a Clinical Pharmacist in a Rural Clinic
Favorite
2:00 PM – 3:00 PM
(12-257) Implementation of standardized protocol for pharmacist response to QTc interval prolongation
Favorite
2:00 PM – 3:00 PM
(12-258) Implementation of a pharmacist led fall prevention program to reduce the risk of patient falls during hospital admission
Favorite
2:00 PM – 3:00 PM
(12-259) Evaluation of Statin Use and Achievement of LDL Targets among Adult Patients with Diabetes at a FQHC
Favorite
2:00 PM – 3:00 PM
(12-260) Assessment of antibiotic prescribing for community-acquired pneumonia in hospitalized patients
Favorite
2:00 PM – 3:00 PM
(12-261) Evaluation of icatibant use within a regional health network
Favorite
2:00 PM – 3:00 PM
(12-262) Percentage of Patients with Type II Diabetes Mellitus and Cardiovascular Disease Prescribed a GLP-1 Agonist or SGLT2 Inhibitor with Proven Cardiovascular Benefit
Favorite
2:00 PM – 3:00 PM
(12-263) Evaluation of Appropriate Transitions from Cangrelor to Oral P2Y12 Inhibitor Therapy
Favorite
2:00 PM – 3:00 PM
(12-264) Evaluation of the Management of Direct Oral Anticoagulants with the Concomitant Use of Nirmatrelvir/Ritonavir for Mild-Moderate COVID-19 Infections Within Allegheny Health Network (AHN)
Favorite
2:00 PM – 3:00 PM
(12-265) Rituximab Utilization for Non-Oncologic Indications at a Tertiary Care Center
Favorite
2:00 PM – 3:00 PM
(12-266) Assessment of eptifibatide safety and prescribing practices in the setting of endovascular interventions
Favorite
2:00 PM – 3:00 PM
(12-267) Evaluation of Venous Thromboembolism Prophylaxis in Orthopedic Surgery Patients Across an Integrated Health System
Favorite
2:00 PM – 3:00 PM
(12-268) Assessment of Suspected Urinary Tract Infection Documentation Practices and Empiric Antibiotic Selection
Favorite
2:00 PM – 3:00 PM
(12-269) Evaluation of Inpatient Growth Factor Use for Febrile Neutropenia Prophylaxis at Allegheny Health Network
Favorite
2:00 PM – 3:00 PM
(12-271) Assessment of Pharmacist-Led Nutrition Support Interventions Conducted Under a Collaborative Practice Agreement in the Home Infusion Setting.
Favorite
2:00 PM – 3:00 PM
(12-272) Medication Use Evaluation for Infliximab Intensification During Induction
Favorite
2:00 PM – 3:00 PM
(12-273) Evaluation of Emapalumab Use at a Pediatric Academic Medical Center
Favorite
2:00 PM – 3:00 PM
(12-274) Medication Use Evaluation of Intrapleural Alteplase and Dornase Alfa in Pleural Infection
Favorite
2:00 PM – 3:00 PM
(12-275) Evaluation of sugammadex use for paralytic agent reversal by anesthesia
Favorite
2:00 PM – 3:00 PM
(12-276) Evaluation of the Ordering Habits of Albumin 25%
Favorite
2:00 PM – 3:00 PM
(12-277) Medication use evaluation of inhaled epoprostenol (iEP) at and beyond a 6-hour window in patients with acute respiratory distress syndrome (ARDS)
Favorite
2:00 PM – 3:00 PM
(12-278) Medication Use Evaluation of Insulin Aspart Pen-injector for Sliding Scale Insulin Orders in a Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-279) Medication Use Evaluation of Intravenous Olanzapine Use at a Tertiary Medical Center
Favorite
2:00 PM – 3:00 PM
(12-280) Evaluating Medications Administered Via Feeding Tubes
Favorite
2:00 PM – 3:00 PM
(12-281) Evaluation of the Best Practice Advisory in Patients Ordered Antihypertensives and Vasopressors
Favorite
2:00 PM – 3:00 PM
(12-282) Evaluation of discharge antibiotic prescribing at an academic medical center in western Pennsylvania
Favorite
2:00 PM – 3:00 PM
(12-283) Evaluation of Laboratory Monitoring Following Initiation of a Sodium-Glucose Cotransporter-2 Inhibitor
Favorite
2:00 PM – 3:00 PM
(12-284) Evaluation of benzodiazepine use in patients without a maintenance medication for the treatment of anxiety in the Geisinger outpatient setting
Favorite
2:00 PM – 3:00 PM
(12-285) Prevalence of Medicare Patients on Warfarin Therapy for Stroke Prevention in Atrial Fibrillation that are Otherwise Eligible for Direct Oral Anticoagulant Therapy
Favorite
2:00 PM – 3:00 PM
(12-286) Evaluation of Patient’s Completion of the 2-dose Hepatitis B Vaccination Series Compared to the 3-dose Series
Favorite
2:00 PM – 3:00 PM
(12-287) Evaluation of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor (PCSK9i) Prescribing Practices for Patients with Clinical Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein (LDL)
Favorite
2:00 PM – 3:00 PM
(12-288) Evaluation of time to sedative initiation after administration of neuromuscular blocking agents in Geisinger Emergency Departments
Favorite
2:00 PM – 3:00 PM
(12-289) Adherence assessment to Health System Protocol for Diabetic Foot Infections (DFIs)
Favorite
2:00 PM – 3:00 PM
(12-290) Utilization of an in-EHR patient education library for patients newly discharged on an anticoagulant.
Favorite
2:00 PM – 3:00 PM
(12-291) Review of a Pharmacist-Driven Rapid Rituximab Infusion Pharmacy Interchange Protocol
Favorite
2:00 PM – 3:00 PM
(12-292) Inpatient Evaluation of Infliximab Rescue Therapy in Acute Severe Inflammatory Bowel Disease
Favorite
2:00 PM – 3:00 PM
(12-293) Adherence Assessment to the Geisinger Health System Protocol for Surgical Prophylactic Antibiotics in Elective Joint Replacement Procedures
Favorite
2:00 PM – 3:00 PM
(12-294) Evaluation of Rifaximin and Lactulose for Hepatic Encephalopathy
Favorite
2:00 PM – 3:00 PM
(12-295) DA-EPOCH Dose Level Adjustments at Geisinger Cancer Institute
Favorite
2:00 PM – 3:00 PM
(12-296) Post-Implementation Evaluation of a Peripheral Vasopressor Administration Guideline
Favorite
2:00 PM – 3:00 PM
(12-297) Evaluation of Naloxegol in Critically Ill Patients with Opioid-Induced Constipation
Favorite
2:00 PM – 3:00 PM
(12-298) Intravenous to oral therapeutic interchange review at Geisinger using Bugsy, an electronic clinical decision support tool within Epic
Favorite
2:00 PM – 3:00 PM
(12-299) Appropriate Use and Optimum Inventory of Digoxin Immune Fab within Geisinger Hospitals
Favorite
2:00 PM – 3:00 PM
(12-300) Hospital Acquired Venous Thromboembolism within the Geisinger Trauma Population
Favorite
2:00 PM – 3:00 PM
(12-301) Evaluation of Appropriate Use of Tranexamic Acid in Patients with Trauma-Associated Hemorrhage
Favorite
2:00 PM – 3:00 PM
(12-302) Cumulative Acetaminophen Daily Dose throughout Surgical Care
Favorite
2:00 PM – 3:00 PM
(12-303) Evaluation of Adherence to Antimicrobial Prophylaxis Guidelines for Cardiac Surgery Patients at Geisinger
Favorite
2:00 PM – 3:00 PM
(12-304) Pharmacist-Led Intervention Study for Improving Medication Adherence and Health Outcomes in a Rural Population of Patients with COPD
Favorite
2:00 PM – 3:00 PM
(12-305) Evaluation of medication regimen complexity-ICU score before and after implementation of a virtual intensive care model in a multisite, rural health-system
Favorite
2:00 PM – 3:00 PM
(12-307) Characterizing and assessing the use of olanzapine as an antiemetic for patients initiating highly emetogenic chemotherapy: A quality improvement project
Favorite
2:00 PM – 3:00 PM
(12-308) Treatment Persistence of Off-label Biologic Disease Modifying Antirheumatic Drug Dosing Schedules for Patients with Spondyloarthritis Conditions
Favorite
2:00 PM – 3:00 PM
(12-309) Real-World Experience Using Ideal Body Weight Dosing of Rabbit Anti-Thymocyte Globulin for Induction Immunosuppression in Kidney Transplant Recipients
Favorite
2:00 PM – 3:00 PM
(12-310) Categorization of Pain Management Practice at a Local Community Teaching Facility
Favorite
2:00 PM – 3:00 PM
(12-311) Assessment of Targeted Antifungal Prophylaxis in Lung Transplant Recipients
Favorite
2:00 PM – 3:00 PM
(12-312) Evaluation of the Effect of Time on the Predictive Value of Methicillin-Resistant Staphylococcus Aureus Nares Screening in Critically Ill Patients
Favorite
2:00 PM – 3:00 PM
(12-313) Comparison of Low-dose vs. High-dose Phenobarbital Loading for the Management of Alcohol Withdrawal Syndrome in the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-314) The Impact of Liposomal Bupivacaine Intercostal Nerve Block on Opioid Use and Pain Scores in Lung Transplantation Surgery
Favorite
2:00 PM – 3:00 PM
(12-315) Retrospective analysis of condensed versus standard consolidation therapy with high-dose cytarabine (HiDAC) for the treatment of acute myeloid leukemia
Favorite
2:00 PM – 3:00 PM
(12-316) Characterization of Alteplase and Tenecteplase Outcomes for Acute Ischemic Stroke at a Comprehensive Stroke Center
Favorite
2:00 PM – 3:00 PM
(12-317) Treatment of Borderline Rejection Episodes in Kidney Transplant Recipients
Favorite
2:00 PM – 3:00 PM
(12-318) Incidence and Characterization of Bleeding Events in Patients Receiving Tyrosine Kinase Inhibitors and Undergoing a Lumbar Puncture
Favorite
2:00 PM – 3:00 PM
(12-319) Evaluation of survival in patients treated with intravenous non-formulary antineoplastic agents
Favorite
2:00 PM – 3:00 PM
(12-320) Long versus Short Duration of Empiric Antifungal Use Among Patients with Sepsis and Septic Shock
Favorite
2:00 PM – 3:00 PM
(12-321) Real-World Experience of Post-Operative Mediastinitis Incidence Utilizing Blood Glucose Targets of 110-150 mg/dL after Cardiac Surgery
Favorite
2:00 PM – 3:00 PM
(12-322) Comparison of Strategies for Stem Cell Mobilization in Multiple Myeloma (MM)
Favorite
2:00 PM – 3:00 PM
(12-323) Susceptibilities of Staphylococcus aureus in skin and skin structure infections among people who use fentanyl
Favorite
2:00 PM – 3:00 PM
(12-324) Evaluating Dispensing Activities and Workflow of Current Omnicell XR2 and Swisslog PillPick Robots to Successfully Decommission Swisslog PillPick Robot
Favorite
2:00 PM – 3:00 PM
(12-325) Utilization of Meropenem and Ertapenem in the Intensive Care Unit
Favorite
2:00 PM – 3:00 PM
(12-326) Dexmedetomidine- Associated Hemodynamic Instability in Surgical Trauma Intensive Care Unit Patients
Favorite
2:00 PM – 3:00 PM
(12-327) Assessment of Adherence to Tolvaptan Formulary Restrictions at Jefferson Abington Hospital
Favorite
2:00 PM – 3:00 PM
(12-328) Evaluation of Rasburicase Use for the Treatment of Hyperuricemia in Tumor Lysis Syndrome: A Retrospective Review
Favorite
2:00 PM – 3:00 PM
(12-329) Assessing the use of Rocuronium for Rapid Sequence Intubation in the Emergency Trauma Center
Favorite
2:00 PM – 3:00 PM
(12-330) Evaluation of Rejection Rates in Liver Transplant Recipients Initiated on Cyclosporine Instead of Tacrolimus to Avoid Neuropsychiatric Adverse Effects
Favorite
2:00 PM – 3:00 PM
(12-331) Interim Analysis: Evaluation of Length of Stay, Cost, and Protocol Adherence in Patients Initiated on Intravenous Versus Oral Sotalol Post Atrial Fibrillation Ablation
Favorite
2:00 PM – 3:00 PM
(12-332) Evaluation of antipsychotic therapy in patients with Parkinson’s disease residing in long term care facilities
Favorite
2:00 PM – 3:00 PM
(12-333) Albumin utilization in a community-teaching hospital
Favorite
2:00 PM – 3:00 PM
(12-334) Evaluation of Appropriate Palivizumab Use within the Neonatal Intensive Care Unit
Favorite
2:00 PM – 3:00 PM
(12-335) Comparison of Medications Administered Intra-articular and Periarticular During Knee Arthroplasty
Favorite
2:00 PM – 3:00 PM
(12-336) Medication Use Evaluation of Intranasal and Buccal Dexmedetomidine for Procedural Sedation
Favorite
2:00 PM – 3:00 PM
(12-337) Medication Use Evaluation of Oxytocin and Hemorrhage Rates Pre and Post Shortage
Favorite
2:00 PM – 3:00 PM
(12-338) Medication Use Evaluation of Starter Total Parenteral Nutrition
Favorite
2:00 PM – 3:00 PM
(12-339) Evaluation of Dose Rounding Opportunities for Cytotoxic Preparations and Monoclonal Antibodies in Pediatric Patients
Favorite
2:00 PM – 3:00 PM
(12-340) Evaluating Compliance with Guideline Recommendations for the Management of Community-Acquired Pneumonia in a Critical Access Hospital
Favorite
2:00 PM – 3:00 PM
(12-341) Evaluation of a Pharmacist on an Interprofessional Team in a Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-342) Emergency Department Discharge Antibiotics for Urinary Tract Infections: An Evaluation of Provider Adherence to Antimicrobial Stewardship Program Guidelines
Favorite
2:00 PM – 3:00 PM
(12-343) Evaluation of Appropriate Use of Hormone Therapy for Menopausal Symptom Management
Favorite
2:00 PM – 3:00 PM
(12-344) Frequency of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonist concomitant use in a rural community health-system
Favorite
2:00 PM – 3:00 PM
(12-345) Weight-Based Prothrombin Complex Concentrate (PCC) versus Fixed-Dose PCC for Warfarin and Direct Oral Anticoagulant (DOAC) Reversal: Medication Use Evaluation (MUE)
Favorite
2:00 PM – 3:00 PM
(12-346) Impact of a Meds to Beds Program on 30-day Readmission Rate and Patient Satisfaction for Heart Failure Patients
Favorite
2:00 PM – 3:00 PM
(12-347) Evaluation of Oral Fosfomycin Usage at an Academic Medical Center in Philadelphia
Favorite
2:00 PM – 3:00 PM
(12-348) Evaluation of Oral P2Y12 Inhibitor Use and Interconversion
Favorite
2:00 PM – 3:00 PM
(12-349) Evaluation of clinical outcomes of every 8-week versus every 6- and every 4-week Stelara dosing
Favorite
2:00 PM – 3:00 PM
(12-350) Evaluating the use of Sodium Zirconium Cyclosilicate in the management of hyperkalemia at Pennsylvania Hospital
Favorite
2:00 PM – 3:00 PM
(12-351) Evaluation of the Discontinuation Rate of Sodium Glucose Co-transporter 2 Inhibitors in Heart Failure Patients
Favorite
2:00 PM – 3:00 PM
(12-352) Evaluation of Venous Thromboembolism Prophylaxis at a Small Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-353) Provider Education and Evaluation of Patient Eligibility for Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Usage in Heart Failure Patients to Improve Utilization and 30-day Readmission Rates
Favorite
2:00 PM – 3:00 PM
(12-354) Impact of a pharmacist led antimicrobial stewardship initiative on the appropriate use of ciprofloxacin
Favorite
2:00 PM – 3:00 PM
(12-355) Implementation of a Pharmacist Protocol for Direct Oral Anticoagulants: A Comparison of Appropriate Dosing Inpatient and at Discharge
Favorite
2:00 PM – 3:00 PM
(12-356) Outcomes Among Human Immunodeficiency Virus Patients Switched from Oral Antiretroviral Therapy to Long-Acting Intramuscular Antiretroviral Therapy at a Human Immunodeficiency Virus Clinic
Favorite
2:00 PM – 3:00 PM
(12-357) Evaluation of Pharmacist Impact on 30-Day Readmission Rates in a Multidisciplinary Family Medicine Transitions of Care Clinic
Favorite
2:00 PM – 3:00 PM
(12-358) Evaluation of Preoperative Antibiotics Used for Surgical Prophylaxis at a Community Teaching Hospital
Favorite
2:00 PM – 3:00 PM
(12-360) Medication Use Evaluation of Desmopressin for Antiplatelet Reversal
Favorite
2:00 PM – 3:00 PM
(12-361) Medication Use Evaluation of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
Favorite
2:00 PM – 3:00 PM
(12-362) Medication Use Evaluation of Non-Depolarizing Neuromuscular Blocking Agents for Rapid Sequence Intubation
Favorite
2:00 PM – 3:00 PM
(12-363) Evaluation of an Electronic Glucose Management System (eGMS) versus a Weight-Based Algorithm in Diabetic Ketoacidosis (DKA) Outcomes
Favorite
2:00 PM – 3:00 PM
(12-364) Hospital-acquired Clostridioides difficile Infection and Associated Inappropriate Antibiotic Use
Favorite
2:00 PM – 3:00 PM
(12-365) Feasibility and Safety of Outpatient Therapy Initiation of Teclistamab in Relapsed/Refractory Multiple Myeloma Patients
Favorite
2:00 PM – 3:00 PM
(12-366) Impact of Prospective Pharmacist Intervention on the Incidence of Medication Errors upon ICU Transitions of Care: A Pre- and Post- Evaluation
Favorite
2:00 PM – 3:00 PM
(12-367) Assessment of Granulocyte Colony-Stimulating Factor Utilization in Solid Organ Transplant Recipients
Favorite
2:00 PM – 3:00 PM
(12-368) Development and comparison of stratified antibiograms based on days of hospitalization and location of infection onset
Favorite
2:00 PM – 3:00 PM
(12-369) Treatment of diabetic ketoacidosis at a community hospital utilizing EndoTool glucose management system
Favorite
2:00 PM – 3:00 PM
(12-370) Characterization of Methadone Titration in Patients Receiving Palliative Care Consultation
Favorite
2:00 PM – 3:00 PM
(12-371) Evaluation of inpatient and emergency department use of dalbavancin for gram-positive infections
Favorite
2:00 PM – 3:00 PM
(12-372) Evaluation of Hypoglycemic Events in Hospitalized Patients Receiving Subcutaneous Insulin
Favorite
2:00 PM – 3:00 PM
(12-373) Evaluation of the Use of Clevidipine Throughout Jefferson Health
Favorite
2:00 PM – 3:00 PM
(12-374) Incidence of Hyperglycemia in Continuously Tube Fed Patients Receiving Lispro vs. Regular Correctional Dose Insulin
Favorite
2:00 PM – 3:00 PM
(12-375) Medication Use Evaluation of the High-Dose Methotrexate Monitoring and Toxicity Management Protocol
Favorite
2:00 PM – 3:00 PM
(12-376) Cost-Savings of Dose Rounding for Anticancer Agents
Favorite
2:00 PM – 3:00 PM
(12-377) Evaluation of haloperidol verses droperidol with a benzodiazepine for acute agitation in the emergency department
Favorite
2:00 PM – 3:00 PM
(12-378) Evaluation of Allopurinol Dosing for Tumor Lysis Syndrome in the Acute Setting
Favorite
2:00 PM – 3:00 PM
(12-379) Evaluation of the Financial Impact of Ketamine Waste in a Large Academic Hospital
Favorite
2:00 PM – 3:00 PM
(12-380) Paxlovid-induced Severe Cutaneous Adverse Reaction: A Case Report
Favorite
2:00 PM – 3:00 PM
(12-381) Assessing the Impact of Psychiatric Consult Services in the Management of Clozapine Therapy in Acute Medical Illness
Favorite
2:00 PM – 3:00 PM
(12-382) Evaluation of P2Y12 Inhibitor Conversion Practices at a Multi-Site Health System
Favorite
2:00 PM – 3:00 PM
(12-383) Review and Evaluation of Fosaprepitant Use at a Multi-Hospital Health System
Favorite
2:00 PM – 3:00 PM
(12-384) Pilot Study to Assess Patient Outcomes and Cost Savings Associated with Sugammadex Dosing Based on Adjusted Body Weight
Favorite
2:00 PM – 3:00 PM
(12-386) Status epilepticus in a patient with skull osteomyelitis
Favorite
2:00 PM – 3:00 PM
(12-387) Intravenous methylene blue in refractory septic shock: a case report
Favorite
2:00 PM – 3:00 PM
(12-388) HSV-1 Encephalitis with a Background of Waldenström Macroglobulinemia: A Case Report
Favorite
2:00 PM – 3:00 PM
(12-389) Anaphylactic Shock Related Hospitalization Results in Unexpected Diagnosis of Cardiomyopathy
Favorite
2:00 PM – 3:00 PM
(12-390) Dalbavancin related acute kidney injury
Favorite
2:00 PM – 3:00 PM
(12-391) Evaluation of the IV/IM olanzapine order turnaround time after transitioning from IV room preparation to kit dispensary
Favorite
2:00 PM – 3:00 PM
(12-392) Therapeutic Drug Monitoring of Clozapine and Its Clinical Utility in Patients Admitted to an Acute Psychiatric Hospital
Favorite
2:00 PM – 3:00 PM
(12-393) Evaluation of Intravenous Iron Administration at a Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-394) Enhancing Prescribing Practices: A Quasi-Experimental Study to Reduce Inappropriate Cephalosporin Use in Enterococcal Urinary Tract Infections
Favorite
2:00 PM – 3:00 PM
(12-395) Energy intake in critically ill patients receiving total parenteral nutrition: adherence to guideline recommendations
Favorite
2:00 PM – 3:00 PM
(12-396) Evaluation of Empiric Vancomycin in Patients with Febrile Neutropenia
Favorite
2:00 PM – 3:00 PM
(12-397) Evaluation of vitamin K administration for anticoagulant reversal
Favorite
2:00 PM – 3:00 PM
(12-398) Evaluation of Subcutaneous Methylnaltrexone Use in a Community Health System
Favorite
2:00 PM – 3:00 PM
(12-399) Review of Sacubitril/Valsartan Utilization in Patients with Heart Failure in a Pharmacist Led Ambulatory Clinic
Favorite
2:00 PM – 3:00 PM
(12-400) Evaluating Injectable Semaglutide Use and Alternative Therapies Following Price Increase and Backorders in a Pharmacist-led 340B Outpatient Clinic
Favorite
2:00 PM – 3:00 PM
(12-401) Efficacy and Safety of Tenecteplase versus Alteplase for the Acute Management of Ischemic Stroke in Puerto Rico
Favorite
2:00 PM – 3:00 PM
(12-402) Understanding the Treatment Experience: A Qualitative Study of people living with HIV who transitioned from Oral Antiretrovirals to Cabotegravir/Rilpivirine Injectable Therapy
Favorite
2:00 PM – 3:00 PM
(12-403) Effect of Remote Patient Monitoring (RPM) on Glucose Control in Patients Enrolled in a Diabetes Management Program
Favorite
2:00 PM – 3:00 PM
(12-404) Development of a Pharmacist-led Oral Chemotherapy Patient Education and Monitoring Program
Favorite
2:00 PM – 3:00 PM
(12-405) Evaluation of Appropriate Therapy for Pulmonary Embolism Before and After Implementation of Institutional Order Set
Favorite
2:00 PM – 3:00 PM
(12-406) Comparing Post-Total Joint Arthroplasty Surgical Site Infection Incidence in Patients with Beta-lactam Allergies Treated with Perioperative Cefazolin vs Second-line Antibiotics within a Small Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-407) Effect of Intravenous Iron Sucrose Dosing on Hospital Readmissions in Patients with Heart Failure and Iron Deficiency in a Small Community Hospital
Favorite
2:00 PM – 3:00 PM
(12-408) Evaluation of Mechanical Ventilation Duration Post Fentanyl Bolus Panel Implementation
Favorite
2:00 PM – 3:00 PM
(12-409) Optimizing Pharmacist-Team Integration for ICU patient Management (OPTIM): An exploration of pharmacist-to-patient ratio; A collaborative sub-study at McLeod Regional Medical Center
Favorite
2:00 PM – 3:00 PM
(12-410) Intravenous versus partial oral therapy for gram-positive bacteremia
Favorite
2:00 PM – 3:00 PM
(12-411) Assessment of Antimicrobial Prescribing Appropriateness at Discharge from the Emergency Department for Common Infectious Indications
Favorite
2:00 PM – 3:00 PM
(12-412) Heart Failure with Reduced Ejection Fraction (HFrEF) Objectives in Current Anticoagulation Patients to Assess Opportunity for Pharmacist Service Expansion
Favorite
2:00 PM – 3:00 PM
(12-413) Profitability of 340B Contract Pharmacy
Favorite
2:00 PM – 3:00 PM
(12-414) Analysis of Proton Pump Inhibitor Utilization in Patients with Gastrointestinal Bleed at an Academic Medical Center
Favorite
2:00 PM – 3:00 PM
(12-415) Evaluation of Adherence to Institutional Guideline-Recommended Antibiotic Duration in Adults with Community Acquired Bacterial Pneumonia Discharged from a Multi-site Tertiary care Center
Favorite
2:00 PM – 3:00 PM
(12-416) Long-acting Injectable Antipsychotics Use in the Emergency Department
Favorite
2:00 PM – 3:00 PM
(12-417) Predictive Value of Methicillin-Resistant Staphylococcus aureus Nasal PCRs in Skin and Soft Tissue Infections in Children
Favorite
2:00 PM – 3:00 PM
(12-418) Evaluation of insulin reduction postpartum
Favorite
2:00 PM – 3:00 PM
(12-419) Evaluation of Subcutaneous Furosemide in an Outpatient Advanced Heart Failure Clinic
Favorite
2:00 PM – 3:00 PM
(12-420) What are the Alternatives: Assessing the Impact of Dynamic Alternative Decision Support in the Acute Care Setting
Favorite
2:00 PM – 3:00 PM
(12-421) Utilization of Intravenous Immunoglobulin after a Protocol Change: A Quality Improvement Project
Favorite
2:00 PM – 3:00 PM
(12-422) Utilization of Concentrated Sodium Bicarbonate Drips
Favorite
2:00 PM – 3:00 PM
(12-423) Evaluation of Current Oral Chemotherapy Ordering and Verification Processes in a Multi-centered Health-system
Favorite
2:00 PM – 3:00 PM
(12-424) Utilization of Phytonadione to Correct Coagulopathies in the Pediatric Intensive Care Unit
Favorite
2:00 PM – 3:00 PM
(12-425) Variations in dosing parameters in titratable weight-based ketamine infusions
Favorite
2:00 PM – 3:00 PM
(12-426) Evaluation of Rivaroxaban 2.5mg Utilization in Patients with Peripheral Artery Disease in an Outpatient Cardiology Practice
Favorite
2:00 PM – 3:00 PM
(12-427) Direct oral anticoagulant appropriateness in a geriatric primary care clinic
Favorite
2:00 PM – 3:00 PM
(12-428) Review of Non-Formulary Pulmonary Hypertension Medication Usage at Prisma Health
Favorite
2:00 PM – 3:00 PM
(12-429) Evaluation of Patients Eligible for Discharge Evolocumab After Hospitalization for Acute Coronary Syndrome (ACS) Event
Favorite
2:00 PM – 3:00 PM
(12-430) Hypoglycemia Events in Patients on Hemodialysis During Hospitalization
Favorite
2:00 PM – 3:00 PM
(12-431) Evaluating Length of Stay of Opioid-Exposed and Methamphetamine-Exposed NICU Patients
Favorite
2:00 PM – 3:00 PM
(12-432) 4-Factor Prothrombin Complex Concentration (4F-PCC) Utilization for the Reversal of Oral Anticoagulation
Favorite
2:00 PM – 3:00 PM
(12-433) Appropriate Intubation Conditions for Rapid Sequence Intubation and Bedside Procedural Neuromuscular Blockade
Favorite
2:00 PM – 3:00 PM
(12-434) Impact of Oral vs Long-Acting Injectable Antipsychotics on Hospital Readmission Rates
Favorite
2:00 PM – 3:00 PM
(12-435) Impact of Norepinephrine Dosing at the Time of Vasopressin Initiation on Intensive Care Unit Length of Stay
Favorite
2:00 PM – 3:00 PM
(12-436) Impact of Meds-to-Beds on Psychiatric Readmission Rates at a Rural Medical Hospital
Favorite
2:00 PM – 3:00 PM
(12-437) Implementation of Pharmacist-Driven Penicillin Allergy Assessment via the PEN-FAST Tool in a Rural Hospital
Favorite
2:00 PM – 3:00 PM
(12-438) Impact on Medication Adherence Following Implementation of a Pharmacist-Led Procurement Service for P2Y12 Inhibitors at Discharge Post Percutaneous Coronary Intervention
Favorite
2:00 PM – 3:00 PM
(12-439) Evaluation of Magnesium and Phosphorus for Inpatient Use: A Quality Improvement Project
Favorite
2:00 PM – 3:00 PM
(12-440) Evaluation of Iron Sucrose Prescribing Practices for Inpatient Iron Deficiency Anemia: A Quality Improvement Project
Favorite
2:00 PM – 3:00 PM
(12-441) Evaluating Agents Used in Oncologic Emergencies with an Emphasis on Hypercalcemia of Malignancies and Hyperuricemia Medication Therapy
Favorite
2:00 PM – 3:00 PM
(12-442) Retrospective Assessment of Health System Compliance with 2022 Perioperative Anticoagulation Management Guidelines
Favorite
2:00 PM – 3:00 PM
(12-443) Evaluation of the Safety and Effectiveness of Apixaban in Patients with a BMI ≥ 40 kg/m2 in a Medically Underserved Area
Favorite
2:00 PM – 3:00 PM
(12-444) Implementation of a Satellite Sterile Compounding Pharmacy within an Infusion Center
Favorite
2:00 PM – 3:00 PM
(12-445) Health System Medication Waste Management through Utilization of Centralized Distribution System
Favorite
2:00 PM – 3:00 PM
(12-446) Assessment of the Incidence of Clinical and Laboratory Tumor Lysis Syndrome in Patients Treated with Venetoclax for Acute Myeloid Leukemia
Favorite
2:00 PM – 3:00 PM
(12-447) Effects of Adjunctive Continuous Infusion Ketamine on the Use of Sedative, Vasopressor and Analgesic Agents in the Intensive Care Unit
Favorite
2:00 PM – 3:00 PM
(12-448) Treatment Dose Enoxaparin Adjustments Based on Anti-Xa Levels in Hospitalized Patients with Obesity
Favorite
2:00 PM – 3:00 PM
(12-449) Efficiency in Identification of Heparin-Induced Thrombocytopenia Following Modification of Laboratory Testing
Favorite
2:00 PM – 3:00 PM
(12-450) Utilization and Efficacy of Intravenous Epinephrine in Patients with In-Hospital Cardiac Arrest
Favorite
2:00 PM – 3:00 PM
(12-451) Management of Suspected HIT
Favorite
3:15 PM – 4:15 PM
(13-001) Assessment of Sex Disparities in Lipid Lowering Therapy Among Patients with Established Clinical ASCVD
Favorite
3:15 PM – 4:15 PM
(13-002) Evaluation of Low versus Ultra-Low Dose Ketamine for Acute Pain in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-003) Assessing the Efficacy and Safety of Clonidine Use for Dexmedetomidine Weaning in ICU Patients
Favorite
3:15 PM – 4:15 PM
(13-004) Evaluation of Empiric Meropenem Usage in Adult Critically Ill Patients
Favorite
3:15 PM – 4:15 PM
(13-005) Efficacy of Ketamine in the Treatment of Refractory Status Epilepticus Within a Neuro Critical Care Unit at a Large Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-006) Assessment of the Utilization of the Meds-to-Beds Program at a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-007) Impact of a Transitions of Care Pharmacist on HFrEF Readmissions
Favorite
3:15 PM – 4:15 PM
(13-008) An evaluation of the use of milrinone versus dobutamine in patients with heart failure
Favorite
3:15 PM – 4:15 PM
(13-009) Evaluation of patient compliance with initial and second prescription fills for newly started antiplatelet agents post MI
Favorite
3:15 PM – 4:15 PM
(13-010) Impact of Pharmacist driven Preapproval Process for Parenteral Pulmonary Arterial Hypertension Therapies on Length of Stay
Favorite
3:15 PM – 4:15 PM
(13-011) Evaluation of Empiric Meropenem Usage in Adult Non-Critically Ill Patients
Favorite
3:15 PM – 4:15 PM
(13-012) Incidence of AKI in Vancomycin AUC Dosing versus Traditional Trough Dosing
Favorite
3:15 PM – 4:15 PM
(13-013) Comparison of Clopidogrel 300 mg vs. 600 mg Loading Dose for Dual-Antiplatelet Therapy in the Secondary Prevention of Acute Ischemic Stroke and Transient Ischemic Attack
Favorite
3:15 PM – 4:15 PM
(13-014) Impact of Implementing a Hospital Outpatient Infusion Clinic Pharmacist Service
Favorite
3:15 PM – 4:15 PM
(13-015) Implementation of Tenecteplase in the Treatment of Acute Ischemic Stroke in a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-016) Determining the Need for a Pharmacist Led Congestive Heart Failure Titration Clinic by Evaluating Current Prescribing Trends
Favorite
3:15 PM – 4:15 PM
(13-017) Off-Label Use of Dalbavancin and Oritavancin in a Rural Health System
Favorite
3:15 PM – 4:15 PM
(13-018) Evaluation of Missed Medication Doses Within the Hospital System
Favorite
3:15 PM – 4:15 PM
(13-019) Cost Impact of a Pharmacist Protocol to Introduce a Multi-Chamber Parenteral Nutrition Option in a Defined Patient Population
Favorite
3:15 PM – 4:15 PM
(13-020) Evaluation of Anti-pseudomonal versus Narrow-spectrum Agents for Intra-abdominal Infections
Favorite
3:15 PM – 4:15 PM
(13-021) Evaluation of the Appropriate Use of Sugammadex in Accordance with Updated Guidelines Within a Community Hospital Setting
Favorite
3:15 PM – 4:15 PM
(13-022) Clinical Outcomes of a Pharmacist Managed Inpatient Service for the Management of Chemotherapy-Induced Febrile Neutropenia
Favorite
3:15 PM – 4:15 PM
(13-023) Impact of Pharmacist Driven De-escalation of Empiric Vancomycin for Treatment of Pneumonia Using Polymerase Chain Reaction Nasal Swab
Favorite
3:15 PM – 4:15 PM
(13-024) Pharmacist Driven Identification of Transthyretin Amyloid Cardiomyopathy Utilizing a Clinical Decision Support System at a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-025) Implementation of Vancomycin Area Under the Curve Calculated from Steady-State Trough-Only Pharmacokinetic Monitoring
Favorite
3:15 PM – 4:15 PM
(13-026) Initiating Antidepressant Therapy: Examining Resident Physician Prescribing Practices and Attitudes Towards Antidepressant Medications in Primary Care
Favorite
3:15 PM – 4:15 PM
(13-027) Oral Antibiotic Therapy for the Treatment of Staphylococcus aureus Pneumonia
Favorite
3:15 PM – 4:15 PM
(13-028) Efficacy and Safety of Sequential Nephron Blockade Compared to Standard Loop Diuretic for Fluid De-resuscitation in the ICU
Favorite
3:15 PM – 4:15 PM
(13-029) Analysis of Transition from Continuous Opioid Infusion to Bolus Administration Following Comfort Care Protocol Implementation.
Favorite
3:15 PM – 4:15 PM
(13-030) Comparative Analysis of Glycemic Outcomes Following Implementation of a Pharmacist-led Insulin Management Service in Postoperative Cardiothoracic Surgery Patients
Favorite
3:15 PM – 4:15 PM
(13-031) Evaluation of Continuous Renal Replacement Therapy Practices to Improve Patient Outcomes and Identify Cost Reduction Strategies
Favorite
3:15 PM – 4:15 PM
(13-032) Evaluation of Opioid Use and Post-Op Complications after Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Total Hip or Knee Surgery
Favorite
3:15 PM – 4:15 PM
(13-033) Incidence of Antibiotic De-escalation in the Treatment of Moderate to Severe Skin and Soft Tissue Infections
Favorite
3:15 PM – 4:15 PM
(13-034) Evaluation of Intravenous Iron Product Utilization
Favorite
3:15 PM – 4:15 PM
(13-035) The Use of Hydromorphone in the Inpatient Setting
Favorite
3:15 PM – 4:15 PM
(13-036) Benzodiazepine use before and after alcohol withdrawal order set revision
Favorite
3:15 PM – 4:15 PM
(13-037) Unfractionated heparin patterns of use for prophylaxis of venous thromboembolism
Favorite
3:15 PM – 4:15 PM
(13-038) De-Escalation of Empiric Antibiotics in Patients with Negative Cultures
Favorite
3:15 PM – 4:15 PM
(13-039) Analysis of Hospital Pharmacy Workflow for Automated Dispensing Cabinet Medication Delivery
Favorite
3:15 PM – 4:15 PM
(13-040) Impact of Educational Intervention for Corticosteroid Use Treating Acute Respiratory Tract Infections in an Urgent Care Setting
Favorite
3:15 PM – 4:15 PM
(13-041) Evaluation of Treatment Options for Moderate-to-Severe Alcohol Withdrawal Syndrome
Favorite
3:15 PM – 4:15 PM
(13-042) Utilizing independent double checks judiciously, an analysis to describe effective utilization
Favorite
3:15 PM – 4:15 PM
(13-043) Risk Factors for Patients Classified as Low Risk for Falls That Fell: A Retrospective Multi-Site Study
Favorite
3:15 PM – 4:15 PM
(13-044) Optimization and management of clinical decision support system tools to reduce alert burden in a newly implemented electronic health record system
Favorite
3:15 PM – 4:15 PM
(13-045) Exploring the Opioid and COVID-19 Syndemic among Adult Trauma Inpatients in a Large Hospital Network
Favorite
3:15 PM – 4:15 PM
(13-046) Analysis of Prophylactic Oral Vancomycin for the Prevention of C. difficile Infection in Patients Receiving Systemic Antibiotics
Favorite
3:15 PM – 4:15 PM
(13-047) Evaluation of Hospital Pharmacy Pricing and Utilization Trend on Hospital Expenses: Prediction versus Reality
Favorite
3:15 PM – 4:15 PM
(13-048) Heartfelt Care: Enhancing Patient Education and Discharge Strategies to Reduce Heart Failure Re-Admission Rates
Favorite
3:15 PM – 4:15 PM
(13-049) Development of the Clinical Anticoagulation Stewardship Pharmacist Position at Holston Valley Medical Center
Favorite
3:15 PM – 4:15 PM
(13-050) Evaluation of procedural sedation and analgesic usage in an interventional radiology department of a tertiary care hospital.
Favorite
3:15 PM – 4:15 PM
(13-051) Retrospective evaluation of the appropriateness of desmopressin use in the hospital setting
Favorite
3:15 PM – 4:15 PM
(13-052) Evaluation of Micafungin Use in a Tertiary Care Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-053) Evaluation of the Impact of the Pharmacy Technician Shortage on Pharmacy Workflow and Resources
Favorite
3:15 PM – 4:15 PM
(13-054) Rate of addition of SGLT2 inhibitor in patients with heart failure
Favorite
3:15 PM – 4:15 PM
(13-055) Evaluating Safety of Continuation of Oral Methotrexate During Inpatient Admissions
Favorite
3:15 PM – 4:15 PM
(13-056) Evaluating Dose Standardization of Famotidine at a Tertiary Care Children's Hospital
Favorite
3:15 PM – 4:15 PM
(13-057) Evaluating Use of Nebulized Tobramycin Against Updated CLSI Breakpoints at a Tertiary Care Pediatric Hospital
Favorite
3:15 PM – 4:15 PM
(13-058) Evaluation of Nebulized Albuterol Products at a Tertiary Care Children’s Hospital
Favorite
3:15 PM – 4:15 PM
(13-059) Evaluation of product selection when prescribing amoxicillin-clavulanic acid suspension at a pediatric tertiary care hospital
Favorite
3:15 PM – 4:15 PM
(13-060) Evaluation of Pediatric Advanced Life Support Medications Utilized from Pharmacy-Supplied Code Bags
Favorite
3:15 PM – 4:15 PM
(13-061) Analysis of the Financial and Workforce Impact of Controlled Substance Drug Waste in a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-062) Evaluating and Expanding BCMA Coverage in a Multihospital Health System: Navigating EHR Diversity for Optimal Patient Safety
Favorite
3:15 PM – 4:15 PM
(13-063) Evaluating Phenobarbital versus Traditional Benzodiazepine-Based Protocol for Alcohol Withdrawal
Favorite
3:15 PM – 4:15 PM
(13-064) Evaluation of the Management of Chemotherapy Induced Febrile Neutropenia in a Rural Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-065) Evaluating the Impact of a Meds-to-Beds Program on Readmission Rates in Heart Failure Patients
Favorite
3:15 PM – 4:15 PM
(13-066) Appropriateness of Empiric Piperacillin/Tazobactam and Cefepime
Favorite
3:15 PM – 4:15 PM
(13-067) Examining the Accuracy of a Hospital System-Developed Vancomycin Area-Under-the-Curve Dosing Calculator
Favorite
3:15 PM – 4:15 PM
(13-068) Drug Use Evaluation of Droperidol within an Academic and Community Health-System
Favorite
3:15 PM – 4:15 PM
(13-069) Evaluation of Electronic Health Record Rule to Improve Alert Significance with Combined Use of Gabapentinoids and Opioids
Favorite
3:15 PM – 4:15 PM
(13-070) Evaluation of an Albumin Powerplan for Sepsis Fluid Resuscitation at a Tertiary Medical Center
Favorite
3:15 PM – 4:15 PM
(13-071) Assessing Inappropriate Granulocyte Colony-Stimulating Factor Utilization in the Medical Oncology Outpatient Setting
Favorite
3:15 PM – 4:15 PM
(13-072) Evaluation of Compliance to Fentanyl Bolus from Bag Protocol
Favorite
3:15 PM – 4:15 PM
(13-073) Characterization of Micafungin Orders in the Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-074) Evaluation of Anti-thymocyte Globulin Infusion-related Reactions After Protocol Changes in Kidney Transplant Patients
Favorite
3:15 PM – 4:15 PM
(13-075) Evaluation of Epoetin Alfa Utilization and Adherence to Criteria for Use
Favorite
3:15 PM – 4:15 PM
(13-076) TenectePLACE in Stroke: Safety and Evaluation of Tenecteplase in the Setting of Acute Ischemic Stroke at Methodist Le Bonheur Healthcare
Favorite
3:15 PM – 4:15 PM
(13-077) Evaluation of Sodium Zirconium Cyclosilicate Usage and Efficacy in Acute Hyperkalemia
Favorite
3:15 PM – 4:15 PM
(13-078) Evaluation of Surgical Antimicrobial Prophylaxis Appropriateness in a Medium-Size, Small Metropolitan Hospital
Favorite
3:15 PM – 4:15 PM
(13-079) Evaluation and Impact of Antibiotic Stewardship Methodology on Antimicrobial Usage in Asymptomatic Bacteriuria
Favorite
3:15 PM – 4:15 PM
(13-080) A multicenter, retrospective outcome analysis of vancomycin area under the curve vs. trough-based dosing strategies in patients with burn or inhalational injuries (MONITOR)
Favorite
3:15 PM – 4:15 PM
(13-081) Retrospective analysis of pathogens for guided creation of an EMPIRic antibiotic prEscribing pathway (EMPIRE)
Favorite
3:15 PM – 4:15 PM
(13-082) Assessment of Inhaled Corticosteroid Prescribing Patterns in Patients with Chronic Obstructive Lung Disease
Favorite
3:15 PM – 4:15 PM
(13-083) Implementation of an Integrated Home Infusion Software in a Pediatric Oncology Research Hospital
Favorite
3:15 PM – 4:15 PM
(13-084) Leveraging Pharmacogenomics for Medication Safety of Chronic PPI Prescribing: Don’t Turn a Blind Eye to PPIs!
Favorite
3:15 PM – 4:15 PM
(13-085) Evaluation of Pharmacy-driven Procalcitonin Protocol for Antibiotic De-escalation in a Critical Care Unit
Favorite
3:15 PM – 4:15 PM
(13-086) Diversion Prevention: The Role of Technology in Identification of High-Risk Persons of Interest
Favorite
3:15 PM – 4:15 PM
(13-087) Medication use evaluation of hyaluronidase administration at Le Bonheur Children’s Hospital
Favorite
3:15 PM – 4:15 PM
(13-088) Evaluation of Thrombocytopenia Associated with Epoprostenol Therapy
Favorite
3:15 PM – 4:15 PM
(13-089) Hyperglycemia Occurrence in Enterally Fed Ischemic Stroke Patients
Favorite
3:15 PM – 4:15 PM
(13-090) Predictors of Successful Prescription for Smoking Cessation Pharmacotherapy in Hospitalized Patients
Favorite
3:15 PM – 4:15 PM
(13-091) Trends in Vasopressin (AVP) Use in the Intraoperative Setting in Adult Non-Cardiothoracic Surgical Patients
Favorite
3:15 PM – 4:15 PM
(13-092) Evaluation of Methylene Blue Utilization at a Tertiary Care Facility
Favorite
3:15 PM – 4:15 PM
(13-093) Analysis of Meropenem Utilization
Favorite
3:15 PM – 4:15 PM
(13-094) Medication Use Evaluation of Tenecteplase versus Alteplase to Assess the Impact on Stroke Core Measures for Acute Ischemic Stroke
Favorite
3:15 PM – 4:15 PM
(13-095) Impact of Inpatient Dapagliflozin Initiation in Patients Hospitalized due to Heart Failure
Favorite
3:15 PM – 4:15 PM
(13-096) Comparison of Droperidol to Alternative Agents in the Management of Acute Agitation in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-097) Assessing the Effectiveness of a Sodium Zirconium Cyclosilicate Policy: A Medication Use Evaluation
Favorite
3:15 PM – 4:15 PM
(13-098) Appropriate use of Penicillin G Benzathine
Favorite
3:15 PM – 4:15 PM
(13-099) Evaluation of warfarin loading doses versus resumption of maintenance therapy following interruption of warfarin therapy
Favorite
3:15 PM – 4:15 PM
(13-100) Evaluation of vasopressin response in obese and non-obese patients with septic shock
Favorite
3:15 PM – 4:15 PM
(13-101) Effect of Opioid Administration on Clostridioides difficile Infection
Favorite
3:15 PM – 4:15 PM
(13-102) Impact of Social Vulnerability Index on Continued Opioid Use in Opioid Naïve Patients following Continuous Fentanyl Infusions for COVID-19
Favorite
3:15 PM – 4:15 PM
(13-103) Outcomes of Empiric Fluoroquinolone Therapy in Cystitis Due to Resistant Pathogens
Favorite
3:15 PM – 4:15 PM
(13-104) Opioid Analgesia in Patients Taking Buprenorphine for Opioid Use Disorder
Favorite
3:15 PM – 4:15 PM
(13-105) Efficacy of Clonidine to Transition from Dexmedetomidine in Trauma-Surgical ICU Patients
Favorite
3:15 PM – 4:15 PM
(13-106) Evaluation of Lipid Management in Very High Risk Patients of an Outpatient Cardiology Practice
Favorite
3:15 PM – 4:15 PM
(13-107) Comparison of a Phenobarbital Monotherapy Protocol vs. Symptom-Triggered Benzodiazepines Protocol for Alcohol Withdrawal Syndrome in the Trauma Surgical Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-108) Evaluation of serotonin syndrome with linezolid and high-risk serotonergic agents
Favorite
3:15 PM – 4:15 PM
(13-109) Clinical Impact of Proton-Pump Inhibitor Therapy in Combination with Certain Tyrosine Kinase Inhibitors in Adult Patients with Chronic Myeloid Leukemia
Favorite
3:15 PM – 4:15 PM
(13-110) Impact of pharmacist involvement in the transitions of care process at an academic medical center
Favorite
3:15 PM – 4:15 PM
(13-111) Implementation of a Specialty Pharmacist-Led Patient Reported Outcomes Monitoring in Inflammatory Bowel Disease
Favorite
3:15 PM – 4:15 PM
(13-112) Assessing the impact of Community-Based Specialty Pharmacist provided blister packaging intervention in Neurology Patients taking three of more oral medications
Favorite
3:15 PM – 4:15 PM
(13-113) Evaluation of Initial Loop Diuretic Dosing in Acute Decompensated Heart Failure and Subsequent Outcomes
Favorite
3:15 PM – 4:15 PM
(13-114) Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
Favorite
3:15 PM – 4:15 PM
(13-115) Effect of a Health System Funded Prescription Assistance Card Program for Underinsured Patients
Favorite
3:15 PM – 4:15 PM
(13-116) Daily Morphine Milligram Equivalent Requirements Following Decannulation in ECMO Patients Treated with Hydromorphone Versus Fentanyl
Favorite
3:15 PM – 4:15 PM
(13-117) Short-Course Antimicrobial Therapy for Intraabdominal Infections in Critically Ill Patients with Septic Shock
Favorite
3:15 PM – 4:15 PM
(13-118) Evaluating the Safety and Efficacy of Apixaban Versus Warfarin for Treatment of Venous Thromboembolism in Patients with Severe Renal Impairment: A Multicenter Study
Favorite
3:15 PM – 4:15 PM
(13-119) A Comparison of the Efficacy and Safety of a Standard versus Nonstandard Apixaban Initiation Period for Acute Venous Thromboembolism
Favorite
3:15 PM – 4:15 PM
(13-120) A Comparison of In-House Versus Reference Laboratory Antifungal Susceptibility Testing on De-Escalation Rates of Echinocandin Therapy in Candidemia
Favorite
3:15 PM – 4:15 PM
(13-121) Incidence of Urinary Tract Infections (UTIs) with Increased Inpatient Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Use
Favorite
3:15 PM – 4:15 PM
(13-122) “Two Paths to Paralysis”: A Multicenter Comparison of Cisatracurium and Atracurium in the Management of Acute Respiratory Distress Syndrome (ARDS) within the Ascension Health System.
Favorite
3:15 PM – 4:15 PM
(13-123) Comparison of Dexamethasone and Fludrocortisone Substituted for Hydrocortisone in Septic Shock in the Setting of a Hydrocortisone Shortage
Favorite
3:15 PM – 4:15 PM
(13-124) The Impact of Obtaining Prescriptions Upon Discharge in a Large Healthcare System on Hospital Readmissions
Favorite
3:15 PM – 4:15 PM
(13-125) Evaluation of Diabetes Care with Pharmacist Management
Favorite
3:15 PM – 4:15 PM
(13-126) Association Between Inpatient and/or Discharge Initiation of Sodium-Glucose Cotransporter-2 Inhibitors on Prescription Rates in Patients with Heart Failure with Preserved or Mildly Reduced Ejection Fraction
Favorite
3:15 PM – 4:15 PM
(13-127) Apixaban: Are We Underdosing in Atrial Fibrillation?
Favorite
3:15 PM – 4:15 PM
(13-128) Evaluation of Appropriate Use of Angiotensin II for The Treatment of Vasodilatory Shock
Favorite
3:15 PM – 4:15 PM
(13-129) Implementation and Analytic Analyses of an Artificial Intelligence Drug Diversion Program
Favorite
3:15 PM – 4:15 PM
(13-130) Evaluation of Remote Pharmacist Intervention on Type 2 Diabetes HbA1c Reduction in an Accountable Care Organization
Favorite
3:15 PM – 4:15 PM
(13-131) Evaluating the Outcomes and Safety of Different Durations of Antibiotic Therapy in Patients Diagnosed with Cystitis Without Documented Symptoms, With or Without Bacteriuria
Favorite
3:15 PM – 4:15 PM
(13-132) Evaluation of the Impact of a Pharmacy Resident in an Outpatient Cancer Clinic
Favorite
3:15 PM – 4:15 PM
(13-133) Oral Vancomycin Prophylaxis to Prevent Clostridium difficile Infection in Patients Undergoing Acute Leukemia Induction Therapy
Favorite
3:15 PM – 4:15 PM
(13-134) Evaluating the Effects of a Clinic-Embedded Pharmacist Program on Glucocorticoid Therapy Exposure in Patients with Rheumatoid Arthritis
Favorite
3:15 PM – 4:15 PM
(13-135) Patient-reported Satisfaction and Feasibility with Long-acting Injection Cabotegravir and Rilpivirine in an Outpatient Setting
Favorite
3:15 PM – 4:15 PM
(13-136) Evaluating Dexmedetomidine to Enteral Clonidine Tapers Use in Pediatric Patients
Favorite
3:15 PM – 4:15 PM
(13-137) Gauging the impact of a Multiplex PCR panel on antibiotic usage in community acquired Pneumonia in the Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-138) Evaluation of Guideline-Directed Medical Therapy Initiation Strategies in Recently Discharged Patients with Newly Diagnosed Heart Failure with Reduced Ejection Fraction
Favorite
3:15 PM – 4:15 PM
(13-139) Rates of Adverse Events in Patients Taking and Oral Tyrosine Kinase Inhibitor With and Without Hypoalbuminemia
Favorite
3:15 PM – 4:15 PM
(13-140) Assessing Clinical Outcomes of Prednisone Tapers in Liver Transplant Patients
Favorite
3:15 PM – 4:15 PM
(13-141) Safety of Colchicine for Cardiovascular Indications in Patients with Renal Impairment
Favorite
3:15 PM – 4:15 PM
(13-142) Evaluation of Toxicities in Leukemia Patients Receiving Concomitant Azole Antifungals and Oral Chemotherapies
Favorite
3:15 PM – 4:15 PM
(13-143) Implementation of a Pharmacist Transitions of Care Initiative for All-Cause Seven-Day Readmission Rates
Favorite
3:15 PM – 4:15 PM
(13-144) Reduction of hypoglycemia events utilizing a nutrition-related toolkit in non-critical care hospitalized patients
Favorite
3:15 PM – 4:15 PM
(13-145) Comparison of Early vs Delayed Initiation of Vasopressin in Vasoplegic Shock Post-Cardiothoracic Shock
Favorite
3:15 PM – 4:15 PM
(13-146) Evaluation of Tolvaptan Use at Baylor University Medical Center (BUMC)
Favorite
3:15 PM – 4:15 PM
(13-147) Evaluation of Safety, Cost, and Adherence to Restriction Criteria for Intravenous Methocarbamol
Favorite
3:15 PM – 4:15 PM
(13-148) Evaluation of Adherence to Formulary Restriction Criteria for Angiotensin II
Favorite
3:15 PM – 4:15 PM
(13-149) Evaluation of Safety of IV Push Levetiracetam at Doses Greater Than 1,500mg
Favorite
3:15 PM – 4:15 PM
(13-150) Fixed Dosing vs Weight Based Dosing of 4-Factor Prothrombin Complex for Anticoagulation Reversal in Life Threatening Bleeds at a Rural Community Teaching Hospital.
Favorite
3:15 PM – 4:15 PM
(13-151) Evaluation of Retention in Care in HIV Positive Patients at a Federally Qualified Health Center along the United States-Mexico Border
Favorite
3:15 PM – 4:15 PM
(13-152) Comparing ertapenem versus meropenem for the treatment of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales bacteremia
Favorite
3:15 PM – 4:15 PM
(13-153) Tacrolimus Weight-based Dosing in Obese and Non-obese Kidney Transplant Recipients
Favorite
3:15 PM – 4:15 PM
(13-154) Evaluation of Intranasal Midazolam Administration at a Freestanding Pediatric Institution
Favorite
3:15 PM – 4:15 PM
(13-155) Evaluation of Erythropoiesis-stimulating Agent Utilization in a Neonatal Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-156) Evaluating Intravenous Iron Use After Implementation of Order Restrictions
Favorite
3:15 PM – 4:15 PM
(13-157) Evaluating Appropriate Use and Prescribing Patterns of Albumin at CHRISTUS Mother Frances Hospital
Favorite
3:15 PM – 4:15 PM
(13-158) Evaluation of meropenem appropriate use and prescribing patterns at a large, tertiary care, community hospital
Favorite
3:15 PM – 4:15 PM
(13-159) Evaluation of Post-Procedural Hydrocodone/Acetaminophen Prescribing Habits in Pediatric Patients Ages 12 or Under
Favorite
3:15 PM – 4:15 PM
(13-160) Safety and Efficacy of Intrawound Tobramycin and Vancomycin Powder Applied Locally During Orthopedic Surgeries
Favorite
3:15 PM – 4:15 PM
(13-161) Weight-Based versus Fixed Dosing of IV Push Diltiazem in the Emergency Department to Achieve Rate Control in Patients with Atrial Fibrillation with Rapid Ventricular Response
Favorite
3:15 PM – 4:15 PM
(13-162) Retrospective Evaluation of Clinical Outcomes Between Clopidogrel versus Ticagrelor in Acute Coronary Syndrome
Favorite
3:15 PM – 4:15 PM
(13-163) Evaluation of Early Basal Insulin Administration on the Resolution of Diabetic Ketoacidosis
Favorite
3:15 PM – 4:15 PM
(13-164) Evaluation of Bleeding Rates Among Patients on Warfarin versus Direct Oral Anticoagulants (DOACs) Presenting with Traumatic Brain Injury in an Acute Care Setting
Favorite
3:15 PM – 4:15 PM
(13-165) The efficacy and safety of intravenous hydromorphone versus intravenous morphine in patients with impaired renal function
Favorite
3:15 PM – 4:15 PM
(13-166) Evaluation of significant warfarin drug-drug interactions at CHRISTUS Trinity Anticoagulation Clinics
Favorite
3:15 PM – 4:15 PM
(13-167) Incidence of Urinary Tract Infections Among Kidney and Kidney-Pancreas Transplant Recipients on Trimethoprim/Sulfamethoxazole vs Alternatives for Pneumocystis Jirovecii Pneumonia Prophylaxis
Favorite
3:15 PM – 4:15 PM
(13-168) Patient Perspectives on Use of American Diabetes Association Guideline-Compliant Language Recommendations Among People with Diabetes at Federally Qualified Health Centers
Favorite
3:15 PM – 4:15 PM
(13-169) Continuous Glucose Monitoring (CGM) Based Glycemic Control Among Underserved Populations with Type 2 Diabetes at a Federally Qualified Health Center (FQHC)
Favorite
3:15 PM – 4:15 PM
(13-170) Medication use evaluation of rivaroxaban and serum creatinine in an infant population
Favorite
3:15 PM – 4:15 PM
(13-171) Medication Use Evaluation of Antifungals in the Neonatal Intensive Care Unit for Prophylaxis
Favorite
3:15 PM – 4:15 PM
(13-172) Medication use evaluation of partial clonidine patch utilization in a freestanding pediatric hospital
Favorite
3:15 PM – 4:15 PM
(13-173) Comparing the Efficacy and Prescribing Patterns of Naltrexone, Disulfiram, and Acamprosate in Preventing Psychiatric Rehospitalizations for Alcohol Use Disorder
Favorite
3:15 PM – 4:15 PM
(13-174) Ceftaroline and Daptomycin Monotherapy Versus Combination Therapy Against MRSA Bacteremia
Favorite
3:15 PM – 4:15 PM
(13-176) Enhancing Pharmacist Antibiotic De-escalation: the Impact of Respiratory Polymerase Chain Reaction (PCR) Panel and Procalcitonin on Antibiotic Duration
Favorite
3:15 PM – 4:15 PM
(13-177) Assessing Opioid Risk Factors: Correlating Emergent Naloxone Reversals at Covenant Medical Center
Favorite
3:15 PM – 4:15 PM
(13-178) Medication Use Evaluation of Meropenem-Vaborbactam in a South Texas Institution
Favorite
3:15 PM – 4:15 PM
(13-179) Medication Use Evaluation of Ofirmev
Favorite
3:15 PM – 4:15 PM
(13-180) Medication Use Evaluation of Liposomal Bupivacaine in Reducing Pain and Opioid Use in Post Surgical Patients at a Medical Center in South Texas
Favorite
3:15 PM – 4:15 PM
(13-181) Medication Use Evaluation of Daptomycin
Favorite
3:15 PM – 4:15 PM
(13-182) Evaluation of Institutional Policy Compliance for Heparin Utilization in a Pediatric Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-183) Evaluation of Institutional Policy Compliance for Antithrombin III Utilization in a Pediatric Hospital
Favorite
3:15 PM – 4:15 PM
(13-184) Assessment of institutional prescribing patterns and evaluation of compliance with national standards for the appropriate use of cangrelor within an academic county hospital
Favorite
3:15 PM – 4:15 PM
(13-185) Institution Experience with Transition of Daratumumab from Intravenous to Subcutaneous: Safety and Financial Impact
Favorite
3:15 PM – 4:15 PM
(13-186) Cost-Benefit Analysis of the Utilization and Impact of Future State Over-the-Counter Naloxone Nasal Spray in a Large Academic County Health System
Favorite
3:15 PM – 4:15 PM
(13-187) Evaluation of Tigecycline Utilization at Two Hospitals Within an Academic Health System
Favorite
3:15 PM – 4:15 PM
(13-188) Cost-Utilization Assessment of Long-Acting Injectable Antipsychotic Drugs Following the Implementation of Drug Replacement Programs at a Large Academic County Health System
Favorite
3:15 PM – 4:15 PM
(13-189) The Use of Biosimilars in Oncology: Financial Impact and Lessons Learned from Trastuzumab
Favorite
3:15 PM – 4:15 PM
(13-190) Optimization of Automated Dispensing Cabinet Override Settings to Reduce the Number of Inappropriate Medication Overrides Within an Academic Health System
Favorite
3:15 PM – 4:15 PM
(13-191) Evaluating the Impact of Direct Oral Anticoagulants on the Treatment of Intracardiac Thrombus in an Academic Healthcare System
Favorite
3:15 PM – 4:15 PM
(13-192) Expansion of Diabetes Clinical Pharmacy Telemedicine Services at a Large Academic Health System
Favorite
3:15 PM – 4:15 PM
(13-193) Evaluation of Processes in the Tracking of Controlled Substance Discrepancies Within a Large Academic Health System
Favorite
3:15 PM – 4:15 PM
(13-194) Assessing the Impact of Medication Adherence 90 Days Following Pharmacist-Led “Meds-To-Beds” Intervention in Post-Myocardial Infarction (MI) Patients
Favorite
3:15 PM – 4:15 PM
(13-195) Impact of Pharmacists in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-196) Assessment of IV/PO antibiotics in the management of urinary tract infection.
Favorite
3:15 PM – 4:15 PM
(13-197) The Impact on door-to-needle time in patients who received tenecteplase versus alteplase for acute ischemic stroke
Favorite
3:15 PM – 4:15 PM
(13-198) Droperidol for the Treatment of Acute Agitation in the Emergency Department (ED)
Favorite
3:15 PM – 4:15 PM
(13-199) Retrospective comparison of alteplase and tenecteplase clinical outcomes for acute ischemic stroke
Favorite
3:15 PM – 4:15 PM
(13-200) The Clinical and Economic Impact of Anti-Obesity Pharmacotherapy: A Claims Database Retrospective Analysis
Favorite
3:15 PM – 4:15 PM
(13-201) A Comparison of Viral Suppression Rates of Patients Receiving Long-Acting Injectable Antiretroviral Therapy (ART) Versus Oral Therapy
Favorite
3:15 PM – 4:15 PM
(13-202) Comparison of Tocilizumab vs. Baricitinib in the Causation of Post-COVID-19 Bacterial and Fungal Infections
Favorite
3:15 PM – 4:15 PM
(13-203) Incidence of Cytomegalovirus Infection in Low versus High Dose Rabbit Anti-thymocyte Globulin for Induction in Kidney Transplant Recipients
Favorite
3:15 PM – 4:15 PM
(13-205) Evaluation of Thrombolytic Use in a Community Acute Care Hospital
Favorite
3:15 PM – 4:15 PM
(13-206) Evaluating the Role of an Intermediate Care Unit in the Treatment of Mild to Moderate Diabetic Ketoacidosis Utilizing a Nursing-Driven Intravenous Insulin Protocol
Favorite
3:15 PM – 4:15 PM
(13-207) Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage
Favorite
3:15 PM – 4:15 PM
(13-208) Don’t Treat Ghosts: Anti-MRSA Antibiotics in Osteomyelitis without Identified MRSA
Favorite
3:15 PM – 4:15 PM
(13-209) Short Versus Long Antibiotic Treatment of Streptococcus Pneumoniae Bacteremia
Favorite
3:15 PM – 4:15 PM
(13-210) Utilization of Continuous Infusion Neuromuscular Blocking Agents in a Large Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-211) Retrospective Medication Use Evaluation of Rasburicase at Methodist Hospital San Antonio
Favorite
3:15 PM – 4:15 PM
(13-212) Evaluating Antimicrobial Use and Outcomes in Extended Spectrum Beta Lactamase Urinary Tract Infections
Favorite
3:15 PM – 4:15 PM
(13-213) Weight gain Associated with Integrase Inhibitors and Tenofovir Alafenamide (TAF) and Impact on Comorbid Disease States
Favorite
3:15 PM – 4:15 PM
(13-214) Evaluating Patient-Driven Preferences for Vaccination Administration Settings
Favorite
3:15 PM – 4:15 PM
(13-215) Medication Use Evaluation of Opioid Administration Amongst Intensive Care Unit Patients Receiving Continuous Infusion of Ketamine
Favorite
3:15 PM – 4:15 PM
(13-216) Evaluation of Anticoagulant Outcomes After an Institutional Change to Weight-Based Heparin Titration from Standardized Non-Weight Based Heparin Titration
Favorite
3:15 PM – 4:15 PM
(13-217) Impact of Multiplex Polymerase Chain Reaction Assay Blood Culture Identification on Time to Implementation of Targeted Antimicrobial Therapy for Methicillin Susceptible Staphylococcus Aureus Bacteremia
Favorite
3:15 PM – 4:15 PM
(13-218) Incidence of Potentially Inappropriate Antibiotic Therapy Secondary To Reported Penicillin Allergies
Favorite
3:15 PM – 4:15 PM
(13-219) Utilizing Clinical Surveillance to Decrease Opioid Requirements in Post-operative Patients at a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-220) Comparison of Safety and Clinical Outcomes Between Crotalidae Polyvalent Ovine Fab and Crotalidae Immune Equine F(ab’)2 for Snake Envenomations
Favorite
3:15 PM – 4:15 PM
(13-221) Implementation and Integration of a Pharmacist-Driven Pharmacogenomics Service In a Rural Behavioral Health Clinic
Favorite
3:15 PM – 4:15 PM
(13-222) Direct Oral Anticoagulants versus Warfarin in Nonvalvular Atrial Fibrillation Patients with End-Stage Renal Disease on Dialysis
Favorite
3:15 PM – 4:15 PM
(13-223) Evaluation of adherence to the parenteral nutrition policy and procedure at a large quaternary free standing children’s hospital
Favorite
3:15 PM – 4:15 PM
(13-224) Evaluation of Enoxaparin Dosing for the Management of Venous Thrombosis in the Pediatric Population
Favorite
3:15 PM – 4:15 PM
(13-225) Evaluation of Palivizumab (Synagis) Prescribing Adherence to the Criteria Recommended by the American Academy of Pediatrics Guidelines
Favorite
3:15 PM – 4:15 PM
(13-226) Description of Enteral Arginine Supplementation Use in a Level IV Neonatal Intensive Care Unit at a Large Freestanding Pediatric Hospital
Favorite
3:15 PM – 4:15 PM
(13-227) Saturday Night Fever: Impact of Incorporating Standing Nursing Orders for Neutropenic Fever into Leukemia Order Set
Favorite
3:15 PM – 4:15 PM
(13-228) Calculating Free Phenytoin Serum Concentrations Using Various Versions of the Winter-Tozer Equation
Favorite
3:15 PM – 4:15 PM
(13-229) Comparing the Need for Repeat Administration with Crotalidae Immune F(ab’)2 and Crotalidae Polyvalent Immune Fab for Snake Bite Envenomation.
Favorite
3:15 PM – 4:15 PM
(13-230) Retrospective Analysis of Intravenous Push Versus Extended Infusion Meropenem in Critically Ill Patients
Favorite
3:15 PM – 4:15 PM
(13-231) Weight-based versus Fixed-dose Calcitonin to Treat Hypercalcemia in Hospitalized Patients
Favorite
3:15 PM – 4:15 PM
(13-232) Utilization of Pen-Fast Allergy Tool in De-escalating Meropenem
Favorite
3:15 PM – 4:15 PM
(13-233) Sodium Bicarbonate Versus Heparin Purge Solutions in Patients with a Left-Sided Impella Device
Favorite
3:15 PM – 4:15 PM
(13-234) Impact of a newly implemented financial medication assistance program within an integrated health system
Favorite
3:15 PM – 4:15 PM
(13-235) Medication Use Evaluation of Sulfamethoxazole-Trimethoprim Dosing in Stenotrophomonas maltophilia Pneumonia at UTMB Health System
Favorite
3:15 PM – 4:15 PM
(13-236) Impact of Central Pharmacy Dispensing Robot Implementation on Inventory Management in an Academic Medical Center Inpatient Pharmacy
Favorite
3:15 PM – 4:15 PM
(13-237) Impact of Antimicrobial Stewardship End Date Intervention on Inpatient Treatment of Community-Acquired Pneumonia
Favorite
3:15 PM – 4:15 PM
(13-238) Evaluating the Difference in Rates of Vancomycin Induced Nephrotoxicity After Implementation of Area Under the Curve Guided Dosing Protocol versus Trough Guided Dosing
Favorite
3:15 PM – 4:15 PM
(13-239) Vancomycin Extraction Through F160 OptiFlux High Flux Filter
Favorite
3:15 PM – 4:15 PM
(13-241) Evaluate the Utilization and Acceptance of Non-Occupational Post Exposure Prophylaxis for HIV after Sexual Assaults in An Emergency Department at the border of US-Mexico
Favorite
3:15 PM – 4:15 PM
(13-242) Characterization of Knowledge and Attitudes Surrounding Transgender and Gender-Diverse Health: A Comparison of Health Professions Faculty at a Hispanic Serving Institution
Favorite
3:15 PM – 4:15 PM
(13-243) Evaluation of Same-Day Versus Next-Day Pegfilgrastim in Patients with Solid Tumor Malignancy at an Academic Medical Center
Favorite
3:15 PM – 4:15 PM
(13-244) Evaluating Amiodarone Loading Doses in New-Onset Atrial Fibrillation in Septic Shock
Favorite
3:15 PM – 4:15 PM
(13-245) Implementation of a Scoring Tool to Improve Pharmacist Renal Dosing of Medications in Acute Care
Favorite
3:15 PM – 4:15 PM
(13-246) Safety and Efficacy of Letermovir for CMV Primary Prophylaxis in Lung Transplant Recipients
Favorite
3:15 PM – 4:15 PM
(13-247) NIMO21: Nimodipine's Impact on Modified Rankin Scale Outcomes in Aneurysmal Subarachnoid Hemorrhages if Compliant for 21-Days
Favorite
3:15 PM – 4:15 PM
(13-249) Evaluation of 3% versus 23.4% Hypertonic Saline for Cerebral Edema in the Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-250) Assessment of Patient Outcomes and Nursing Satisfaction in a Rural Community Hospital after Pharmacist-Driven Updates to the Diabetic Ketoacidosis (DKA) Protocol.
Favorite
3:15 PM – 4:15 PM
(13-251) Resolving medication adherence barriers in community-based specialty pharmacies with adalimumab
Favorite
3:15 PM – 4:15 PM
(13-252) A Retrospective Quality Improvement Study of Glucose-6-Phosphate Dehydrogenase (G6PD) Testing in Immunocompromised Patients
Favorite
3:15 PM – 4:15 PM
(13-253) Intermountain Medication Assistance Program and its Benefit on Medication Adherence
Favorite
3:15 PM – 4:15 PM
(13-254) Bolus Dose of Intravenous Vancomycin vs Oral Anti-methicillin Resistant Staphylococcus Aureus Agents for Uncomplicated Skin and Soft Tissue Infections
Favorite
3:15 PM – 4:15 PM
(13-255) Lithium and Non-Steroidal Anti-Inflammatory Drug Interaction Alert Implementation: Retrospective Quality Improvement Study
Favorite
3:15 PM – 4:15 PM
(13-256) Downstream Effects of Boarding Crisis Patients in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-257) Evaluation of ESR and CRP Serial Monitoring for ID OPAT Patients
Favorite
3:15 PM – 4:15 PM
(13-258) Analgosedation differences by biological sex in mechanically ventilated patients with acute respiratory distress syndrome
Favorite
3:15 PM – 4:15 PM
(13-259) Comparison of Amoxicillin versus Alternative Therapy for Ampicillin-Susceptible Enterococcal Uncomplicated Bacteremia
Favorite
3:15 PM – 4:15 PM
(13-260) Effects of Treating Asymptomatic Bacteriuria in Older Patients Admitted to the Trauma Service at a Large Urban Hospital
Favorite
3:15 PM – 4:15 PM
(13-261) Retrospective Review of Clinical Outcomes when Comparing Tirzepatide to Dulaglutide in Adult Type 2 Diabetes Mellitus at Intermountain Health
Favorite
3:15 PM – 4:15 PM
(13-262) Bolus-only Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement
Favorite
3:15 PM – 4:15 PM
(13-263) Retrospective Descriptive Study of Concomitant Sildenafil Administration with Intravenous Nitric Oxide Donors within a Pediatric Population
Favorite
3:15 PM – 4:15 PM
(13-264) Evaluation of High-dose versus Standard-dose of Daptomycin with methicillin-sensitive Staphylococcus aureus (MSSA) Bloodstream Infections
Favorite
3:15 PM – 4:15 PM
(13-265) Baseline Evaluation of the Management of Bacteremia in Patients Discharged from the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-266) Outcomes of Conversion to Belatacept in Renal Transplant Recipients
Favorite
3:15 PM – 4:15 PM
(13-267) Evaluation of Naloxone Requirements in Patients with Reported Heroin Balloon Ingestion During Police Apprehension
Favorite
3:15 PM – 4:15 PM
(13-268) Variability in Nursing Analgosedation Practices in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome
Favorite
3:15 PM – 4:15 PM
(13-269) Aneurysmal Subarachnoid Hemorrhage Risk Assessment Model to Identify Patients for Early Discharge
Favorite
3:15 PM – 4:15 PM
(13-270) Incidences of Ifosfamide Related Adverse Effects with Concomitant Fosaprepitant or Aprepitant Administration at a Pediatric Hospital
Favorite
3:15 PM – 4:15 PM
(13-271) Implementation of a Pediatric Seizure Guideline in the Emergency Room
Favorite
3:15 PM – 4:15 PM
(13-272) Implementation of Pharmacy-Led Delirium Guidelines in an Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-273) Respiratory PCR Panel Use and Antibiotic Prescribing in Pediatric Patients in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-274) Comparison of Two Electronic Glucose Management Algorithms in the Treatment of Diabetic Ketoacidosis in Adult Patients
Favorite
3:15 PM – 4:15 PM
(13-275) Impact of Rapid Polymerase Chain Reaction Diagnostic Testing on Vancomycin De-Escalation in Methicillin-Susceptible Staphylococcus Aureus Bacteremia: Insights from a Small Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-276) Evaluation of Safety Event Classification Education on the Accuracy of Medication Event Scores
Favorite
3:15 PM – 4:15 PM
(13-277) Effect of an Albumin 5% Drug Shortage on Patient Outcomes in Elective Hip and Knee Joint Arthroplasty
Favorite
3:15 PM – 4:15 PM
(13-278) Economic Evaluation of Inhaled Respiratory Medication use at a Community Hospital (ECO-INSPIRE)
Favorite
3:15 PM – 4:15 PM
(13-279) Implementation of a Standardized Pharmaceutical Care Patient Assessment, Handoff, and Intervention Documentation Process for Pharmacists Rounding in a Community Hospital Medical Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-280) Comparison of Misoprostol and Dinoprostone for Labor Induction
Favorite
3:15 PM – 4:15 PM
(13-281) Evaluation of Intravenous Push Levetiracetam in Pediatrics
Favorite
3:15 PM – 4:15 PM
(13-282) Evaluation of Weight-Based Changes to an ACS Heparin Infusion Nomogram
Favorite
3:15 PM – 4:15 PM
(13-283) Evaluating the Rate of Acute Kidney Injury with Vancomycin Traditional Dosing (Trough-Based) versus Area Under the Curve/Minimum Inhibitory Concentration (AUC/MIC) Dosing
Favorite
3:15 PM – 4:15 PM
(13-284) Expansion of an Opioid Stewardship Program in the Community Hospital Setting
Favorite
3:15 PM – 4:15 PM
(13-285) It’s DAX Season: Evaluating the appropriate use of fidaxomicin for hospitalized patients
Favorite
3:15 PM – 4:15 PM
(13-286) Inpatient Utilization of Cancer Chemotherapy at a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-287) Review of non-standard direct-acting anticoagulant dosing for nonvalvular atrial fibrillation
Favorite
3:15 PM – 4:15 PM
(13-288) Determining the Impact of an Opioid Harm Reduction Tool in a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-289) Evaluation of Tisdale Risk Scoring to Identify Patients at High Risk for prolonged QT interval in a Multicenter Health System
Favorite
3:15 PM – 4:15 PM
(13-290) Effect of Palliative Chemotherapy in Hospitalized Adult Patients with Advance Solid Tumors
Favorite
3:15 PM – 4:15 PM
(13-291) Correlation Between Activated Partial Thromboplastin Time (aPTT) and Thromboelastography Reaction-Time (TEG R-time) in Patients on Extracorporeal Membrane Oxygenation (ECMO) and Bivalirudin
Favorite
3:15 PM – 4:15 PM
(13-292) Tenecteplase versus Alteplase Door-to-Needle Time in Acute Ischemic Stroke Managed with Thrombolytics
Favorite
3:15 PM – 4:15 PM
(13-293) Comparison of Bleeding Outcomes Between Unfractionated Heparin and Bivalirudin in Patients on Extracorporeal Membrane Oxygenation (ECMO)
Favorite
3:15 PM – 4:15 PM
(13-294) Correlation Between Anti-Xa Activity and Thromboelastography (TEG) Reaction (R) Time in Patients Receiving Unfractionated Heparin (UFH) on Extracorporeal Membrane Oxygenation (ECMO)
Favorite
3:15 PM – 4:15 PM
(13-295) Wrong Route Medication Errors: Opportunities for Improving Safety
Favorite
3:15 PM – 4:15 PM
(13-296) Medication Use of Insulin in the Transitions of Care Setting
Favorite
3:15 PM – 4:15 PM
(13-297) Urinary Tract Infection Diagnosis and Treatment in Emergency Department with Pharmacist-led Culture Call-back Program
Favorite
3:15 PM – 4:15 PM
(13-298) Identifying Opportunities to Prevent Opioid-related Harm in a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-299) Evaluating the Effect of Prescribing GLP-1 Receptor Agonists Alongside DPP-4 Inhibitors for Treatment of Type 2 Diabetes Mellitus
Favorite
3:15 PM – 4:15 PM
(13-300) Evaluation of Zoster Vaccine Recombinant Adjuvanted Immunization Rates Among Immunocompromised Patients Aged 19 to 49 Years in Oncology and HIV Clinics
Favorite
3:15 PM – 4:15 PM
(13-302) Implementation of a Detox Screening Tool Including Benzodiazepines, Opioids, and Alcohol Within an Integrated Healthcare System
Favorite
3:15 PM – 4:15 PM
(13-303) Evaluating the effectiveness of an electrolyte replacement protocol (ERP) at improving electrolyte levels for intensive care patients
Favorite
3:15 PM – 4:15 PM
(13-304) Developing a Palliative Care Pathway: An innovative standard of care for people living with dementia and their care team
Favorite
3:15 PM – 4:15 PM
(13-305) Evaluation of Glucose Control Through Insulin Therapy Management by Pharmacy Residents in a Community Medical Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-306) Continuous Glucose Monitoring Devices To Help Aid Patients With Type 2 Diabetes Increase Physical Activity
Favorite
3:15 PM – 4:15 PM
(13-307) Effect of a Reduced Maximum Default Propofol Infusion Rate on the Frequency of Propofol Related Infusion Syndrome Related Elements
Favorite
3:15 PM – 4:15 PM
(13-308) Belatacept for maintenance immunosuppression in heart transplant patients
Favorite
3:15 PM – 4:15 PM
(13-309) Evaluation of Antimicrobial Duration of Therapy Compared to Guidelines in a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-310) Appropriateness of Empiric Antibiotic Therapy for Treatment of Uncomplicated Cystitis at a Charitable Medical Clinic
Favorite
3:15 PM – 4:15 PM
(13-311) Glucagon Use for Acute Esophageal Impaction in the Emergency Department Setting
Favorite
3:15 PM – 4:15 PM
(13-312) Evaluation of Anemia Management with Erythropoiesis Stimulating Agents (ESAs) in Non-Intensive Care Units
Favorite
3:15 PM – 4:15 PM
(13-313) The Impact of Sodium Glucose Co-transporter 2 Inhibitors (SGLT2i) on Rates of Diabetic Ketoacidosis
Favorite
3:15 PM – 4:15 PM
(13-314) Medication Use Evaluation and Cost Analysis of Dinoprostone Versus Misoprostol for the Induction and Augmentation of Labor in a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-315) Actionable Alerts: Reducing Alert Fatigue in a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-316) Evaluation and assessment of patients in Confluence Health diagnosed with non-valvular atrial fibrillation not on oral anticoagulation.
Favorite
3:15 PM – 4:15 PM
(13-317) Pharmacy Integration into Health System Revenue Cycle Processes
Favorite
3:15 PM – 4:15 PM
(13-318) Implementing a Subcutaneous Insulin Calculator for Inpatient Glucose Control
Favorite
3:15 PM – 4:15 PM
(13-319) To MAOI-b or Not to MAOI-b? Assessing the Incidence of Major Serotonergic and Adrenergic Drug Interactions with Linezolid
Favorite
3:15 PM – 4:15 PM
(13-320) Evaluation of IV bisphosphonate treatment for hypercalcemia of malignancy in patients who present with an acute kidney injury and/or underlying chronic kidney disease.
Favorite
3:15 PM – 4:15 PM
(13-321) Impact of Electronic Prior Authorization (ePA) In the Medicare Population
Favorite
3:15 PM – 4:15 PM
(13-322) Prescriber Response to Change in Renal Function Post Sodium Glucose CoTransporter-2 Inhibitor (SGLT-2i) Therapy
Favorite
3:15 PM – 4:15 PM
(13-323) Implementation of a Pharmacist-Driven Culture Callback Program in a Pediatric Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-324) Assessing the Role of Pharmacist Intervention in Patients Initiating New Anticoagulation Therapy
Favorite
3:15 PM – 4:15 PM
(13-325) Expansion of Pharmacist Services in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-326) Implementation of Standardized Compounding Processes in an Electronic Health Record Across a Multi-Site Health System
Favorite
3:15 PM – 4:15 PM
(13-327) Implementation of an inpatient pharmacist credentialing and privileging process
Favorite
3:15 PM – 4:15 PM
(13-328) Impact of a Transitions of Care (TOC) Pharmacist at a Children’s Hospital
Favorite
3:15 PM – 4:15 PM
(13-329) Implementation of Pharmacist-Driven Medication Administration Protocol in Feeding Tube and Dysphagia Populations
Favorite
3:15 PM – 4:15 PM
(13-330) Pharmacist-Driven Penicillin Allergy De-Labeling and Oral Challenge in Hospitalized Patients
Favorite
3:15 PM – 4:15 PM
(13-331) Assessing the Need for a Vitamin D Supplementation Protocol through Dual-Energy X-Ray Absorptiometry (DXA) Monitoring in Pediatrics with Cancer
Favorite
3:15 PM – 4:15 PM
(13-332) Implementation of a Transitions of Care Pharmacist Service at a Community Access Hospital for Patients Transitioning to Hospice Care
Favorite
3:15 PM – 4:15 PM
(13-333) Implementation of a health system wide journal club to increase professional development among the pharmacy department
Favorite
3:15 PM – 4:15 PM
(13-334) Optimization of Clinical Pharmacy Services post-COVID in a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-335) Re-Initiation of a Meds-to-Beds Program at a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-336) Eliminate Paper-based Clinical Monitoring Processes
Favorite
3:15 PM – 4:15 PM
(13-337) Creation of a Pharmacist-Run Outpatient Antipsychotic Injection Service
Favorite
3:15 PM – 4:15 PM
(13-338) Development of Use Criteria for Non-formulary High-cost Medications in a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-339) Development and Implementation of Heparin Dosing by Pharmacists at PeaceHealth Southwest Medical Center
Favorite
3:15 PM – 4:15 PM
(13-340) Improving Allergy Documentation via Updates to Medication Reconciliation Interviews & Workflow at PeaceHealth St John Medical Center
Favorite
3:15 PM – 4:15 PM
(13-341) Developing an Antibiotic Allergy De-Labeling Protocol at St. John Medical Center (SJMC)
Favorite
3:15 PM – 4:15 PM
(13-342) Assessment of Antibiotic Usage and Potential Interventions in a Community Hospital Setting
Favorite
3:15 PM – 4:15 PM
(13-343) Optimizing Hyponatremia Management with Hypertonic Saline 3%: Developing a Guide for Pharmacists at a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-344) Development and Implementation of a Pharmacist-Led Drug Dosing Protocol for Critically Ill Patients on Prolonged Intermittent Renal Replacement Therapy in the Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-345) Optimizing Ceftriaxone Utilization for Definitive Treatment in Urinary Tract Infections
Favorite
3:15 PM – 4:15 PM
(13-346) Impact of a Collaborative Transitions of Care Clinic on Readmission Rates
Favorite
3:15 PM – 4:15 PM
(13-347) Clinical pharmacists' impact on population health outcomes in primary care
Favorite
3:15 PM – 4:15 PM
(13-348) Current Gaps in Medication Management for Inpatient and Emergency Department Behavioral Health Patients
Favorite
3:15 PM – 4:15 PM
(13-349) Improving Pharmacy Team Response During Mass Casualty Incident and EMR Downtime
Favorite
3:15 PM – 4:15 PM
(13-350) Pathway for Pharmacy Recommendations in Management of Tumor Lysis Syndrome
Favorite
3:15 PM – 4:15 PM
(13-351) Dalbavancin Pathway in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-352) Assessing the Impact of A Pharmacist-Led Multiple Sclerosis Service
Favorite
3:15 PM – 4:15 PM
(13-353) Standardization of a Treatment Pathway for Management of Febrile Neutropenia in Adult Oncology Population
Favorite
3:15 PM – 4:15 PM
(13-354) Establishing a Comprehensive Pharmacist-Driven Intravenous to Oral Medication Interchange Protocol in the Pediatric Population
Favorite
3:15 PM – 4:15 PM
(13-355) Development of a Standardized Venous Thromboembolism Prophylaxis Protocol in the Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-356) Implementation of a Peri-Operative Antibiotic Optimization Protocol
Favorite
3:15 PM – 4:15 PM
(13-357) Expansion of the Post Discharge Pharmacist Driven Protocol to Include Treatment of Sexually Transmitted Infections in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-358) Enhancing Current Processes for Anemia Management in a Pharmacist Led Ambulatory Care Setting
Favorite
3:15 PM – 4:15 PM
(13-359) Assessing the Impact of Adding Pharmacy Services to an Interdisciplinary Fall Prevention Team on Secondary Falls in Community-dwelling Older Adults
Favorite
3:15 PM – 4:15 PM
(13-360) Implementation of a Pharmacist-Led Positive Culture Protocol for Discharged Emergency Department Patients
Favorite
3:15 PM – 4:15 PM
(13-361) Impact of Pharmacist Intervention on Reducing Hospital Readmission Rates for Patients Transitioning to Skilled Nursing Facilities
Favorite
3:15 PM – 4:15 PM
(13-362) Pharmacist-led Education to Optimize Patient Medication History Processes
Favorite
3:15 PM – 4:15 PM
(13-363) Optimization of laboratory draw workflow in a Pharmacist-Led Osteoporosis Pharmaceutical Care Clinic
Favorite
3:15 PM – 4:15 PM
(13-364) Pharmacist-Driven Asthma Management Service in the Ambulatory Care Setting
Favorite
3:15 PM – 4:15 PM
(13-365) Optimizing Standard Operating Procedures to Improve Pharmacy Staff Workflow and Patient Care
Favorite
3:15 PM – 4:15 PM
(13-366) Implementation of Surface Sampling and Design of Compounded Sterile Products (CSPs) Quality Assurance
Favorite
3:15 PM – 4:15 PM
(13-367) Implementation of a Virtual Carousel at a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-368) Designing and Implementing Medication Safety Information Sheets With Nurses to Increase Interdepartmental Communication
Favorite
3:15 PM – 4:15 PM
(13-369) Integration of Clinical Pharmacist Services in the Pediatric Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-370) Implementation of Medication Optimization and Discharge Education for Patients with Heart Failure
Favorite
3:15 PM – 4:15 PM
(13-371) Evaluating the Safety and Efficacy of a Pharmacist-Driven Protocol to De-escalate Antibiotics for Pneumonia in the Intensive Care Unit
Favorite
3:15 PM – 4:15 PM
(13-372) Evaluating the Safety and Efficacy of Using Clindamycin vs. Linezolid for Necrotizing Fasciitis
Favorite
3:15 PM – 4:15 PM
(13-373) Evaluation of Patient Outcomes from Critical Care Insulin Sliding Scale Order Set
Favorite
3:15 PM – 4:15 PM
(13-374) Infusion clinic revenue integrity: optimization of the medication prior authorization process
Favorite
3:15 PM – 4:15 PM
(13-375) Establish and Implement a Standardized Dosing Protocol for Phenobarbital Use in Alcohol Withdrawal
Favorite
3:15 PM – 4:15 PM
(13-376) Implementation of a Standard Pharmacy Operating System within Health System Retail and Specialty Pharmacies
Favorite
3:15 PM – 4:15 PM
(13-377) Infusion Clinic Revenue Integrity: Reconciling Medical Necessity Criteria
Favorite
3:15 PM – 4:15 PM
(13-378) Vancomycin Utilization- Evaluating Trough Goals vs Area Under the Curve
Favorite
3:15 PM – 4:15 PM
(13-379) Prospective Pharmacist Review of Antibiotics at Discharge
Favorite
3:15 PM – 4:15 PM
(13-380) Transitional Care Protocol for Patients Needing Short Course Infusions or Injectables
Favorite
3:15 PM – 4:15 PM
(13-381) Evaluation and Optimization of Computer-Directed IV Insulin Algorithm Therapy and Transition to Subcutaneous Therapy
Favorite
3:15 PM – 4:15 PM
(13-382) Standardization of Pharmacist Population Health Workflow and Metrics Reporting
Favorite
3:15 PM – 4:15 PM
(13-383) Development of Division-Wide Protocol To Identify and De-Label Admitted Patients With Reported Penicillin Allergy
Favorite
3:15 PM – 4:15 PM
(13-384) Standardizing Virginia Mason Franciscan Health Patient Medication Assistance Program Protocol
Favorite
3:15 PM – 4:15 PM
(13-385) Linezolid Versus Vancomycin in the Treatment of Skin and Soft Tissue Infections
Favorite
3:15 PM – 4:15 PM
(13-386) Predictors, disparities, and prescription patterns of kidney protective medications among patients with diabetes and chronic kidney disease
Favorite
3:15 PM – 4:15 PM
(13-387) Impact of a Standardized Pharmacy-led Infection Diseases Protocol to optimize Inpatient Antiretroviral Therapy (ART)
Favorite
3:15 PM – 4:15 PM
(13-388) Adjunctive use of Clindamycin in the Treatment of Pulmonary and Skin Infections Among Intensive Care Unit (ICU) Patients
Favorite
3:15 PM – 4:15 PM
(13-389) Safety and efficacy of SGLT2 Inhibitors and nitrate combination therapy versus nitrate monotherapy among heart failure patients at a Community Teaching Hospital
Favorite
3:15 PM – 4:15 PM
(13-390) The Impact of Sickle Cell Disease Order Set in Pain Management in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-391) Assessment of Time in Therapeutic INR Range Post-Implementation of Pharmacist Warfarin Dosing in Left Ventricular Assist Device (LVAD) Clinic
Favorite
3:15 PM – 4:15 PM
(13-392) Neonatal Intensive Care Unit (NICU) Antimicrobial Stewardship focusing on ampicillin and gentamicin for early-onset neonatal sepsis (EONS) empiric treatment at MedStar Washington Hospital Center (MWHC)
Favorite
3:15 PM – 4:15 PM
(13-393) Evaluation of a Modified Venous Thromboembolism Prophylaxis Protocol Utilizing Higher Doses of Enoxaparin and Anti-Xa Levels in Burn Patients
Favorite
3:15 PM – 4:15 PM
(13-394) Operational, economic, and clinical outcomes of real-world conversion from peg-filgrastim On-Body Injector (OBI) to peg-filgrastim biosimilars in an outpatient oncology setting
Favorite
3:15 PM – 4:15 PM
(13-395) The implementation of an in-house endocrine service impact on glycemic control of admitted diabetic patients
Favorite
3:15 PM – 4:15 PM
(13-396) Assessing the Efficacy of Intravenous Ketamine and Lidocaine as Non-Opioid Alternatives for Acute Pain Management in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-397) Implementation of Pharmacist-Led Meds2Beds Service Improvement Initiative and the Impact on Older Adults
Favorite
3:15 PM – 4:15 PM
(13-398) Single-Center, Retrospective, Observational Study to Assess Utilization of a Pediatric Hypoglycemia Protocol at a Children's Hospital
Favorite
3:15 PM – 4:15 PM
(13-399) Association Between Alternative Alpha-2 Adrenoreceptor Agonists After Dexmedetomidine Infusion and Rebound Hypertension or Tachycardia in Adult and Pediatric Patients: A Retrospective Cohort Study
Favorite
3:15 PM – 4:15 PM
(13-400) Assessing antidote inventory management at a West Virginia regional academic medical center
Favorite
3:15 PM – 4:15 PM
(13-401) Hydroxocobalamin for vasoplegia following cardiothoracic surgery
Favorite
3:15 PM – 4:15 PM
(13-402) Antibiotic Prophylaxis for Prevention of Central Nervous System Infections for Patients with Pneumocephalus
Favorite
3:15 PM – 4:15 PM
(13-403) MRSA Decolonization Protocol and its Impact on Negative Predictive Value of MRSA Screens
Favorite
3:15 PM – 4:15 PM
(13-404) Angiotensin II as a Third-Line Vasopressor in Septic Shock
Favorite
3:15 PM – 4:15 PM
(13-405) Belatacept Outcomes after Conversion from Tacrolimus in Kidney Transplant Recipients
Favorite
3:15 PM – 4:15 PM
(13-406) Assessing the Benefits and Costs of Obtaining Follow-up Blood Cultures for Gram-negative Bacteremia After Initiation of Appropriate Antibiotic Therapy
Favorite
3:15 PM – 4:15 PM
(13-407) Evaluation of Treatment Incidence of PCR Positive/Toxin Negative Clostridioides Difficile Infections
Favorite
3:15 PM – 4:15 PM
(13-408) Incidence of hyperchloremia with isotonic saline use in pediatric patients
Favorite
3:15 PM – 4:15 PM
(13-409) A Review of the Effects Patient Financial Assistance has on Glycemic Control in Patients with Type I and Type II Diabetes Mellitus
Favorite
3:15 PM – 4:15 PM
(13-410) Retrospective Evaluation of Succinylcholine vs. Rocuronium in Patients with Traumatic Brain Injury
Favorite
3:15 PM – 4:15 PM
(13-411) Assessment of Glycemic Control in Patients with Combined Continuous Glucose Monitoring and Pharmacist Intervention
Favorite
3:15 PM – 4:15 PM
(13-412) Implementation and optimization of safety considerations for push dose vasopressors in the community hospital setting
Favorite
3:15 PM – 4:15 PM
(13-413) Impact of emergency department diuretic regimen and adjunctive agents for patients with heart failure on length of stay and readmission rate at a community hospital.
Favorite
3:15 PM – 4:15 PM
(13-414) Evaluation of a new standardized vancomycin dosing algorithm across Ascension Wisconsin Hospitals
Favorite
3:15 PM – 4:15 PM
(13-415) Norepinephrine Thresholds and Secondary Vasopressor Strategies: A Comparative Study
Favorite
3:15 PM – 4:15 PM
(13-416) Assessment of antibiotic usage in Emergency Department Patients treated for suspected Urinary Tract Infection
Favorite
3:15 PM – 4:15 PM
(13-417) Treating Asymptomatic Hypertension in the Inpatient Setting
Favorite
3:15 PM – 4:15 PM
(13-418) Evaluation of Blood Pressure Control After Intravenous Thrombolytic Administration in Acute Ischemic Stroke
Favorite
3:15 PM – 4:15 PM
(13-419) Pharmacist-Driven Medication Management in Patients with Cirrhosis
Favorite
3:15 PM – 4:15 PM
(13-420) Pre-Post Implementation of an Alcohol Withdrawal Order Set in an Inpatient Setting in a Statewide Community Hospital Health System
Favorite
3:15 PM – 4:15 PM
(13-421) Antipsychotic utilization in the intensive care unit and in transitions of care
Favorite
3:15 PM – 4:15 PM
(13-422) Examining Migraine Management by Primary Care Providers in Migraine Related Emergency Department Visits in a Statewide Community/Hospital Health System
Favorite
3:15 PM – 4:15 PM
(13-423) Impact of Glucagon-like Peptide 1 Receptor Agonists (GLP-1) Use on Patient Outcomes Throughout a Statewide Healthcare System
Favorite
3:15 PM – 4:15 PM
(13-424) Development of a Systemwide Protocol and Training Program for Non-Sterile Compounding in Compliance with USP Guidelines
Favorite
3:15 PM – 4:15 PM
(13-425) Managing Bispecific T-Cell Engager Toxicities in a Community Health System: Expanding Education Beyond Oncology
Favorite
3:15 PM – 4:15 PM
(13-426) Establishment of a Collaborative Screening Process and Buprenorphine Treatment Guideline for Opioid Use Disorder in an Acute Care Setting
Favorite
3:15 PM – 4:15 PM
(13-427) Development of Antimicrobial Stewardship Education and Competency for Clinical Pharmacists at a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-428) Impact of Pharmacist-managed Urine Culture Review at a Community Hospital Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-429) Incidence of cytomegalovirus (CMV) viremia and adverse effects of valganciclovir following dosing strategy using renal function and body-surface area in the pediatric kidney transplant population
Favorite
3:15 PM – 4:15 PM
(13-430) Low versus High Dose Clopidogrel for Prophylaxis in Pediatric Patients Following Cardiac Catheterization
Favorite
3:15 PM – 4:15 PM
(13-431) Evaluation of time to positive blood cultures to determine optimal empiric antibiotic duration for neonatal sepsis evaluation
Favorite
3:15 PM – 4:15 PM
(13-432) Oral breast cancer therapy interventions in an integrated health system: Analysis of patient acceptance rate of clinical pharmacist interventions during medication consultations
Favorite
3:15 PM – 4:15 PM
(13-433) Evaluating Prescriber Acceptance Rates for Pharmacist Interventions in Health System Specialty Pharmacy Patients
Favorite
3:15 PM – 4:15 PM
(13-434) Development and Implementation of a Urinary Tract Infection Treatment Guideline for Pediatric Patients within a Rural Health System
Favorite
3:15 PM – 4:15 PM
(13-435) Implementation of a Clinical Guideline for Rasburicase in Management of Tumor Lysis Syndrome in a Rural Health System
Favorite
3:15 PM – 4:15 PM
(13-436) Retrospective Cohort Study Evaluating the Efficacy of Low-dose Naltrexone in Patients Managed in a Rural Health Center Pain Clinic
Favorite
3:15 PM – 4:15 PM
(13-437) Impact of a Pharmacist Led Comprehensive Medication Management Review in Patients with Type 2 Diabetes in a Rural Health Care Setting
Favorite
3:15 PM – 4:15 PM
(13-438) Comparing Commercial Pharmacogenomic Testing Results and Recommendations with Established Guidelines
Favorite
3:15 PM – 4:15 PM
(13-439) Incorporation of a Clinical Pharmacist into Care of Patients with Cystic Fibrosis in a Rural Health Care Setting
Favorite
3:15 PM – 4:15 PM
(13-440) Pharmacoeconomic Analysis of Vancomycin versus Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia
Favorite
3:15 PM – 4:15 PM
(13-441) GLP-1 RA’s... Are you getting a bang for your buck?
Favorite
3:15 PM – 4:15 PM
(13-442) Optimization of Urinary Tract Infection Antibiotics in the Emergency Department
Favorite
3:15 PM – 4:15 PM
(13-443) Optimizing the Acute Coronary Syndrome Heparin Dosing Protocol at a Community Hospital
Favorite
3:15 PM – 4:15 PM
(13-444) Evaluating the Safety of High-Dose Levetiracetam Load for Status Epilepticus and Undiluted Intravenous (IV) Administration
Favorite
3:15 PM – 4:15 PM
(13-445) Establishing a Pharmacist-Assisted Buprenorphine-Naloxone Induction and Maintenance Service
Favorite
3:15 PM – 4:15 PM
(13-446) The Impact of Pharmacogenomic Testing on PHQ-9 Scores in Patients with Depression
Favorite
3:15 PM – 4:15 PM
(13-447) Analyzing insurance coverage for vedolizumab prescribing at non-every 8 weeks intervals
Favorite
3:15 PM – 4:15 PM
(13-448) Implementation of Systemwide Standardized Admission Medication History Process Including Education and User Competency Evaluation
Favorite
3:15 PM – 4:15 PM
(13-449) Enoxaparin vs. Unfractionated Heparin in Acute Coronary Syndrome: Assessing Utilization and Providers' Perspectives
Favorite
3:15 PM – 4:15 PM
(13-450) Efficacy of Angiotensin II for Refractory Vasoplegic Shock after Cardiothoracic Surgery
Favorite
3:15 PM – 4:15 PM
(13-451) Impact of a Pharmacist-led Antimicrobial Stewardship Workflow and Provider-focused Education in the Emergency Department on the Treatment of Urinary Tract Infections
Favorite
3:15 PM – 4:15 PM
(13-452) Impact of a Pharmacist-Driven Aminoglycoside Dosing Protocol
Favorite
3:15 PM – 4:15 PM
(13-453) Clinical pharmacist implementation into UnityPoint Health – Meriter maternal fetal medicine (MFM) clinic workflow
Favorite
3:15 PM – 4:15 PM
(13-454) Reduced Dosing of Intravenous (IV) Regular Insulin for the Treatment of Hyperkalemia
Favorite
3:15 PM – 4:15 PM
(13-455) Analysis of Automated Dispensing Cabinet Override Rates
Favorite
3:15 PM – 4:15 PM
(13-456) Effect of Scheduled Gabapentin and Acetaminophen on Opioid Use Post-Cardiothoracic Surgery
Favorite
3:15 PM – 4:15 PM
(13-457) Utilizing a Risk-Stratification Model to Evaluate Length of Stay in Chemotherapy-Induced Febrile Neutropenia within a Rural Community Hospital Setting
Favorite
3:15 PM – 4:15 PM
(13-458) Development of Referral Rate Optimization Tools for Specialty Pharmacy
Favorite
